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      Abstract 
The search for antifungal secondary metabolites from cruciferous plants exhibiting 
resistance to pathogenic fungi led to the investigation of Eruca sativa (rocket). Chemical 
analysis of extracts showed arvelexin (51) as the only inducible component. Bioassay 
guided isolation (FCC, PTLC) and characterization (NMR, MS) led to the identification 
of two phytoanticipins, 4-methylthiobutyl isothiocyanate (166) and bis(4-
isothiocyanatobutyl)disulfide (167). Compounds 166 and 167 inhibited the germination 
of spores of Cladosporium cucumerinum in TLC biodetection assays. 
Next, isotopically labeled compounds containing 2H and 34S at specific sites were 
synthesized for use in studying of the biosynthetic pathway of crucifer phytoalexins and 
indolyl glucosinolates. Among the synthesized precursors, [4',5',6',7'-2H4]indolyl-3-
[34S]acetothiohydroxamic acid (174a), the first sulfur-34 containing indolyl derivative 
was synthesized. In addition, non-isotopically labeled compounds (containing 1-methyl, 
1-boc and 1-acetyl groups), that is, substrates used for precursor-directed biosynthesis, 
were also prepared. 
With the precursors in hand, the biosynthetic pathway(s) and biogenetic 
relationship between phytoalexins was investigated using the tuberous crucifers, 
Brassica napus L. ssp rapifera (rutabaga) and B. rapa (turnip), and detached leaves of 
Erucastrum gallicum (dog mustard). The biosynthetic relationship between indolyl 
glucosinolates and phytoalexins was investigated in rutabaga and turnip. The indolyl 
moiety of the phytoalexins cyclobrassinin (28), rutalexin (33), spirobrassinin (34), 
brassicanate A (43), and rapalexin A (53), as well as indolyl glucosinolates 
glucobrassicin (70), 4-methoxyglucobrassicin (156), and neoglucobrassicin (199) was 
confirmed to derive from L-tryptophan (78). The 1-methoxy-containing phytoalexins, 
erucalexin (38) and 1-methoxyspirobrassinin (35) were shown to derive from indolyl-3-
acetaldoxime (112) through 1-methoxyindolyl-3-acetaldoxime (116). The 1-methoxy 
substituent of neoglucobrassicin was also shown to derive from 1-methoxyindolyl-3-
acetaldoxime (116). 
The incorporation of indolyl-3-acetothiohydroxamic acid (174) into the 
phytoalexins cyclobrassinin, rutalexin, brassicanate A, rapalexin A, and spirobrassinin, 
and into the glucosinolate glucobrassicin is reported for the first time. On the other hand, 
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incorporation of 174 into 4-methoxyglucobrassicin and neoglucobrassicin was not 
detected under current experimental conditions. Cyclobrassinin was incorporated into 
spirobrassinin among the NH-containing phytoalexins, whereas sinalbin B (31) 
[biosynthesized from 1-methoxybrassinin (18)] was incorporated into erucalexin and 1-
methoxyspirobrassinin. The efficient metabolism of [SC2H3]brassicanal A into 
[SC2H3]brassicanate A suggested a biogenetic relationship between these two 
phytoalexins, whereas absence of incorporation of indolyl-3-acetonitrile (49) into 
rutabaga phytoalexins or indolyl glucosinolates indicated that 49 is not a precursor of 
these secondary metabolites under the current experimental conditions. 
The rutabaga and turnip tubers separately metabolized 1-methylindolyl-3-
acetaldoxime (170) and 1-methylindolyl-3-acetothiohydroxamic acid (178) into 1-
methylglucobrassicin (201); however, no 1-methyl-containing phytoalexins were 
detected in the extracts. Rutabaga tissues metabolized 1-(tert-butoxycarbonyl)indolyl-3-
methylisothiocyanate (180) into 1-(tert-butoxycarbonyl)brassinin (181) and 1-(tert-
butoxycarbonyl)spirobrassinin (196), whereas 1-acetylbrassinin (184) was the only 
detectable metabolic product of 1-acetylindolyl-3-methylisothiocyanate (183) in both 
rutabaga and turnip root tissues. 
In conclusion, indolyl-3-acetothiohydroxamic acid (174) seems to be the branching 
point between brassinin and glucobrassicin. The biosynthetic pathway of NH-containing 
crucifer phytoalexins was mapped and follows the sequence L-tryptophan, indolyl-3-
acetaldoxime, indolyl-3-acetothiohydroxamic acid, brassinin (possibly through indolyl-
3-methylisothiocyanate), and other phytoalexins. The biosynthetic pathway of 1-
methoxy-containing phytoalexins follows a similar sequence through 1-methoxyindolyl-
3-acetaldoxime (biosynthesized from indolyl-3-acetaldoxime). 
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CHAPTER 1  
1. Introduction 
1.1 General objectives 
Plants belonging to the family Brassicaceae biosynthesize de novo, indolyl 
phytoalexins of diverse chemical structures in response to various forms of stress 
(Pedras et al., 2007b). This family is also known to produce phytoanticipins including 
indolyl glucosinolates (Fahey et al., 2001), a class of secondary metabolites that is a part 
of the complex chemical defense system that these plants use to protect themselves 
against various forms of stress including microbial attack (Halkier and Gershenzon, 
2006). Many crucifers are susceptible to pathogenic fungal diseases such as blackspot, 
blackleg, clubroot, stem rot, and root rot among others, leading to massive yield losses 
and low food production for the growing world population. Some crucifers (wild and 
cultivated) that are resistant to devastation by some of the fungal diseases have been 
identified (Conn et al., 1988; Gugel et al., 1990; Lefol et al., 1997; Pedras and Zaharia, 
2000). Some of the resistant crucifers produce phytoalexins with unique structural 
characteristics, and possessing remarkable antifungal activity against a variety of 
pathogens (Pedras et al., 2007b; 2007c). Such resistant species may provide a good 
genetic source for controlling the devastating effect of the various fungal pathogens. The 
identification and structural characterization of the various phytoalexins provides an 
opportunity for the synthesis of precursors to study their biosynthetic pathway(s). An 
understanding of the biosynthetic pathway(s) of secondary metabolites produced by 
resistant crucifers may facilitate the transfer of such pathway(s) to the susceptible 
species, allowing them to produce similar secondary metabolites that may confer 
resistance to pathogens (Dixon, 2005). Due to environmental impact of synthetic 
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chemical compounds, such genetic manipulations provide an alternative to protecting 
crop plants against various pathogens, in addition to design and synthesis of safe crop 
protecting agents (Pedras et al., 2007f; Pedras and Hossain, 2006). 
Objectives of my research were: 
(1) Investigation of the antifungal secondary metabolites of Eruca sativa 
(rocket). 
(2) Investigation of the biosynthetic pathways of phytoalexins produced in 
Erucastrum gallicum (dog mustard). 
(3) Investigation of the biosynthetic pathway(s) of phytoalexins and indolyl 
glucosinolates produced in Brassica napus L. ssp rapifera (rutabaga), and 
B. rapa (turnip). 
The research above included: 
(1) Syntheses of isotopically labeled (2H and 34S) precursors for the study of 
biosynthetic pathway(s) and biogenetic relationship of crucifer 
phytoalexins and indolyl glucosinolates. 
(2) Syntheses of non-natural indolyl-based precursors as probes for the 
biosynthetic pathway(s) of crucifer phytoalexins and indolyl 
glucosinolates. 
 
1.2 Plant secondary metabolites 
Plants, like all other living organisms, possess primary metabolic pathways by 
which they synthesize and utilize essential compounds such as sugars, amino acids, 
common fatty acids, and nucleotides for their normal growth, development and 
reproduction. These chemical compounds are generally referred to as primary 
metabolites. Plants also have secondary metabolic pathways by which they produce 
compounds (secondary metabolites) that are not essential for their basic metabolic 
processes, but are necessary for their survival ability. Secondary metabolite production 
may be activated during particular stages of growth and development, their importance is 
of an ecological nature as they can mediate interactions such as plant-plant, plant-insect, 
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plant-microbial and plant-animal. There are three principal building blocks for secondary 
metabolites: (i) shikimic acid, the precursor of many aromatic compounds including 
aromatic amino acids and various polyphenols, (ii) amino acids giving rise to alkaloids 
and peptide antibiotics, (iii) acetate, precursor of polyacetylenes, polyphenols, and 
isoprenoids (Mann, 1994). Some of these precursors are also utilized in the biosynthesis 
of certain primary metabolites such as proteins and fatty acids. Secondary metabolic 
pathways are products of the genetic make-up of the producing organisms (Mann, 1994). 
Their production and distribution is limited within a group of closely related species, 
thus making them important chemotaxonomic markers. For example, the plant genus 
Potentilla with more than 300 species in the family Rosaceae was characterized by the 
occurrence of certain polyphenolic and triterpenoid compounds. The common 
occurrence of ellagic acid and its derivatives in Potentilla is thought to be of taxonomic 
importance in this genus (Tomczyk, 2006; Xue et al., 2005). The plant genus Ligularia 
in the family Compositae comprises of about 100 species. The species within Ligularia 
were chemotaxonomically characterized by the presence of typical pyrrolizidine 
alkaloids and sesquiterpenoids. Moreover, many genera within Compositae are known to 
contain bisaboline sesquiterpenoids (Tan et al., 2007). Classification of the genera 
Stemona and Croomia within the plant family Stemonaceae was not complete because 
some specialists thought that they should be separated (Jiang et al., 2006). 
Chemotaxonomic investigation of the two genera, Stemona and Croomia revealed that 
they both produce stemona alkaloids that are only found in the family Stemonaceae in 
the plant kingdom. It was therefore proposed that the two genera belong to the same 
family as they had been placed and should not be separated (Jiang et al., 2006). These 
examples reveal the importance of secondary metabolites in the chemotaxonomy of plant 
kingdom. 
1.2.1 Plant chemical defenses 
Plants are continuously challenged by biotic and abiotic factors in their 
environment, both above and below the ground. Plants must therefore adapt to their 
environment for their survival. Part of this adaptation involves the evolutionary 
production of a diverse array of secondary metabolites to counter the various forms of 
 4 
challenges. The term allelopathy has been used to refer to chemical interaction between 
plants and their environment. This term is derived from the Latin words allelon ‘of each 
other’ and pathos ‘to suffer’ (Weir et al. 2004). Use of the term allelopathy has been 
extended from plant-plant interaction to microbe-microbe, plant-microbe, and plant-
insect or plant-herbivore chemical communication (Weir et al. 2004). Allelochemicals 
occur in aerial and sub aerial parts of the plant; they are delivered into the rhizosphere 
through volatile emissions, root exudation, foliar leaching and decomposing residue. 
These compounds can affect the growth and development of other neighboring plants, 
they act as feeding deterrents against herbivores, and they have antimicrobial activities. 
Due to the environment impact and human health concerns about synthetic pesticides 
and fungicides, the naturally occuring allelochemicals are receiving special attention for 
their applicability in agronomy (Dayan et al., 2000).  
One of the strongest known allelochemicals is (S)-3,4-dihydroxyphenylalanine (L-
DOPA, 1) (Nishihara et al., 2004), a non-protein amino acid and a precursor of alkaloids, 
phenylpropanoids, flavonoids, lignin, and melanin (Mann, 1994). L-DOPA is exuded by 
the roots of Mucuna pruriens (velvet beans), a tropical leguminous plant that has found 
among other uses, control of weeds (Nishihara et al, 2005). Velvet beans were found to 
be allelopathic to Lactuta sativa (lettuce). Chemical analysis showed that L-DOPA 
exuding from velvet bean roots inhibited lettuce radicle growth (Hachinohe and 
Matsumoto, 2005; Nishihara et al, 2005), and soybean root growth (Soares et al., 2007). 
L-DOPA was also shown to suppress carrot cell growth by 60% (Hachinohe and 
Matsumoto, 2005). Studies on the absorption, translocation, and metabolism of L-DOPA 
using susceptible (lettuce) and tolerant (Echinochloa crus-galli, barnyardgrass) plants 
suggested that L-DOPA is itself the active species-selective toxin and not its metabolic 
products (Hachinohe et al., 2004). 
 
CO2HHO
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Some invasive weeds use allelochemicals to displace other competing plant 
species. Acroptilon repens (Russian knapweed) and Centaurea maculosa (spotted 
knapweed) are two examples of successful exotic plants in North America that replace 
native plant species (Bais et al., 2003; Stermitz et al., 2003). Chemical analysis of the 
root exudates of Russian knapweed yielded 7,8-benzoflavone (2) as the allelopathic 
compound (Stermitz et al., 2003). 7,8-Benzoflavone was isolated from soil samples 
collected from areas infested with Russian knapweed; the concentration of 2 from the 
soil samples supported the previous claims that it is the active allelopathic compound 
that these plants use to invade the native plant species (Alford et al., 2007). In bioassays, 
7,8-benzoflavone caused mortality in plant species such as Gaillardia aristata, Linaria 
dalmatica, and Arobidopsis thaliana (Stermitz et al., 2003). The spotted knapweed, 
another successful invasive weed of North American plant species exudes from its roots 
a mixture of (-)-catechin (3) and (+)-catechin (4) (Bais et al., 2002; 2003; Perry et al., 
2005). (-)-Catechin exhibited allelopathic activity by inhibiting growth and germination 
of other native plant species, whereas (+)-catechin was inactive (Bais et al., 2002). The 
allelopathic activity of (-)-catechin was confirmed by its isolation together with (+)-
catechin from soil collected from spotted knapweed-invaded fields (Bais et al., 2002; 
2003; Perry et al., 2005). Interestingly, (+)-catechin (4) exhibited antibacterial activity 
against root-infesting pathogens, a property that (-)-catechin did not have. These 
observations suggested the biological significance of root exudation of the racemic 
mixture of catechins (Bais et al., 2002). One other example of successful invasive weed 
is Mikania micrantha (bittervine), a native to South and Central America that has 
become a serious problem in Southeast Asia and Pacific regions (Shao et al., 2005). 
Bittervine suppresses the growth of crops and trees in its neighborhood leading to their 
eventual death. Chemical analysis of aerial extracts of bittervine led to the isolation and 
identification of three compounds, dihydromikanolide (5), deoxymikanolide (6), and 2,3-
epoxy-1-hydroxy-4,9-germcradiene-12,8:15,6-diolide (7). All the three compounds were 
found to inhibit seed germination and radicle elongation of other plant species. The three 
compounds were therefore thought to be responsible for the allelopathic activity of 
bittervine (Shao et al., 2005). 
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Many Oryza sativa (rice) varieties inhibited growth of several plant species 
including weeds when they were grown together under field and/or laboratory 
conditions. These observations have suggested that probably rice produces and releases 
allelochemicals into the neighboring environment causing the inhibitory effect on other 
plant species (Kato-Noguchi, 2004; Kato-Noguchi and Ino, 2004; Kong et al., 2006). 
Chemical investigation of rice root exudates led to the isolation of momilactone B (8) as 
the possible allelopathic candidate. Momilactone B was previously isolated from rice 
leaves, husks and straw as growth inhibitor, Kato-Noguchi and co-workers (2002) later 
isolated momilactone B from rice root exudates for the first time. Bioassays revealed 
that momilactone B was an active allelopathic compound that inhibited the growth of 
lettuce, Lepidium sativum (cress), and Medicago sativa (alfalfa) (Kato-Noguchi et al., 
2002; 2004; Kato-Noguchi and Ino, 2004). 
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Plant secondary metabolites may also act as feeding and oviposition deterrents 
against specialized or generalized herbivores (Anaya et al., 2003; Harvey et al., 2005). 
One such plant species is the Callicarpa accuminata (alahualte), a shrub or small tree 
that was suspected to have allelopathic activity. Chemical investigation of alahualte leaf 
extracts led to the isolation and characterization of a number of secondary metabolites 
(Anaya et al., 2003). Laboratory testing of some of the secondary metabolites showed 
that methyl isopimaric acid (9), akhdarenol (10), and α-amyrin (11) had strong insect 
anti-feedant activity against Leptinotarsa decemlineata (Colorado potato beetle). These 
tests suggested that these compounds protect alahualte against herbivory by these beetles 
(Anaya et al., 2003). The fresh water plant Micranthemum umbrosum (baby tears) 
exhibited feeding deterrence to crayfish, a property that was thought to be due to 
allelopathic compounds produced by this plant species. Chemical analysis of whole plant 
extract led to the isolation of two compounds, elemicin (12), and β-apopicropodophyllin 
(13). In anti-feedant bioassays, the two compounds, 12 and 13, exhibited remarkable 
activity against crayfish, suggesting that they are the allelopathic components of baby 
tears (Lane and Kubanek, 2006). 
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A number of plants also respond to various forms of stress including microbial 
attack by producing de novo secondary metabolites that are generally referred to as 
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phytoalexins. The term phytoalexin was proposed to refer to defensive substances that 
plants produce during infection (Bailey and Mansfield, 1982). The term was coined from 
Greek words meaning, “warding-off agents in plants” (Bailey and Mansfield, 1982). 
Müller and co-workers established that infecting potato (Solanum tuberosum) tuber 
tissues with an incompatible race of Phytophthora infestans induces resistance to 
subsequent infection by inoculation with a compatible race of P. infestans or a tuber-
infecting Fusarium (Hammerschmidt, 1999). Based on these observations, it was 
hypothesized that the tuber tissues responded to the incompatible interaction by 
producing compounds (phytoalexins) that inhibited further growth of the pathogen as 
well as protecting the tissues against later infection (Hammerschmidt, 1999). Following 
the proposal of phytoalexin concept in 1940, the first antifungal compound that fit the 
definition of a phytoalexin, (+)-pisatin (14) was isolated a few years later from Pisum 
sativum (pea) pods inoculated with fungal spores of Moniliania fructiocola. Soon after, a 
closely related compound, (-)-phaseollin (15) was isolated from fungus-inoculated pods 
of Phaseolus vulgaris (beans) (Bailey and Mansfield, 1982). It was further established 
that phytoalexin production was not only elicited by biotic factors, but also abiotic 
factors such as mercuric or copper chloride spray (Bailey and Mansfield, 1982). 
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Figure 1.1 Chemical structures of (+)-pisatin (14) and (-)-phaseollin (15). 
 
Since isolation of the first two phytoalexins, many others have been isolated and 
identified from different plant families (Bailey and Mansfield, 1982). With the 
progresses in isolation, characterization and understanding of phytoalexins, a working 
definition for the term phytoalexin has been changed to “low molecular weight 
antimicrobial compounds produced by plants in response to infection or stress” (Kuć, 
14 15 
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1995). Besides microbial attack, phytoalexin accumulation may result from response to 
stress by elicitors such as inorganic salts, oligoglucans, ethylene, fatty acids, chitosan 
oligomers, and polypeptides (Kuć, 1995). The localization of phytoalexin production at 
the site of infection suggests the significant role played by these compounds in response 
to pathogen invasion (Dixon et al., 1994). 
1.3 Cruciferous chemical defenses 
Brassicaceae (syn. Cruciferae) is a plant family containing a large number of 
economically important crops generally referred to as crucifers. The cruciferous crops 
comprise cabbages (Brassica oleraceae var. capitata), a variety of vegetables such as 
broccoli (B. oleraceae var. botrytis), and kales (B. oleraceae var. acephala) among 
others. The crucifer family also comprises a number of economically important oilseeds 
canola and rapeseed (B. napus and B. rapa), and condiments such as mustards (B. 
juncea, B. carinata, Sinapis alba) and wasabi (Wasabiae japonica) that are cultivated 
and consumed worldwide (Pedras et al., 1998; 2000). Most of the cultivated crucifers are 
susceptible to a number of fungal diseases leading to massive yield losses. The disease 
resistance of cruciferous plants (like in many other plant species) can be attributed to 
complex metabolic processes involving both induced (phytoalexins) and constitutive 
(phytoanticipins) chemical defenses (Pedras and Sorensen, 1998; Pedras et al., 2000). 
A number of wild crucifers have been reported to exhibit resistance to a variety of 
crucifer pathogens. For example, Camelina sativa (false flax), Capsella bursa-pastoris 
(Shepherd’s purse) and Eruca sativa (rocket) were reported to exhibit resistance against 
Alternaria brassicae (Conn et al., 1988). Erucastrum gallicum (dog mustard) was 
reported to exhibit resistance against Sclerotinia sclerotiorum, a fungal pathogen that 
causes stem rot disease of crucifers and many other plant families (Lefol et al., 1997). 
Resistance of Thlaspi arvense (stinkweed/pennycress) against blackleg disease has also 
been reported (Gugel et al., 1990). The blackleg disease of crucifers is caused by the 
fungus Leptosphaeria maculans (Desm.) Ces et de Not. [asexual stage Phoma lingam 
(Tode ex Fr.) Desm.]. Some cultivated crucifers have been reported to exhibit resistance 
to the devastating effect of fungal pathogens. For example, Sinapis alba (white mustard) 
exhibited resistance to economically important diseases of crucifers such as Alternaria 
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blackspot and Phoma blackleg that are caused by the fungal pathogens A. brassicae and 
L. maculans/P. lingam, respectively (Pedras and Zaharia, 2000). 
1.3.1 Phytoalexins 
Crucifer phytoalexins were the first sulfur-containing phytoalexins reported 
(Takasugi et al., 1986). Brassinin (16), 1-methoxybrassinin (18), and cyclobrassinin (28) 
were isolated from Chinese cabbage (B. campestris L. ssp. pekinensis) following 
inoculation with the bacterium Pseudomonas cichorri (Takasugi et al., 1986) (Figure 
1.2). Since this first isolation, close to 40 crucifer phytoalexins have been reported 
(Figures 1.2). Several of these phytoalexins have been isolated and characterized from 
more than one plant species, and their elicitation by diverse pathogens and/or abiotic 
factors has been demonstrated (Pedras et al., 2007b). Considering the early development 
and wide use of dithiocarbamate fungicides and pesticides, it is interesting to note that 
crucifers are the only plants reported to produce compounds containing as toxophore a 
dithiocarbamate or thiocarbamate group (16, 17, 18, 19, 20) (Pedras et al., 2007b). A 
general structural characteristic among the crucifer phytoalexins includes the presence of 
an indole ring or derivative with substitution at C-3 and additional nitrogen or sulfur 
atoms (Figure 1.2). The only non-sulfur containing crucifer phytoalexins are methyl 1-
methoxyindole-3-carboxylate (47), caulexin B (48), indolyl-3-acetonitrile (49), caulexin 
C (50), arvelexin (51), and isalexin (52) (Figure 1.2). The synthesis and biosynthesis of 
crucifer phytoalexins was recently reviewed (Pedras et al., 2007b). Of the 40 crucifer 
phytoalexins isolated, erucalexin (38, isolated from dog mustard) is the first phytoalexin 
to have a carbon substituent at C-2, whereas all other phytoalexins have carbon 
substituents at C-3 (Pedras et al., 2006a; 2007b). In mycelial growth inhibition assays, 
erucalexin displayed remarkable potency against Rhizoctonia solani whereas its 
regioisomer 1-methoxyspirobrassinin (35) displayed higher inhibitory effect on S. 
sclerotiorum (Pedras et al., 2006a; Pedras et al., 2007b). Caulilexins A (42), B (48) and 
C (50) were isolated from cauliflower florets and displayed antifungal activity against 
Leptosphaeria maculans, R. solani and S. sclerotiorum in mycelial growth inhibition 
assays (Pedras et al., 2006b; 2007b). Caulilexin A (42) is the first known phytoalexin to 
possess a disulfide bridge and to date it is the most potent phytoalexin against S. 
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sclerotiorum (Pedras et al., 2006b; 2007b). Rapalexins A (53) and B (54) isolated from 
B. rapa (canola) represent the first known naturally occurring aromatic isothiocyanates 
(Pedras et al., 2007a; 2007b). Both 53 and 54 inhibited the germination of Albugo 
candida zoospores on impregnated cellulose membranes, rapalexin A was more potent 
than B (Pedras et al., 2007a). Wasalexins A (23) and B (24) were first isolated from 
wasabi (Pedras et al., 1999; 2007b), they were recently isolated from Thellungiella 
halophila (Pedras and Adio, 2007), whereas wasalexin A was also isolated from 
stinkweed (Pedras et al., 2003a). Wasalexin A displayed antifungal activity against 
isolates of L. maculans in mycelial growth inhibition assays (Pedras et al., 2003a; 
2007b), as well as inhibition of L. maculans spore germination (Pedras et al., 1999; 
2007b). Arvelexin (51), first isolated from stinkweed, displayed higher antifungal 
activity against R. solani than against L. maculans and S. sclerotiorum in mycelial 
growth inhibition assays (Pedras et al., 2003a; 2006b; 2007b). Sinalbins A (30) and B 
(31) were first isolated from white mustard (Pedras and Zaharia, 2000; 2007b). Sinalbin 
A displayed higher activity than sinalbin B in L maculans spore germination inhibition 
assays (Pedras and Zaharia, 2000; 2007b). The phytoalexins rutalexin (33), brassicanate 
A (43) and isalexin (52) were isolated from rutabaga tubers for the first time (Pedras et 
al., 2004; 2007b). At the same concentration, brassicanate A completely inhibited 
mycelial growth of L. maculans, R. solani and S. sclerotiorum, whereas isalexin only 
displayed moderate antifungal activity against L. maculans (Pedras et al., 2004; 2007b). 
Brassicanals A (39) and C (41) displayed high antifungal activity against L. maculans, 
but moderate activity against R. solani and S. sclerotiorum in mycelial growth inhibition 
assays (Pedras et al., 2006b; 2007b). The two compounds also inhibited conidial 
germination of Bipolaris leersiae (Monde et al., 1991a; Pedras et al., 2007b). Other 
phytoalexins that inhibited B. leersiae conidial germination include, brassicanal B (40) 
(Monde et al., 1990a; Pedras et al., 2007b), brassitin (17), 1-methoxyspirobrassinol (36), 
1-methoxyspirobrassinol methyl ether (37) (Monde et al., 1995b; Pedras et al., 2007b), 
dehydro-4-methoxycylobrassinin (32) (Monde et al., 1994b; Pedras et al., 2007b), 
dioxybrassinin (25) (Monde et al., 1991a; Pedras et al., 2007b), 1-methoxybrassenins A 
(21) and B (22) (Monde et al., 1991b; Pedras et al., 2007b), 1-methoxybrassinin (18), 1-
methoxybrassitin (20) (Takasugi et al., 1988; Pedras et al., 2007b), and 4-
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methoxybrassinin (19) (Monde et al., 1990b; Pedras et al., 2007b). The antifungal and 
antibacterial properties of camalexin (44) against many fungi and bacteria have been 
investigated (Pedras et al., 2007b). For example, camalexin displayed mycelial growth 
and spore germination inhibition of fungi L. maculans, and A. brassicae, as well as 
mycelial growth inhibition of phytopathogenic bacteria Pseudomona syringae, P. 
cichorii, Erwinia carotovora, and Xanthomonas campestris (Pedras et al., 1998b). The 
antifungal and antibacterial activity of 6-methoxycamalexin (45) was investigated with a 
similar range of phytopathogens as that of camalexin (44) (Pedras et al., 2007b), whereas 
1-methxylcamalexin (46) was found to inhibit germination of C. cucumerinum spores 
(Jimenez et al., 1997; Pedras et al., 2007b). Methyl 1-methoxyindole-3-carboxylate (47) 
inhibited L. maculans and Phoma wasabiae mycelial growth; it also inhibited spore 
germination of C. cucumerinum on TLC plates (Pedras et al., 2007b; Pedras and 
Sorensen, 1998). Cyclobrassinin (28) and spirobrassinin (34) displayed strong inhibitory 
effects on mycelial growth of A. brassicae and spore germination of C. cucumerinum, 
but the two phytoalexins exhibited moderate antifungal activity against L. maculans, R. 
solani, S. sclerotiorum, Botrytis cinerea, Fusarium nivale, and Pithium ultimum (Dahyia 
and Rimmer, 1988). The antifungal activity of cyclobrassinin (28) and spirobrassinin 
(34) against other fungal species has also been investigated (Pedras et al., 2007b). The 
structural difference between brassilexin (26) and sinalexin (27) is the presence of 1-
methoxy group in 27. The two phytoalexins displayed complete inhibition of mycelial 
growth in R. solani and S. sclerotiorum, but moderate antifungal activity against A. 
brassicae and L. maculans at same concentrations (Pedras and Zaharia, 2001). Sinalexin 
(27) also inhibited C. cucumerinum spore germination in TLC biodetection assays 
(Pedras and Smith, 1997). Production of 1-methoxy-containing phytoalexins in elicited 
stinkweed and white mustard indicates the role played by these phytoalexins as a part of 
defense response to pathogen invasion. Since the last review (Pedras et al., 2007b) one 
new phytoalexin, brussalexin A (55) was isolated from B. oleracea var. gemmifera 
(Brussels sprouts) (Pedras et al., 2007c). Brussalexin A is the first phytoalexin known to 
contain an allyl thiolcarbamate group, a skeletal structure that does not seem to fit with 
the presently known biosynthetic pathway of crucifer phytoalexins isolated to date 
(Figure 1.2) (Pedras et al., 2007b). In mycelial growth inhibition assays, brussalexin A 
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displayed higher inhibitory effect against S. sclerotiorum than against other pathogens 
Alternaria brassicicola, L. maculans, and R. solani (Pedras et al., 2007c). 
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Figure 1.2 Structure of cruciferous phytoalexins: brassinin (16), brassitin (17), 1-
methoxybrassinin (18), 4-methoxybrassinin (19), 1-methoxybrassitin (20), 1-
methoxybrassenin A (21), 1-methoxybrassenin B (22), wasalexin A (23), wasalexin B 
(24), dioxibrassinin (25), brassilexin (26), sinalexin (27), cyclobrassinin (28), 
cyclobrassinin sulfoxide (29), sinalbin A (30), sinalbin B (31), dehydro-4-
methoxycyclobrassinin (32), rutalexin (33), (S)-spirobrassinin (34), (R)-1-
methoxyspirobrassinin (35), 1-methoxyspirobrassinol (36), (2R,3R)-1-
methoxyspirobrassinol methyl ether (37), erucalexin (38), brassicanal A (39), brassicanal 
B (40), brassicanal C (41), caulilexin A (42), brassicanate A (43), camalexin (44), 6-
methoxycamalexin (45), 1-methylcamalexin (46), methyl 1-methoxyindole-3-
carboxylate (47), caulilexin B (48), indolyl-3-acetonitrile (49), caulilexin C (50), 
arvelexin (51), isalexin (52), rapalexin A (53), rapalexin B (54), brussalexin A (55) 
(Pedras et al., 2007b; 2007c). 
 
1.3.2 Phytoanticipins 
Constitutive chemical defenses exist in healthy plants in their biologically active 
form, or as inactive precursors that are activated in response to tissue damage or 
pathogen attack. The activation of these chemical defenses involves plant enzymes that 
breakdown the preformed compounds to release biologically active products (Osbourne, 
1996). The preformed compounds have been referred to as phytoanticipins in order to 
distinguish them from phytoalexins (biosynthesized de novo), the name phytoanticipins 
was coined by Mansfield (VanEtten et al., 1994). Phytoanticipins were thus defined as 
“low molecular weight antimicrobial compounds that are present in plants before 
challenge by microorganism or are produced after infection solely from preexisting 
constituents” (VanEtten et al., 1994). A large number of phytoanticipins exhibit 
antifungal activity and these include phenols and phenolic glycosides, unsaturated 
lactones, sulfur compounds, saponins, cyanogenic glycosides, and glucosinolates 
(Osbourne, 1996). 
Since the isolation of the first two glucosinolates sinigrin (56) and sinalbin (57) 
(Figure 1.3) from black (B. nigra) and white (S. alba) mustard seeds, respectively, in the 
1980s, about 120 glucosinolates have been isolated and characterized (Fahey et al., 
2001; Halkier and Gershenzon, 2006). The importance of these nitrogen- and sulfur-
containing compounds has increased following their discovery as potential cancer-
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preventing agents, crop-protection compounds, and biofumigants in agriculture (Halkier 
and Gershenzon, 2006; Sarwar et al., 1998). Although glucosinolates have been reported 
almost exclusively from the order Capparales, which contain 15 families including 
Brassicaceae, some glucosinolates have been isolated from the genus Drypetes from the 
family Euphorbiaceae that is completely unrelated to other glucosinolate containing 
families (Halkier and Gershenzon, 2006). Structurally glucosinolates are β-D-
thioglucoside N-hydroxysulfates also know as (Z)-N-hydroximinosulfate esters or S-
glucopyranosyl thiohydroximates with a side chain R (58) (Figure 1.3, Fahey et al., 
2001; Halkier and Gershenzon, 2006). 
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Figure 1.3 Chemical structures of sinigrin (56), sinalbin (57), and glucosinolates 
(58). 
 
Glucosinolates are derived from one of the eight amino acids and are classified by 
their precursor amino acids and types of modification to the side chain (Halkier and 
Gershenzon, 2006). Those derived from alanine, leucine, isoleucine, methionine, or 
valine are called aliphatic glucosinolates, those derived from phenylalanine and tyrosine 
are called aromatic glucosinolates, and those derived from tryptophan are called indolyl 
glucosinolates (Halkier and Gershenzon, 2006). All the three classes of glucosinolates, 
i.e. aliphatic, aromatic and indolyl glucosinolates have been isolated from Brassicaceae 
family (Fahey et al., 2001). Glucosinolates have been used as taxonomic markers to 
support evolution based classification schemes (Fahey et al., 2001; Mithen et al., 1987). 
Methyl glucosinolate, for example, does not occur in Brassicaceae, but is found in the 
closely related Capparaceae. Glucosinolates having glycosylated R-groups appear to be 
majorly produced by the families Resedaceae and Moringaceae (Fahey et al., 2001). 
Glucosinolate producing plants also possess thioglucosidases known as 
myrosinases that occur in a cell compartment (myrosin cells) different from the 
56 57 58 
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glucosinolates (vacuole) (Bones and Rossiter, 2006; Grubb and Abel, 2006; Rask et al., 
2000). Upon tissue damage, myrosinases are released and they hydrolyze the glucose 
moiety of the respective glucosinolates located in the vacuoles to yield glucose and an 
unstable aglycone (59) that can rearrange to form isothiocyanates (60), thiocyanates 
(61), nitriles (62), oxazolidine-2-thione (63), and other products that possess biological 
(including antifungal) activity (Figure 1.4, Bones and Rossiter, 2006; Halkier and 
Gershenzon, 2006; Rask et al., 2000). Some of these degradation products are also 
responsible for distinctive flavor of the members of Brassicaceae family (Rask et al., 
2000). 
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Figure 1.4 Products of degradation and rearrangement of glucosinolates (58) (Bones 
and Rossiter, 2006; Halkier and Gershenzon, 2006; Grubb and Abel, 2006). 
 
A number of studies have been carried out to determine whether glucosinolates 
and/or their degradation products play a significant role in plant defense. Studies 
correlating glucosinolate contents of different plant genotypes to their disease resistance 
levels have been performed. It was reported that the pathogen resistance of various 
Brassica species does not correlate with the glucosinolate levels (Doughty et al., 1991; 
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Giamoustaris and Mithen, 1992; Mithen and Magrath, 1992). On the other hand, Li and 
co-workers (1999) noted a correlation between pathogen-induced production of indole 
glucosinolates on oilseed rape and its resistance to S. sclerotiorum. These observations 
suggested that glucosinolates have a role in microbial disease resistance (Li et al., 1999). 
Similarly, the level of indolyl glucosinolates increased in the model plant A. thaliana 
upon inoculation with the plant pathogen Erwinia carotovora; the increase was 
attributed to the induction of indolyl glucosinolate biosynthetic pathway by this 
pathogen (Brader et al., 2001). Since the concentration of the phytoalexin camalexin (44) 
from A. thaliana did not increase significantly when compared to the accumulation of 
indolyl glucosinolates, these results suggested the importance of glucosinolates in 
defense against the plant bacterium E. carotovora (Brader et al., 2001). The 
antimicrobial activities of some glucosinolate degradation products against various plant 
pathogens (inhibition of pathogen growth or production of spores) have been 
investigated and compared with those of parent glucosinolates (Brader et al., 2001; 
Manici et al., 1997; 2000; Mayton et al., 1996; Olivier et al., 1999; Mithen et al., 1986). 
From a comparative study of the antifungal activity of several isothiocyanate breakdown 
products, it was shown that aromatic isothiocyanates are more potent than aliphatic 
isothiocyanates against various fungal pathogens. A general trend was noted in which 
the fungal toxicity of aliphatic isothiocyanates decreased with increasing side chain 
length (Manici et al., 1997; Mithen et al., 1986; Sarwar et al., 1998). Although these 
studies showed that the various breakdown products of glucosinolates had antimicrobial 
activity, additional evidence for their significant role in protecting plants against various 
pathogens was shown in the model plant A. thaliana (Tierens et al., 2001). In their 
investigation, Tierens and co-workers found that 4-methylsulphinylbutyl isothiocyanate 
(64), a degradation product of 4-methylsulphinylbutyl glucosinolate (65), accumulated in 
A. thaliana wild type leaves but was absent in glucosinolate-deficient gsm1-1 mutant. 4-
Methylsulphinylbutyl isothiocyanate displayed antimicrobial activity against a number 
of fungi and bacteria in growth inhibition bioassays (Tierens et al., 2001). Manici and 
co-workers established that 3-methylsulfinylpropyl isothiocyanate (66) could completely 
inhibit the growth of the plant pathogens Fusarium culmorum, R. solani, S. sclerotiorum, 
Diaporthe phaseolorum, and Phythium irregulare, whereas the parent compound 
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glucoiberin (3-methylsulfinylpropyl glucosinolate, 67) was inactive towards these fungi 
(Manici et al., 1997; 2000). 
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Volatiles from macerated leaves of genotypes of the crucifers, black mustard 
(Brasssica nigra) and Indian mustard (B. juncea), were shown to inhibit fungal growth 
and sporulation in two plant pathogens, Helminthosporium solani and Verticillium 
dahliae (Mayton et al., 1996; Olivier et al., 1999). Whereas cultivars of black and Indian 
mustard predominantly produce allyl glucosinolate, sinigrin (56) (Daxenbichler et al., 
1991, Olivier et al., 1999), GC analyses of their macerated leaf volatiles showed that 
allyl isothiocyanate (68) (enzymatic hydrolysis product of 56) was the major volatile 
component and that its production significantly varied in different genotypes (Olivier et 
al., 1999). The fungicidal activity of the genotypes investigated was reported to correlate 
with the production of allyl isothiocyanate (68); for example, genotypes producing 
higher amounts of allyl isothiocyanate also exhibited higher fungitoxicity (Olivier et al., 
1999). Allyl isothiocyanate obtained from commercial sources or derived from B. juncea 
was shown to exhibit fungitoxicity against Pennicilium expansum strains that were 
resistant to the synthetic fungicide thiabendazole (69) (Mari et al, 2002). It was shown 
that allyl isothiocyanate could reduce the incidence of blue mould caused by P. 
expansum by as much as 90% (Mari et al, 2002), thus making it a potential biofungicide 
that can be used to control the devastating effects of this pathogen. Allyl isothiocyanate 
also showed remarkable fungitoxity towards L. maculans, an economically important 
pathogen of crucifers (Mithen et al., 1986). 
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Mithen and co-workers (1986) investigated the antifungal activity of 
glucobrassicin (70) and its degradation products against L. maculans. From these 
investigations, it was reported that a mixture of glucobrassicin and myrosinase 
significantly inhibited fungal growth in the cultures compared to glucobrassicin alone 
(Mithen et al., 1986). Antifungal bioassays were also conducted with indole-3-methanol 
(71), indolyl-3-acetonitrile (49) and 3,3'-diindolylmethane (72) (Mithen et al., 1986), the 
degradation products of glucobrassinin (70) (Hanley et al., 1990). The three compounds 
49, 71 and 72 reportedly showed stronger antifungal activity against L. maculans than 
the parent glucobrassicin (70), and indole-3-methanol (71) had the greatest activity 
(Mithen et al., 1986). 2-Phenylethyl glucosinolate (73) is the dominant glucosinolate of 
canola roots (Gardiner et al. 1999). In antimicrobial bioassays using phenylethyl 
isothiocyanate (74), a degradation product of phenylethyl glucosinolate (73), 74 
inhibited the growth of a range of fungi, oomycetes and bacteria (Smith and Kirkegaard, 
2002). The results obtained supported the possible application of these compounds in 
biofumigation to control soil pathogens. 
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Besides antimicrobial activity, several studies have shown that glucosinolates and 
their degradation products play a significant role in plant-insect interaction. These 
activities include stimulation of insect feeding and oviposition, direct plant defense by 
acting as feeding deterrents (including mammals, birds), and indirect defense by 
providing cues to natural enemies of the herbivores (Baker et al., 2006; Halkier and 
Gershenzon, 2006; Rask et al., 2000). Glucosinolates and their volatile degradation 
products that protect plants against some herbivores may also attract specialized 
herbivores or serve as oviposition stimulants (Gabrys and Tjallingii, 2002; Mewis et al., 
2002). Sinigrin (56) for example acted as a feeding detterent to Acyrthosiphon pisum 
(pea aphid), but attracted Brevicoryne brassicae (cabbage aphids) to a non-host plant 
(Gabrys and Tjallingii, 2002). Non-host plants treated with extracts from host plants 
stimulated oviposition behavior of cabbage webworm, Hellula hundalis (Mewis et al., 
2002). Chemical analysis of the host plant (white mustard) extracts revealed that it 
predominantly contained aromatic glucosinolates, sinalbin (57) and benzyl glucosinolate 
(75), unlike the less preferred plants that contained higher amounts of aliphatic and 
indolyl glucosinolates (Mewis et al., 2002). Stimulation of oviposition in cabbage root 
fly (Delia radicum) was attributed to indolyl glucosinolate, glucobrassicin (70) 
(Roessingh et al., 1992), whereas both aliphatic alkenyl glucosinolates 3-butenyl- (76) 
and 4-pentenyl glucosinolates (77) and glucobrassicin (70) stimulated oviposition 
behavior in turnip root fly (D. floralis) (Simmonds et al., 1994). Both flies possessed 
chemoreceptors that responded to different glucosinolates, the response was correlated to 
the number of eggs laid (Roessing et al., 1992; Simmonds et al., 1994). Sinigrin (56), 
sinalbin (57), and allyl isothiocyanate (68) triggered oviposition-probing behavior of 
turnip sawfly (Athalia rosae), these findings indicated that both glucosinolates and their 
degradation products play a significant role in host-finding and oviposition among 
insects (Baker et al., 2006). The volatile isothiocyanates derived from short chain 
aliphatic glucosinolates may serve to attract insects from a distance and help them to 
locate the host plant, whereas glucosinolates within leaf surface waxes (e.g. indolyl 
glucosinolates) may serve as stimulants for egg laying (Giamoustaris and Mithen, 1995; 
Renwick, 2002). 
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Various studies have demonstrated that plants respond to insect herbivory by 
accumulating higher levels of glucosinolates presumably to increase the plants resistance 
to subsequent attacks (Agrawal et al., 2002; Mewis et al., 2005; Traw, 2002; van Dam et 
al., 2005). The levels of sinigrin (56) and glucobrassicin (70) were found to increase by 
19 and 16%, respectively, in black mustard when fed on by white butterfly (Traw, 2002). 
Some plants use glucosinolate degradation products to protect themselves against 
specialist herbivores. For example, allyl isothiocyanate (68), but not allyl glucosinolate 
sinigrin (56) reduced the growth and survival of the crucifer specialist, Pieris rapae 
(white butterfly) (Agrawal and Kurashige, 2003). Although glucosinolates and their 
degradation products may be advantageous to specialist herbivores (e.g. host-recognition 
and feeding stimulation), they are deleterious to generalists. Sinigrin and its allyl 
isothiocyanate degradation product were found to be lethally toxic to the crucifer 
generalist Spodoptera eridania (southern armyworm), whereas the specialist Plutella 
xylostella (cabbage moth) was only affected by allyl isothiocyanate (Li et al., 2000). 
Developing plant lines with increased levels of glucosinolates resulted in greater damage 
by the specialists, while reducing grazing levels by the generalists (Giamoustaris and 
Mithen, 1995). The Brassicaceae specialists seemed to respond to particular 
glucosinolates, suggesting that the plant glucosinolate profile is more important for 
plant-insect interaction rather than the total glucosinolate concentration (Giamoustaris 
and Mithen, 1995). The specialists adapted to particular crucifers have developed 
mechanisms for overcoming the toxic effect of glucosinolates, including rapid excretion, 
inhibition of hydrolysis, or sequestering the glucosinolates (Barker et al., 2006; Halkier 
75 76 
77 
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and Gershenzon, 2006; Renwick, 2002). The insects that sequester glucosinolates use 
them for their own protection by dettering predators such as birds, lizards and ants 
(Halkier and Gershenzon, 2006). 
1.4 Biosynthetic studies in crucifers 
Cruciferous plants produce phytoalexins and phytoanticipins of diverse chemical 
structures. These secondary metabolites play a role in protecting plants against various 
pathogens and have other biological activities, including cytotoxicity and oviposition 
stimulation, as described in previous sections (Halkier and Gershenzon, 2006; Pedras et 
al., 2007b). Understanding of the biosynthetic pathways of these secondary metabolites 
is of vital importance, as this will facilitate the transfer of genes from a resistant to a 
susceptible species (Dixon, 2005). Such genetic manipulations will allow the susceptible 
species to produce secondary metabolites that may confer resistance to pathogens 
(Dixon, 2005). 
1.4.1 Syntheses of precursors 
Biosynthetic investigations can involve administration of precursors (labeled or 
non-labeled) to enzyme preparations or in vivo feeding experiments employing cell 
cultures or plant stems, roots, or leaves. Labeling experiments using stable isotopes, 
radioisotopes, or non-natural substrates allows for the quantification of incorporation and 
mapping of biosynthetic pathways. 
1.4.1.1 L-Tryptophan and tryptamine 
This section covers the synthesis of L-[4'-2H]tryptophan (78a) and [2',4',5',6',7'-
2H5]tryptamine (79a). 
[4'-2H]Tryptophan (79a) 
The L-[4'-2H]tryptophan (78a) was synthesized from L-tryptophan (78) by 
photochemical hydrogen-deuterium exchange reaction (Scheme 1.1, Monde et al., 1994; 
Saito et al, 1984; Shizuka et al., 1988). Thus, irradiation of a solution of L-tryptophan in 
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2H2O resulted in incorporation of 2H into the indole nucleus to give L-[4'-2H]tryptophan 
(Saito et al, 1984; Shizuka et al., 1988). 
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Scheme 1.1 Reagents and conditions: i) hν, 2H2O, p2H 5.5 (Saito et al., 1984; Shizuka 
et al., 1988). 
 
[2',4',5',6',7'-2H4]Tryptamine (79a) 
[2',4',5',6',7'-2H4]Tryptamine (79a) was prepared from [2',4',5',6',7'-2H5]tryptophan 
(78b) in one step using catalytic amount of 2-cyclohexene-1-one in cyclohexanol 
(Scheme 1.2, Pedras et al., 2004). 
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Scheme 1.2 Reagents and conditions: i) C6H12O, C6H8O (Pedras et al., 2004). 
 
1.4.1.2 Thiohydroxamic acids and [4',5',6',7'-2H4]glucobrassicin 
(70a) 
Thiohydroximic acids are proposed intermediates in the biosynthesis of 
glucosinolates (Halkier and Gershenzon, 2006; Grubb and Abel, 2006). Thiohydroxamic 
acids (80) contain different atoms: C, S, N, and O and can coordinate with metal ions to 
form colored complexes that have been utilized in detection and quantification of 
78b 79a 
78 78a 
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different metals (Chimiak et al., 2002). Thiohydroxamic acids also play a significant role 
in bacterial ion-transport systems (Hwu and Tsay, 1990; Mizukami and Nagata, 1966). 
Thiohydroxamic acids (80) exist in equilibrium with thiohydroximic acids (81) (Figure 
1.5). Whereas the thione (80) exist predominantly in the solid state, both thione (80) and 
thiol (81) tautomers exist in solution, although the thiol isomer does not occur in 
significant concentrations (Chimiak et al., 2002; Mizukami and Nagata, 1966). 
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Figure 1.5 Thiohydroxamic acids (80) and thiohydroximic acids (81): R = alkyl, 
aryl; R1 = R2 = R3 = H (Chimiak et al., 2002). 
 
Unsubstituted thiohydroxamic acids (R1 = R2 = H) decompose by extrusion of 
sulfur to yield nitriles and water (Walter and Schaumann, 1971) whereas N-substituted 
derivatives (R = aryl; R1 = aryl; R2 = H) are reportedly stable (Brydan and Ryan, 1966). 
A number of methods have been developed for synthesis of thiohydroxamic acids based 
on thioacylation of hydroxylamine and its N- or O-alkyl derivatives, for example, 
thioacylation of hydroxylamines with dithiocarboxylic acids, dithiocarboxylic acid 
esters, thionocarboxylic acid esters, or thioacyl chlorides, and also by reaction of 
hydroximic acid chlorides or nitrile oxides with hydrogen sulfide (Chimiak et al., 2002; 
Walter and Schaumann, 1971). 
Dithiocarboxylates (83) obtained by reaction of Grignard reagents (82) with carbon 
disulfide are treated with hydroxylamine to give the respective thiohydroxamic acids 
(80) (Scheme 1.3). This method was used to prepare benzohydroxamic acid (Walter and 
Schaumann, 1971). Reaction of hydroxylamine with dithiocarboxylates (83) gives low 
yields of thiohydroxamic acids, but N- and O-derivatives have been prepared in fairly 
good yields (Chimiak et al., 2002). This reaction has been used in preparation of alkyl 
and aromatic thiohydroxamic acids (Walter and Schaumann, 1971). Thiohydroxamic 
acids can be prepared in good yields from S-thioacylthioglycolic acids (86) (Walter and 
Schaumann, 1971) (Scheme 1.3). The S-thioacylthioglycolic acids (86) can be prepared 
80 81 
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by reaction of the dithiocarboxylates (83) with chloroacetic acid (Jensen and Pedersen, 
1961; Ramadas et al., 1983) (Scheme 1.3). S-Thioacylthioglycolic acids (86) have been 
prepared from dithioacids (85) which are obtained from reaction of aldehydes (84) with 
ammonium polysulfide (Jensen and Pedersen, 1961; Ramadas et al., 1983). Treatment of 
dithioacids (85) with chloroacetic acid yields S-thioacylthioglycolic acids (86) (Scheme 
1.3). Reaction of the S-thioacylthioglycolic acids (86) with hydroxylamines or their N- 
and O-derivatives gives the respective thiohydroxamic acids in good yields of 70-80% 
(Chimiak et al., 2002; Jensen and Pedersen, 1961; Ramada et al., 1983; Walter and 
Schaumann, 1971). 
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Scheme 1.3 Thioacylation of hydroxylamine with dithiocarboxylate (83) and S-
thioacylthioglycolic acid (86); R = alkyl or aryl (Chimiak et al., 2002; Jensen and 
Pedersen, 1961; Ramada et al., 1983). 
 
Thioacylation of hydroxylamine with thionocarboxylic acid esters (87) give 
thiohydroxamic acids (80) in low yields compared to dithiocarboxylic acid esters (88) 
(Chimiak et al., 2002) (Scheme 1.4). Thiocarboxylic acid chlorides (89) have not found 
wide application in preparation of thiohydroxamic acids because they are labile 
compounds and are not easily accessible (Chimiak et al., 2002) (Scheme 1.4). 
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Scheme 1.4 Thioacylation of hydroxylamine with thiocarboxylic acid esters (87), 
dithiocarboxylic acid esters (88), and thiocarboxylic acid chlorides (89): R = alkyl or 
aryl (Chimiak et al., 2002; Walter and Schaumann, 1971). 
 
Nucleophilic attack of hydroximic acid chlorides (90) by hydrosulfide ion yields 
thiohydroxamic acids in low yields. Elimination of hydrogen chloride by hydroximic 
acid chlorides gives nitrile oxides (91) that can react with sodium hydrogen sulfide to 
yield the respective thiohydroxamic acids in good yields (Chimiak et al., 2002; Walter 
and Schaumann, 1971) (Scheme 1.5). 
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Scheme 1.5 Preparation of thiohydroxamic acids (80) from hydroximic acid chlorides 
(90) and nitrile oxides (91); R = alkyl or aryl (Chimiak et al., 2002; Walter and 
Schaumann, 1971). 
 
Direct thionation of hydroxamic acids with Lawesson’s reagent have been carried 
out on N-alkyl derivatives (92 R2 = alkyl) to yield N-alkylthiohydroxamic acids (94) 
87 X = OMe, OEt 
88 X = S-alkyl or S-aryl 
89 X = Cl 
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(Przychodzen, 2006; Przychodzen et al., 2005) (Scheme 1.6). Lawesson’s reagent 
thionation of unsubstituted hydroxamic acids (93 R2 = H) does not appear in literature 
reports, perhaps due to instability of the resulting thiohydroxamic acids (80) under these 
conditions. The most recently developed synthesis of thiohydroxamic acids uses the 
concept of counterattack reagent. In these preparations, primary nitro compounds (95) 
are treated with potassium hydride, followed by hexamethyldisilathiane 
[(CH3)3SiSSi(CH3)3] to give thiohydroxamic acids (80) in 56-92% (Scheme 1.6). This 
synthesis is a “one-flask” reaction and can be performed in the presence of additional 
functional groups such as esters, acetals, arenes, and sulfides that are stable under the 
reaction conditions (Hwu et al., 2005; Hwu and Tsay, 1990; Chimiak et al., 2002). 
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Scheme 1.6 Preparation of thiohydroxamic acids (80) and N-alkyl thiohydroxamic 
acids (94); R1 = alkyl, phenyl, benzyl, R2 = alkyl, R3 = alkyl, benzyl, CH2CH2CO2Et, 
(Chimiak et al., 2002; Hwu and Tsay, 1990). 
 
The sodium salts of 2-(3-indolyl)acetothiohydroximate (99) and 3-
phenylpropanothiohydroximate (100) have been prepared from their respective nitriles 
(96) in unreported yields (Scheme 1.7, Reed et al., 1993). The nitriles (96) are converted 
to imidate hydrochlorides (97) using methanolic hydrochloric acid. Reaction of 97 with 
hydrogen sulfide gives the thioates (98) (Marvel et al., 1955), which are treated with 
92 R2 = alkyl 
93 R2 = H 
 
94 R2 = alkyl 
80 95 
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hydroxylamine hydrochloride in the presence of sodium methoxide to yield the desired 
thiohydroximate salts (Mizukami and Nagata, 1966; Reed et al., 1993). 
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Scheme 1.7 Synthesis of sodium 2-(3-indolyl)acetothiohydroximate (99) and sodium 
3-phenylpropanothiohydroximate (100) from their respective nitriles (Mizukami and 
Nagata, 1966; Reed et al., 1993). 
 
[4',5',6',7'-2H4]Glucobrassicin (70a) was prepared from [4,5,6,7-2H4]indole (105a) 
as shown in Scheme 1.8 (Pedras et al., 2002). Firstly, [4,5,6,7-2H4]indole was 
synthesized starting from [2H8]toluene (101a) (Pedras et al., 1998). Treatment of nitric 
acid with [2H8]toluene in acetic anhydride gave [3,4,5,6-2H4]2-nitrotoluene (102a) which 
was converted to nitrobenzylbromide 103a with N-bromosuccinimide. The 
nitrobenzylbromide 103a was allowed to react with potassium cyanide to give [3,4,5,6-
2H4]2-nitrophenylacetonitrile (104a). Catalytic reduction of [3,4,5,6-2H4]2-
nitrophenylacetonitrile yielded [4,5,6,7-2H4]indole (105a). Next, [4,5,6,7-2H4]indole was 
transformed to [4,5,6,7-2H4]indole-3-carboxaldehyde (106a) which was allowed to react 
with nitromethane to give [4,5,6,7-2H4]-3-(2'-nitrovinyl)indole (107a). The [4,5,6,7-2H4]-
3-(2'-nitrovinyl)indole was transformed to 1-acetyl-[4,5,6,7-2H4]-3-(2'-nitrovinyl)indole 
(108a) which was reacted with titanium (IV) chloride and triethylsilane, the resulting 
hyroxymoyl intermediate was then treated with 1-thio-β-D-glucose tetraacetate to give 
glycosyl thiohydroximate 109a. The O-sulfation of 109a followed by removal of acetate 
groups from 110a gave [4',5',6',7'-2H4]glucobrassicin (70a) (Scheme 1.8, Pedras et al., 
2002). 
 
99 R = Indole 
100 R = Benzyl 
98 97 96 R = Indole or R = 
Benzyl 
 29 
2H
2H
2H
2H 2H
C2H3
2H
2H
2H
2H NO2
C2H2CN
N
H
2H
2H
2H
2HN
H
2H
2H
2H
2H
CHO
N
R1
2H
2H
2H
2H
NO2
N
R1
2H
2H
2H
2H
S
N OR2
O OR3OR3
R3O
R3O
2H
2H
2H
2H NO2
C2H3
2H
2H
2H
2H NO2
C2H2Bri ii iii
iv
vvi, vii
viii, ix, x, xi
 
 
Scheme 1.8 Reagents and conditions: i) HNO3, Ac2O; ii) NBS; iii) KCN; iv) H2, 10% 
Pd/C; v) DMF/POCl3; vi) CH3NO2, NH4OAc; vii) Ac2O, DMAP; viii) TiCl4, Et3SiH; ix) 
1-thio-β-D-glucose tetraacetate, Et3N; x) HSO3Cl, pyridine, KHCO3; xi) CH3OK, 
CH3OH (Pedras et al., 2002). 
 
1.4.1.3 Synthesis of indolyl-3-acetaldoximes 
This section covers the synthesis of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
and [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a). 
[4',5',6',7'-2H4]Indolyl-3-acetaldoxime (112a) 
[4',5',6',7'-2H4]Indolyl-3-acetaldoxime (112a) was prepared from [4,5,6,7-
2H4]indole-3-carboxaldehyde (106a) as shown in Scheme 1.9 (Pedras et al., 2002). 
Firstly [4,5,6,7-2H4]indole-3-carboxaldehyde was transformed to [4',5',6',7'-2H4]indolyl-
3-methoxyethylene (111a) which was hydrolyzed to give [4',5',6',7'-2H4]indolyl-3-
acetaldehyde. Treatment of [4',5',6',7'-2H4]indolyl-3-acetaldehyde with hydroxylamine 
107a R1 = H 
108a R1 = Ac 
109a R1 = Ac, R2 = H, R3 = Ac 
110a R1 = Ac, R2 = SO3-K+, R3 = Ac 
70a R1 = H, R2 = SO3-K+, R3 = H 
 
106a 105a 
101a 102a 104a 103a 
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hydrochloride and sodium acetate yielded [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a, 
Scheme 1.9) (Pedras et al., 2002). 
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Scheme 1.9 Reagents and conditions: i) BuLi, Ph3P(Cl)CH2OCH3; ii) HCl, (CH3)2CO; 
iii) HONH2·HCl, NaOAc (Pedras et al., 2002). 
 
[1",1",1"-2H3]1-Methoxyindolyl-3-acetaldoxime (116a) 
[1",1",1"-2H3]1-Methoxyindolyl-3-acetaldoxime (116a) was synthesized in 6 steps 
beginning from tryptamine (Scheme 1.10) (Pedras and Montaut, 2004). The Nb amino 
group of tryptamine was acetylated with acetic anhydride in pyridine to provide Nb-
acetyltryptamine (113) that was reduced with sodium cyanoborohydride in glacial acetic 
acid to yield Nb-acetyl-2,3-dihyroindolyl-3-ethylamine (114). Sodium tungstate 
catalyzed oxidation of 114 with hydrogen peroxide followed by methylation of the 1-
hydroxyindolyl intermediate with hexadeuterated dimethylsulphate (Somei and 
Kawasaki, 1989) yielded [1",1",1"-2H3]Nb-acetyl-1-methoxytryptamine (115a). The Nb-
acetyl group was hydrolyzed with sodium hydroxide to provide [1",1",1"-2H3]1-
methoxytryptamine which was oxidized with hydrogen peroxide (Burckard et al., 1965) 
to yield [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a) (Scheme 1.10). 
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Scheme 1.1.10 Reagents and conditions: i) NaBH3CN, AcOH; ii) Na2WO4·2H2O, 
H2O2, CH3OH; iii) (C2H3O)2SO2, K2CO3, CH3OH; iv) NaOH, CH3OH, reflux; vii) 
Na2WO4·2H2O, H2O2, CH3OH, (Pedras and Montaut, 2004). 
 
1.4.1.4 Synthesis of labeled brassinins, cyclobrassinins, and (±)-
[3,3,3-2H3]dioxibrassinin (25b) 
This section covers the synthesis of [4',5',6',7'-2H4]brassinin (16a), [3,3,3-
2H3]brassinin (16b), [2-14C]brassinin (16c), [4',5',6',7'-2H4]cyclobrassinin (28a), [3,3,3-
2H3]cyclobrassinin (28b), and (±)-[3,3,3-2H3]dioxybrassinin (25b). 
[4',5',6',7'-2H4]Brassinin (16a), [4',5',6',7'-2H4]cyclobrassinin (28a) 
[4',5',6',7'-2H4]Cyclobrassinin (28a) was synthesized from [4',5',6',7'-2H4]brassinin 
(16a) as shown in Scheme 1.11 (Pedras et al., 1998). [4,5,6,7-2H4]Indole-3-
carboxaldehyde (106a) was allowed to react with hydroxylamine hydrochloride to yield 
a mixture of (E)- and (Z)-oximes that were reduced with Devarda’s alloy to yield 
[4',5',6',7'-2H4]indole-3-methanamine (117a). Reaction of 117a with carbon disulfide in 
the presence of pyridine and triethylamine followed by methylation with methyl iodide 
gave [4',5',6',7'-2H4]brassinin (16a) in 80% (Pedras et al., 1998). Treatment of [4',5',6',7'-
113 114 115a 
116a 
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2H4]brassinin with pyridinium bromide perbromide followed by triethylamine gave 
[4',5',6',7'-2H4]cyclobrassinin in 40% (Scheme 1.11). 
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Scheme 1.11 Reagents and conditions: i) HONH2·HCl, EtOH; ii) NaOH, Devarda’s 
alloy, CH3OH, 70%; iii) Et3N, CS2; iv) ICH3, 80%; v) pyridine/HBr/Br2 40% (Pedras et 
al., 1998). 
 
[3,3,3-2H3]Brassinin (16b) and [3,3,3-2H3]cyclobrassinin (28b) 
[3,3,3-2H3]Brassinin (16b) and [3,3,3-2H3]cyclobrassinin (28b) were synthesized as 
shown on Scheme 1.12 (Monde et al., 1994). [3,3,3-2H3]Brassinin (16b) was synthesized 
as described for [4',5',6',7'-2H4]brassinin (16a), but starting from indole-3-
carboxaldehyde (106) (Scheme 1.12). [3,3,3-2H3]Cyclobrassinin (28b) was prepared in 
25% yield from [3,3,3-2H3]brassinin (Scheme 1.12) (Monde et al., 1994). 
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Scheme 1.12 Reagents and conditions: i) HONH2·HCl, EtOH; ii) NaOH, Devarda’s 
alloy, CH3OH; iii) Py, Et3N, CS2; iv) IC2H3, rt, 18 h 34%; v) pyridine/HBr/Br2, 25% 
(Monde et al., 1994). 
 
[2-14C]Brassinin (16c) 
[2-14C]Brassinin (16c) was synthesized from [2-14C]indole (105b) as shown in 
Scheme 1.13 (Pedras et al., 2002). Formylation of [2-14C]indole gave [2-14C]indole-3-
carboxaldehyde (106b) which was used to prepare [2-14C]brassinin (16c) as described 
for 16a (Pedras et al., 2002). 
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Scheme 1.13 Reagents and conditions: i) POCl3, DMF; ii) HONH2·HCl, NaOAc; iii) 
NaBH3CN, TiCl3, NH4OAc; iii) Pyridine, Et3N, CS2; iv) ICH3 (Pedras et al., 2002). 
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(±)-[3,3,3-2H3]Dioxibrassinin (25a) 
(±)-[3,3,3-2H3]Dioxibrassin (25a) was synthesized starting from isatin (118) 
(Scheme 1.14). Addition of nitromethane to isatin followed by hydrogenation yielded 3-
hydroxyindolyl-3-methanamine (119). Reaction of amine 119 with carbon disulfide in 
the presence of pyridine and triethylamine, followed by deuterated methyl iodide 
(IC2H3) yielded [3,3,3-2H3]dioxybrassinin (25a) in 78% (Monde et al., 1994). 
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Scheme 1.14 Reagents and conditions; i) CH3NO2; ii) H2, Pd/AcOH; iii) HCl; iv) 
Pyridine, Et3N, CS2, IC2H3, 78% (Monde et al., 1994; Pedras et al., 2003b). 
 
1.4.2 Biosynthesis 
The biosynthetic pathways of crucifer phytoalexins and glucosinolates have been 
mapped via feeding experiments employing synthetic precursors labeled with stable and 
radio-isotopes, as well as non-natural compounds (Halkier and Gershenzon, 2006; 
Pedras et al., 2007b). 
1.4.2.1 Phytoalexins 
The biosynthesis of phytoalexins was previously reviewed by Pedras and co-
workers (2003b and 2007b, Figure 1.6). 
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Figure 1.6 Map of biosynthetic pathways of crucifer phytoalexins and indolyl 
glucosinolates 70 and 199. Dashed arrows represent proposed steps. Enzymes involved 
in the biosynthetic pathway: i) CYP79B2 and CYP79B3; ii) CYP71A13, and 
CYP79B15 (Pedras et al., 2007b). 
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L-Tryptophan (78), a precursor of majority of crucifer phytoalexins is 
biosynthesized from anthranilic acid (120) via the shikimate pathway (Dewick, 1998). In 
plants, anthranilic acid (120) is transformed to indole (105) which is conjugated with L-
serine (122) to produce L-tryptophan (Dewick, 1998; Shraudolf, 1966). Biosynthesis of 
phytoalexins from L-tryptophan proceeds through indolyl-3-acetaldoxime (112) that 
appears to be the metabolic branching point in a few secondary pathways such as indole 
phytoalexins and indole glucosinolates (Pedras et al, 2007b) (Figures 1.6 and 1.7). 
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Figure 1.7 Biosynthetic pathway of L-tryptophan (78) and indolyl-3-acetaldoxime 
(112) from anthranilic acid (120). 
 
Cytochrome P450 enzymes from the CYP79 family that catalyze conversion of L-
tryptophan to indolyl-3-acetaldoxime have been isolated from different plant sources 
such as white mustard and the model plant A. thaliana (Hansen and Halkier, 2005; Hull 
et al., 2000; Mikkelsen et al., 2000; Naur et al., 2003b). The enzymes CYP79B1 
(isolated from white mustard), CYP79B2, and CYP79B3 (isolated from A. thaliana) 
have been proposed to catalyze N-hydroxylation of L-tryptophan to N-hydroxy-L-
tryptophan that decarboxylates to give indolyl-3-acetaldoxime (Hansen and Halkier, 
2005; Hull et al., 2000; Mikkelsen et al., 2000; Naur et al., 2003b). These 
transformations have been extensively studied in the biosynthetic pathways of 
glucosinolates and are described in the next section (Hansen and Halkier, 2005; Hull et 
al., 2000; Mikkelsen et al., 2000; Naur et al., 2003b). 
The biosynthesis of the crucifer phytoalexins, brassinin (16), cyclobrassinin (28) 
and spirobrassinin (34) was investigated in turnip roots using isotopically labeled (13C 
and 2H) precursors. The origin of indole group was confirmed through deuterium 
120 
122 
105 78 112 
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labeling experiments using L-[4'-2H]tryptophan (Monde et al., 1994) (Figure 1.8). The 
occurrence of a molecular rearrangement in the biosynthetic pathway from L-tryptophan 
(78) to brassinin (16) was investigated by administration of DL-[13C-2]tryptophan to 
turnip root tissues. The 13C NMR of isolated spirobrassinin revealed a 4-fold 
enhancement of the imino carbon NMR signal. These results suggested that a molecular 
rearrangement of L-tryptophan leads to indolyl-3-methylisothiocyanate (123) which is an 
intermediate in the biosynthetic pathway of brassinin (16), and that the thiocarbonyl 
carbon of brassinin originates from C-2 of L-tryptophan (Figure 1.8) (Monde et al., 
1994). Administration of L-[3,3,3-2H3]methionine indicated that the methyl groups of 
brassinin, cyclobrassinin and spirobrassinin derived from L-methionine. Additional 
experiments employing a mixture of L-[3,3,3-2H3]methionine and L-[35S]methionine 
revealed intact incorporation of L-methionine into brassinin. The origin of the 
thiocarbonyl sulfur from L-cysteine was confirmed after incubation of turnip tissues with 
L-[35S]cysteine; high radioactivities of the isolated brassinin and spirobrassinin 
supported the conclusion that the thiocarbonyl sulfur atom originates from L-cysteine 
(Monde et al., 1994) (Figure 1.8). The biogenetic relationship between the phytoalexins 
brassinin (16), dioxibrassinin (25), cyclobrassinin (28), and spirobrassinin (34) in turnip 
root tissues was investigated with [3,3,3-2H3]brassinin (16b), [3,3,3-2H3]dioxibrassinin 
(25a), and [3,3,3-2H3]cyclobrassinin (28b) (Figure 1.8). Labeled brassinin was 
effectively incorporated into cyclobrassinin and spirobrassinin, but neither 
cyclobrassinin nor dioxibrassinin were incorporated in spirobrassinin. Incubation of 
Japanese radish roots (Raphanus sativus var. hortensis) with [3,3,3-2H3]brassinin further 
confirmed the intermediacy of brassinin in the biosynthetic pathway of cyclobrassinin 
(Monde et al., 1995). These experiments therefore revealed that brassinin (16) is an 
advanced precursor in the biosynthetic pathway of many other crucifer phytoalexins 
(Monde et al., 1994; 1995; Pedras et al., 2004). 
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Figure 1.8 Biosynthesis of cruciferous phytoalexins: the occurrence of molecular 
rearrangement, and biogenetic relationship between brassinin (16) and other 
phytoalexins. 
 
The biogenetic relationship between the phytoalexin brassinin (16) and the indole 
glucosinolate glucobrassicin (70) was subject of discussion. Glucobrassicin (70) 
appeared to be biogenetically related to brassinin (16) (Figure 1.9) since both are 
biosynthesized from L-tryptophan (Goetz and Schraudolf, 1983; Kutáček et al., 1962; 
Kutáček and Králová, 1972). Glucobrassicin (70) is also known to undergo enzymatic 
hydrolysis by myrosinases, Lossen-type rearrangement of the resulting intermediate 
yields indolyl-3-methylisothiocyanate (123, Agerbik et al., 1998; Hanley et al., 1990; 
Hanley and Parsley, 1990; Latxague et al., 1991), a proposed intermediate between 
tryptophan and brassinin (Monde et al., 1994). 
 
123 78 16 
25 
34 28 
 39 
N
H
N OSO3 K
S β D Glc
N
H
NCS
N
H
NH
SCH3
S
??
 
 
Figure 1.9 Plausible biogenetic relationship between brassinin (16) and 
glucobrassicin (70). 
 
The preparation of indolyl-3-methylisothiocyanate (123) was unsuccessful 
(Kutschy et al., 1998) due to its instability (Hanley et al., 1990; Hanley and Parsley, 
1990). Monde and co-workers (1994), however, attempted to trap the putative 
isothiocyanate 123 in the biosynthesis of brassinin. Monde and co-workers (1994) 
reported that homogenizing turnip roots in the presence of sodium methanethiolate 
yielded brassinin (16) and a compound that was identified as PhCH2-CH2-NH-CS-SCH3, 
which was named phenylethylbrassinin (124). These metabolites were not isolated in the 
absence of sodium mathanethiolate (Monde et al., 1994). The putative role of 
isothiocyanate in the biosynthesis of brassinin was further demonstrated with benzyl 
isothiocyanate (125) (Figure 1.10). Administration of 125 to turnip tubers in the absence 
of sodium methanethiolate yielded a new metabolite that was named benzylbrassinin 
(126) (Monde et al., 1994). 
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Figure 1.10 Biosynthesis of benzylbrassinin (126) (Monde et al., 1994). 
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The potential intermediacy of glucobrassicin (70) in the biosynthesis of brassinin 
(16) was investigated with [4',5',6',7'-2H4]glucobrassicin (70a) using brown mustard (B. 
juncea) leaves elicited with L. maculans, and with UV-irradiated turnip root slices. 
[4',5',6',7'-2H4]Glucobrassicin (70a) was not incorporated into any of the phytoalexins 
produced by either plant tissue, but was rather metabolized to indole-3-carboxaldehyde 
(106a) and methyl indole-3-carboxylate (121a) by turnip root slices (Pedras et al., 2001; 
2003b) (Figure 1.11). On the other hand, [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
was efficiently incorporated into brasslexin (26a), cyclobrassinin (28a) and 
spirobrassinin (34b) in turnip root slices (Figure 1.11). These results suggested that the 
biosynthetic pathway of brassinin possibly branches before formation of glucobrassicin, 
and that indolyl-3-acetaldoxime or other related intermediate is the common biosynthetic 
precursor between phytoalexins and glucosinolates (Pedras et al., 2003b). 
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Figure 1.11 Biosynthesis of cruciferous phytoalexins: lack of incorporation of 
[4',5',6',7'-2H4]glucobrassicin (70a), and incorporation of [4',5',6',7'-2H4]indolyl-3-
acetaldoxime (112a) (Pedras et al., 2003b). 
 
[3,3,3-2H3]Dioxibrassinin (25a) and [3,3,3-2H3]cyclobrassinin (28b) were not 
incorporated into [3,3,3-2H3]spirobrassinin (34a) suggesting that cyclobrassinin and 
spirobrassinin derive from brassinin (16) via a common intermediate (Monde et al., 
1994). The contribution of such an intermediate was probed with a non-natural 
precursor, 2-methylbrassinin (127, Figure 1.12). In feeding experiments, turnip tissues 
70 
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metabolized 2-methylbrassinin (127) to two metabolites, 129 and 130, that were 
suggested to form through a pinacol-type rearrangement of the diol intermediate 128. 
These results suggested that a similar diol intermediate could be involved in the 
biosynthesis of cyclobrassinin (28) and spirobrassinin (34) from brassinin (16) (Monde 
et al., 1994). 
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Figure 1.12 Probing for the common intermediate in the biosynthesis of 
cyclobrassinin (28) and spirobrassinin (34) from brassinin (16) (Monde et al., 1994). 
 
In other biosynthetic investigations [4',5',6',7'-2H4]brassinin (16a) was incorporated 
into rutalexin (33a), brassicanal A (39a), and brassicanate A (43a) in rutabaga root slices 
(Pedras et al. 2004, Figure 1.13). The occurrence of brassicanal A and brassicanate A in 
rutabaga root tubers suggested a possible biogenetic relationship between these two 
metabolites. Interestingly, the percent incorporation of brassinin (16a) into brassicanate 
A (43a) was much higher than that for brassicanal A (39a) (Pedras et al., 2004). 
Additional deuterium incorporation experiments revealed cyclobrassinin (28a) to be an 
advanced biogenetic precursor of brassilexin (26a) (Pedras et al., 1998; 2007b) and 
rutalexin (33a) (Pedras et al., 2004; 2007b). Rutalexin (33) was isolated from rutabaga 
for the first time and its characterization was a revision of the structure of a compound 
that was previously misassigned as cyclobrassinone (131) (Pedras et al., 2004). 
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The biosynthesis of brassilexin (26a) from indolyl-3-acetaldoxime (112a), 
brassinin (16a), and cyclobrassinin (28a) was also established in feeding experiments 
with turnip root slices and in leaves of B. carinata and B. juncea (Pedras et al., 1998; 
2001, 2007b) (Figure 1.13). The sequence of the biosynthetic pathway of brassilexin 
(26), rutalexin (33), brassicanal A (39), and brassicanate A (43) was therefore 
established (Pedras et al., 1998; 2001; 2007b) (Figure 1.13). 
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Figure 1.13 Biosynthetic sequence of brassilexin (26a), rutalexin (33a), brassicanal A 
(39a), and brassicanate A (43a) from indolyl-3-acetaldoxime (112a) (Pedras et al., 2002; 
2004). 
 
Efficient metabolism of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) to indolyl-3-
acetonitrile (49a) (Figure 1.13) by B. juncea leaves suggested that under these 
experimental conditions 112, but not glucobrassicin (70), is the key intermediate in the 
biosynthesis of 49 (Pedras et al., 2002). 
The biosynthesis of camalexin (44), the principle phytoalexin of the model plant A. 
thaliana is shown in Figure 1.14. Camalexin was first proposed to be biosynthesized 
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through condensation of indole-3-carboxaldehyde (106) with cysteine followed by 
cyclization and decarboxylation (Browne et al., 1991). The thiazole ring of camalexin 
was established to originate from cysteine based on a more efficient incorporation of 
[35S]cysteine than [35S]methionine, thus supporting the initial hypothesis by Browne and 
co-workers (1991). Additional experiments showing incorporation of cysteine labeled 
with 2H, 14C, or 13C and 15N into camalexin supported the previous conclusions (Zook 
and Hammerschmidt, 1997). The efficient incorporation of radioactivity from 
[14C]anthranilate than [3H]tryptophan showed that anthranilic acid (120) but not L-
tryptophan (78) was the precursor of camalexin (Tsuji et al., 1993; Zook and 
Hammerschmidt, 1997). Further biosynthetic experiments using A. thaliana cell cultures 
showed that the biosynthetic pathway of camalexin possibly diverges from that of 
tryptophan at the indole step. The efficiency of incorporation of [14C]indole into 
camalexin was twice that of [14C]anthranilate, suggesting that indole is a closer precursor 
to camalexin than anthranilic acid, whereas tryptophan is not a precursor (Zook, 1998). 
Contrary to these reports, in vivo labeling experiments showed that [14C-2]indolyl-3-
acetaldoxime was incorporated into camalexin in A. thaliana (Glawischnig et al., 2004; 
Pedras et al., 2007b, Figure 1.14). Additional experiments using A. thaliana leaves 
showed incorporation of 6-fluoroindolyl-3-acetaldoxime, 6-fluorotryptophan and 14C-
labeled tryptophan into camalexin and derivatives (Glawischnig et al., 2004). The 
fluorinated or 14C-labeled tryptophan was incorporated albeit with low efficiency 
(Glawischnig et al., 2004), hence the previous assumption that tryptophan is not a 
precursor of camalexin (Tsuji et al., 1993; Zook and Hammerschmidt, 1997) did not 
hold. It was also established that the enzymes CYP79B2 and CYP79B3 catalyze the 
conversion of L-tryptophan (78) to indolyl-3-acetaldoxime (112) in the biosynthetic 
pathway of camalexin in A. thaliana (Glawischnig et al., 2004). Dihydrocamalexic acid 
(132) was shown to accumulate in infected root cultures of phytoalexin deficient A. 
thaliana mutant pad3 (Bednarek et al., 2005). In other biosynthetic studies, (S)-
dihydrocamalexic acid (132) was converted to camalexin (44) on incubation with 
CYP71B15 (PAD3) (Schuhegger et al., 2006). These results suggested that CYP71B15 
catalyzes the oxidative decarboxylation of dihydrocamalexic acid (132), the last step in 
the biosynthetic pathway of camalexin (Pedras et al., 2007b; Schuhegger et al., 2006). In 
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the most recent report, involvement of CYP71A13 enzyme in camalexin biosynthesis 
was demonstrated. It was established that CYP71A13 is required for camalexin (44) 
production. Incubation of CYP71A13 with indolyl-3-acetaldoxime (112) indicated that 
CYP71A13 catalyzes the dehydration of 112 to indolyl-3-acetonitrile (49) in the 
biosynthesis of camalexin (Nafisi et al., 2007). These results rather suggested that 
indolyl-3-acetonitrile (49) is an intermediate in the biosynthesis of camalexin (44) 
(Nafisi et al., 2007). The conversion of indolyl-3-acetonitrile (49) to dihydrocamalexic 
acid (132) is neither understood nor established. 
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Figure 1.14 Biosynthetic intermediates of camalexin (44). Enzymes involved in the 
biosynthetic pathway: i) CYP71A13; ii) CYP71B15 (PAD3) (Pedras et al., 2007b; 
Schuhegger et al., 2006). 
 
The phytoalexins brassicanal A (39) and brassicanate A (43) are examples of 
phytoalexins that have only one sulfur atom. Previously, a trapping experiment was 
performed to establish the potential intermediates in the biosynthetic pathway of 
brassicanal A (39) (Figure 1.15). Addition of aniline to UV-irradiated turnip root slices 
resulted in production of a new compound 136 (Figure 1.15). Compound 136 was 
suggested to be the aniline trapped biosynthetic intermediate 2-mercaptoindole-3-
carboxaldehyde (135) since its biological methylation leads to brassicanal A (Monde et 
al., 1996). The proposed intermediate 135 was suggested to derive from hydrolysis of 
dehydrocyclobrassinin (133), which in turn would be formed from enzymatic 
dehydrogenation of cyclobrassinin (28). Dehydrocyclobrassinin (133) has not been 
isolated, although the 4-methoxy-dervative (32) is known (Monde et al., 1996). 
Biosynthetic investigations employing rutabaga root slices revealed [4',5',6',7'-
2H4]brassinin incorporation into brassicanal A (39a) and brassicanate A (43a), whereas 
112 49 132 44 
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incorporation of [4',5',6',7'-2H4]cyclobrassinin was not detected into either brassicanal A 
or brassicanate A (Pedras et al., 2004). Brassicanal A (39) is a putative precursor of 
brassicanate A (43) (Pedras et al., 2004), and luck of incorporation of cyclobrassinin 
under the experimental conditions suggested that possibly the trapped intermediate 
(Monde et al., 1996) was derived from brassinin (16) and not cyclobrassinin (28). Origin 
of the thiomethyl group at C-2 of indole therefore remains to be established, but could 
perhaps be deriving from methionine. 
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Figure 1.15 Putative biosynthetic pathway of brassicanal A (39). i) Biological 
methylation of 2-mercaptoindole-3-carboxaldehyde (135) yields brassicanal A; ii) 
Incorporation of cyclobrassinin (28) into brassicanal A (39) was not detected in rutabaga 
root slices. Compounds in bracket are proposed intermediates (Monde et al., 1996; 
Pedras et al., 2003b). 
 
The occurrence of brassinin (16), 1-methoxybrassinin (18) and cyclobrassinin (28) 
in Pseudomonas cichorii-inoculated Chinese cabbage and Japanese radish roots 
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suggested a possible N-hydroxylation and subsequent methylation of brassinin to give 1-
methoxybrassinin, and that oxidative cyclization of 1-methoxybrassinin would lead to 
cyclobrassinin (Monde et al., 1995; Pedras et al., 2003b). [3,3,3-2H3]Brassinin (16b) 
however, was efficiently incorporated into cyclobrassinin (28b) and not into 1-
methoxybrassinin (18a) (Monde et al., 1995b) (Figure 1.16). These findings suggested 
that 28 is biosynthesized directly from brassinin (16) and not through 1-
methoxybrassinin (18). These conclusions were further supported by absence of 
incorporation of [3,3,3-2H3]1-methoxybrassinin (18a) into cyclobrassinin (Monde et al., 
1995b). These metabolic studies indicated that perhaps the biosynthetic pathway of 1-
methoxy-containing phytoalexins diverges from the NH-containing phytoalexins before 
formation of brassinin (16), and that 1-methoxybrassinin (18) is the biosynthetic 
precursor of 1-methoxy-containing phytoalexins. Additional investigation employing 
rutabaga root slices showed equal incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime 
(112a) into [4',5',6',7'-2H4]brassinin (16a) and [4',5',6',7'-2H4]1-methoxybrassinin (18b) 
(Pedras et al., 2004), suggesting two parallel biosynthetic pathways leading to 16 and 18 
(Figure 1.16) (Pedras et al., 2003b). To establish the plausible intermediate between 
indolyl-3-acetaldoxime (112) and 1-methoxybrassinin (18), [1",1",1"-2H3]1-
methoxyindolyl-3-acetaldoxime (116a) was synthesized for the first time and was 
incubated with rutabaga and kohlrabi root slices. Mass spectrometry analysis of the 
isolated 1-methoxybrassinin (18a) revealed deuterium incorporation from [1",1",1"-
2H3]1-methoxyindolyl-3-acetaldoxime (116a) in both rutabaga and kohlrabi root slices. 
Additional feeding experiments revealed incorporation of [4',5',6',7'-2H4]indolyl-3-
acetaldoxime into brassinin (16a), 1-methoxybrassinin (18b), and spirobrassinin (34b) 
(Pedras et al., 2004). These metabolic studies were the first to demonstrate that 
biosynthetic pathway of NH-containing and 1-methoxy-containing phytoalexins divert at 
the aldoxime step. It was therefore surmised that indolyl-3-acetaldoxime (112) is 
transformed into brassinin and then to other NH-containing phytoalexins, whereas N-
oxydation and methylation of 112 yields 1-methoxyindolyl-3-acetaldoxime (116), the 
precursor of 1-methoxybrassinin (18) which is the plausible precursor of other 1-
methoxy-containing phytoalexins (Pedras and Montaut, 2004). Biosynthetic pathways of 
erucalexin (38) and 1-methoxyspirobrassinin (35) have been studied (Pedras et al., 
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2007b; Pedras and Okinyo, 2006b) and are part of this thesis, as reported in the Results 
and Discussion sections. 
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Figure 1.16 Biosynthesis of brassinin (16a) and cyclobrassinin (28a) from indolyl-3-
acetaldoxime (112a), and 1-methoxybrassinin (18b) from 1-methoxyindolyl-3-
acetaldoxime (116a) (Pedras and Montaut, 2004; Pedras et al., 2004). 
 
The biosynthesis of many other 1-methoxy-containing phytoalexins such as 1-
methoxybrassenins A (21) and B (22), wasalexins A (23) and B (24), and sinalbins A 
(30) and B (31), among others remain to be investigated. It is therefore necessary to 
carry out biosynthetic studies to unravel the pathways leading to such phytoalexins as 
this may facilitate transfer of these pathways to other cruciferous crops. 
The three most recently reported phytoalexins, rapalexins A (53) and B (54), and 
brussalexin A (55) have introduced yet new structures among the crucifer phytoalexins 
(Pedras et al., 2007b; 2007c). The rapalexins A and B were proposed to derive from 
putative indolyl glucosinolates or from thiohydroximic acids such 137 and 138 (Figure 
1.17). Lossen-type rearrangement to intermediate 139 would then yield 53 and 54 
(Figure 1.17). Brussalexin A (55) represents a unique chemical structure that does not 
seem to fit with the presently known biosynthetic pathway of crucifer phytoalexins 
isolated to date (Pedras et al., 2007b). It was therefore proposed that brussalexin A could 
biosynthetically derive from addition of indolyl-3-methane thiol (142) to allyl 
isothiocyanate 68 (produced from myrosinase hydrolysis of sinigrin, 56, Figure 1.18) 
(Pedras et al., 2007c). 
112 16 28 
116 18 
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Figure 1.17 Proposed biosynthetic precursors of rapalexin A (53) and B (54) (Pedras 
et al., 2007b). 
 
NO3SO
Sβ
K
N
C
S
N
H
S
HN
O
N
H
SH
DGlc
 
 
Figure 1.18 Proposed biosynthetic precursors 56 and 68 of brussalexin A (55) (Pedras 
et al., 2007c). 
 
1.4.4.2 Glucosinolates 
The biosynthesis of glucosinolates can be divided into three different stages: (i) 
chain elongation of certain aliphatic and aromatic amino acids via sequential addition of 
methylene groups, (ii) construction of the core structure of glucosinolates, and (iii) 
secondary modification of the side chain (Grubb and Abel, 2006; Halkier and 
Gershenzon, 2006). 
Side chain elongation 
Chain elongated aliphatic glucosinolates are the most abundant glucosinolates 
found in crucifers including the model plant A. thaliana and many other Brassicaceae 
species (Halkier and Gershenzon, 2006). The extent of side chain elongation and type of 
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55 
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modifications are important for the biological activity of the glucosinolate breakdown 
product (Manici et al., 1997; Mithen et al., 1986; Sarwar et al., 1998). The side chain-
elongation reactions have been investigated using in vivo labeling studies, isolation of 
the participating intermediates, and characterization of the enzymes catalyzing various 
reactions of the biosynthetic pathway. Side chain elongation reactions are shown in 
Figure 1.19. 
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Figure 1.19 Side chain elongation: i) BRANCHED-CHAIN 
AMINOTRANSFERASE4 (BCAT4); ii) 2-(ω-Methylthioalkyl)malate synthase 
(MAMS) or Methylthioalkylmalate synthase 1 (MAM1) or Methylthioalkylmalate 
synthase 3 (MAM3); iii) Isomerization; iv) Oxidative decarboxylation; v) 
Transamination (Graser et al., 2000; Halkier and Gershenzon, 2006). 
 
Side chain-elongation begins with oxidative deamination of the parent amino acid 
(143) to yield the corresponding 2-oxo acid (144). One of the enzymes catalyzing 
oxidative deamination of amino acids, BRANCHED-CHAIN AMINOTRANSFERASE4 
(BCAT4) in the biosynthetic pathway of methionine-derived glucosinolates was 
characterized from A. thaliana (Schuster et al., 2006). The 2-oxo acid (144) enters a 
three step-cycle in which it (i) condenses with acetyl CoA to form a substituted 2-malate 
derivative (145) which (ii) isomerizes by a 1,2-shift of the hydroxyl group to form a 3-
malate derivative (146) that is (iii) oxidatively decarboxylated to yield a new 2-oxo acid 
143 144 
146 
145 
147 148 
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with one additional methylene group (147) (Graser et al., 2000; Halkier and Gershenzon, 
2006; Falk et al., 2004; Textor et al., 2004; 2007). The 2-oxo acid 147 can undergo 
transamination to regenerate the amino acid (148) which enters the biosynthetic pathway 
of short chain aliphatic or aromatic glucosinolates, or it may undergo further cycles of 
chain-elongation to form longer homologs (Textor et al., 2004; 2007). Chain elongation 
products of up to nine cycles are known to occur in plants (Fahey et al, 2001), but only 
six cycles are known in the model plant A. thaliana (Textor et al., 2004; 2007). All 
chain-elongated 2-oxo acids are converted back to the corresponding amino acids that 
participate in the biosynthetic pathway of glucosinolates of varying side-chain lengths 
(Graser et al., 2000). 
An extensive study on the sequence of chain-elongation reactions was conducted 
by carrying out in vivo feeding experiments using stable and radiolabeled isotopes 
(Graser et al., 2000). These experiments revealed that only the acetate methyl group is 
incorporated to form the methylene group in chain-elongated products, thus suggesting 
that the carboxyl group of the first acetate residue is lost as carbon dioxide during the 
second round of chain-elongation, and during aldoxime formation (Graser et al., 2000). 
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Figure 1.20 Condensation of acetyl CoA with a 2-oxo acid (144). 
 
It was established that the nitrogen atom of the parent amino acid is incorporated 
into the core glucosinolate structure arising from the chain-elongated amino acid. It was 
therefore concluded that the transfer of amino group in the first step initiates the 
formation of 2-oxo acid, and re-incorporation into the biosynthetic pathway terminates 
the chain elongation reaction to regenerate the amino acid that is required to take part in 
the biosynthetic pathway of chain-elongated glucosinolates (Graser et al., 2000). 
145 148 144 
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Detection of intermediates and isolation of chain-elongated homologs have further 
supported the chain elongation reactions (Halkier and Gershenzon, 2006). The enzyme 
catalyzing the first step of chain-elongation reaction, 2-(ω-methylthioalkyl)malate 
synthases (MAMS), was partially purified from rocket (Falk et al., 2004). MAMS 
however could not catalyze the second cycle of chain-elongation indicating that it was 
specific for the first round only (Falk et al., 2004). Another methylthioalkylmalate 
synthase, methylthioalkylmalate synthase 1 (MAM1) from A. thaliana was capable of 
catalyzing both first and second rounds of chain-elongation cycles (Kryomann et al., 
2001; Textor et al., 2004). MAM1 was reported to exist together with MAM3 (formerly 
known as MAM-L for MAM-like) in A. thaliana (Textor et al., 2007). Unlike MAM1, 
MAM3 is capable of catalyzing all six condensation reactions of methionine chain-
elongation that occur in Arabidopsis, it also exhibits a broad substrate range of other 
non-methionine derived 2-oxo acids (Textor et al., 2007). 
Biosynthesis of the glucosinolate core structure 
The biosynthesis of aliphatic, aromatic, and indolyl core glucosinolate structure 
involves common intermediates (N-hydroxy amino acid, aldoximes, aci-nitro or nitrile 
oxides, S-alkyl thiohydroximates, thiohydroxamic acids, and desulfoglucosinolates) 
(Figure 1.21). 
 
 52 
R COOH
NH2
[O]
R COOH
NHOH
CO2
H2
R
N OH
[O]
R
N OHO
Cys
R
N OH
S
NH3
H
CO2
R
N OH
SH
UDP-Glc
R
N OH
S β D Glc PAPS
R
N OSO3
S β D Glc
i
ii
iiiiv
vi
v
 
 
Figure 1.21 Proposed biosynthetic pathway of glucosinolates: i) CYP79F1, CYP79F2 
(methionine), CYP79A2 (phenylalanine), CYP79B1, CYP79B3, CYP79B3 
(tryptophan); ii) CYP83A1 (methionine), CYP83B1 (phenylalanine, tryptophan); iii) 
GST?; iv) C-S lyase; v) UGT74B1 v) AtST5a (phenylalanine, tryptophan), AtST5b, 
AtST5c (methionine). Structures in brackets are proposed intermediates (Halkier and 
Gershenzon, 2006). 
 
The first common step in glucosinolate and cyanogenic glucoside biosynthesis is 
the conversion of amino acids (148) to their respective aldoximes (150) (Bennet et al., 
1993; 1997; Dawson et al. 1993; Dewick, 1984; Du et al., 1995; Wittstock and Halkier, 
2000). The aldoxime forming enzyme was proposed to catalyze N-hydroxylation of 
amino acids to the corresponding N-hydroxyamino acids (149) that decarboxylate to 
produce the aldoxime (150). Cytochrome P450 family type of enzymes were shown to 
catalyze such transformations (Halkier and Møller, 1991; Koch et al., 1992). The 
148 149 150 
151 153 
155 154 
152 
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enzymes CYP79F1 and CYP79F2 metabolize chain elongated derivatives of methionine 
to their respective aldoximes in the biosynthesis of aliphatic glucosinolates, but not 
tyrosine, tryptophan, or their derivatives (Chen et al., 2003; Hansen et al., 2001a; 
Reintanz et al., 2001). CYP79A2 on the other hand catalyzes the metabolism 
phenylalanine to phenylacetaldoxime in the biosynthetic pathway of aromatic 
glucosinolates (Wittstock and Halkier, 2000). The enzymes CYP79B1, CYP79B2 and 
CYP79B3 catalyze the conversion of L-tryptophan (78) to indolyl-3-acetaldoxime (112) 
in the biosynthesis of indolyl glucosinolates (Hansen and Halkier, 2005; Hull et al., 
2000; Mikkelsen et al., 2000; Naur et al., 2003b). Overexpression of CYP79B2 in 
Arabidopsis resulted in significant increase in levels of indolyl glucosinolates 
glucobrassicin (70) and 4-methoxyglucobrassicin (156), but not of aliphatic or aromatic 
glucosinolates (Mikkelsen et al., 2000). 
Following its formation, the aldoxime (150) is conjugated with a suitable thiol 
donor to yield an S-alkyl-thiohydroximate (152). Both cysteine and methionine are 
known thiol donors in the biosynthetic pathway of many secondary metabolites, the 
former is however a more efficient donor than the latter (Mikkelsen et al., 2002). The 
aldoxime metabolizing enzymes in the biosynthesis of glucosinolates (in A. thaliana) 
have been characterized. The enzyme CYP83A1 metabolizes aliphatic aldoximes much 
more efficiently than CYP83B1 (Bak and Feyereisen, 2001; Hemm et al., 2003; Naur et 
al., 2003a). The enzyme CYP83B1 catalyzes the metabolism of aromatic aldoximes 
derived from tyrosine and phenylalanine (Hansen et al., 2001b), as well as indolyl-3-
acetaldoxime (Bak and Feyereisen, 2001). CYP83A1 enzyme is capable of metabolizing 
indolyl-3-acetaldoxime albeit with low efficiency (Bak and Feyereisen, 2001). 
Conjugation of the aldoxime (150) with the thiol donor (e.g. L-cysteine) requires 
conversion of 150 into a reactive intermediate that can be attacked by the nucleophilic 
thiol donor. The CYP83 enzymes have been proposed to catalyze the oxidation of 
respective aldoximes to highly reactive 1-aci-nitro compounds (151) or nitrile oxides 
(Bak et al., 2001; Bak and Feyereisen, 2001; Hansen et al., 2001b). Proper conjugation 
of the sulfur donor (L-cysteine) with the reactive intermediate (aci-nitro compound or 
nitrile oxide) is thought to be catalyzed by a glutathione-S-transferase type enzyme 
(Mikkelsen et al., 2004). The C-S bond of S-(thiohydroximoyl)-L-cysteine (152) is 
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hydrolyzed by C-S lyase to form thiohydroximic acid (153) which is the next 
intermediate in the biosynthetic pathway of glucosinolates. The L-cysteine conjugate 
(152) does not accumulate in plant tissues and has therefore not been isolated. In vitro, 
152 rapidly cyclizes to 2-substituted thiazoline-4-carboxylic acid (157) (Figure 1.22), 
leading to a suggestion that the C-S lyases form tightly coupled complexes with CYP83 
enzymes to prevent cylization of the C-S lyase substrates (Hansen et al., 2001b; Halkier 
and Gershenzon, 2006). SUPERROOT1 (SUR1) was characterized as a C-S lyase 
enzyme in the biosynthetic pathway of A. thaliana glucosinolates (Figures 1.21 and 
1.22) (Mikkelsen et al., 2004). 
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Figure 1.22 Cyclization of cysteine conjugate (152) to thiazoline-4-carboxylic acid 
(157), and SUPERROOT1 (SUR1) cleavage of C-S bond (Hansen et al., 2001b). 
 
The thiohydroximic acid (153, Figure 1.22) formed is highly reactive and has not 
been isolated, but is subsequently glycosylated by a sugar nucleotide to produce 
desulfoglucosinolate (154, Figure 1.21). Uridine diphosphate glucose (UDPG) was 
found to be the most efficient glucose donor (Mitsuo and Underhill, 1971). A putative 
UDPG:thiohydroximate glucosyltransferase in the biosynthetic pathway of benzyl 
glucosinolate was isolated from Arabidopsis and was characterized as UGT74B1 (Grubb 
et al., 2004). Loss of UGT74B1 gene function only caused partial reduction of 
glucosinolate accumulation, suggesting that additional enzymes catalyzing glucosylation 
of thiohydroximates are present (Grubb et al., 2004). Enzyme preparations of 
UDPG:thiohydroximate glucosyltransferase purified from Brassica napus seedlings 
were reported to glycosylate sodium 3-phenylpropanothiohydroximate (100) to 
phenylethyl desulfoglucosinolate (158) (Figure 1.23, Reed et al., 1993). The use of 
similar enzyme preparations with sodium 2-(3-indolyl)acetothiohydroximate (99) were 
152 157 153 
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reported to give only detectable amounts of desulfoglucobrassicin (159) since 99 was not 
stable in the buffer used (pH 6) (Figure 1.23, Reed et al., 1993). 
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Figure 1.23 UDPG:thiohydroximate glucosyltransferase glycosylation of sodium 3-
phenylpropanothiohydroximate (100) to phenylethyl desulfoglucosinolate (158) (Reed et 
al., 1993). 
 
The last common step in building glucosinolate core structure (155) (for aliphatic, 
aromatic and indolyl glucosinolates) is the introduction of an active sulfate group from 
3'-phosphoadenosine-5'-phosphosulfate (PAPS) to desulfoglucosinolate (154). Sulfation 
of desulfoglucosinolates is catalyzed by sulfotransferases (Glending and Poulton, 1988; 
1990; Jain et al., 1989;1990; Klein et al., 2006; Piotrowski et al., 2004). Three 
sulfotransferases AtST5a, AtST5b, and AtST5c exhibiting broad substrate range have 
been characterized from A. thaliana (Piotrowski et al., 2004). Whereas AtST5b and 
AtST5c had higher affinity for aliphatic glucosinolates, AtST5a preferred tryptophan- 
and phenylalanine-derived desulfoglucosinolates (Piotrowski et al., 2004). 
Side chain modification 
Glucosinolate side chain modifications play a significant role in determining the 
biological activity of the hydrolysis product (Halkier and Gershenzon, 2006). The side 
chain modifications have been noted to occur in glucosinolates derived from methionine 
100 158 
159 99 
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and its homologs (160), the transformations may involve sequential oxidations, 
eliminations, alkylations, and esterifications (Figure 1.24) (Halkier and Gershenzon, 
2006; Grubb and Abel, 2006). The sulfur can be successively oxidized to 
methylsulfinylalkyl (161) and methylsulfonylalkyl (162) moieties (Halkier and 
Gershenzon, 2006). Further modifications may involve oxidative cleavage of the 
methylsulfinylalkyl moiety to yield alkenyl (163) or hyroxyalkyl (164) side chains for 
which controlling genetic loci are known in Arabidopsis and Brassica species (Halkier 
and Gershenzon, 2006). 
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Figure 1.24 Side chain modifications of methionine-derived glucosinolates with 
varying side chain lengths. APO2 and APO3 are putative enzymes catalyzing the 
reactions in Arabidopsis (Halkier and Gershenzon, 2006; Kliebenstein et al., 2001). 
 
The AOP2 gene product catalyzes the conversion of methylsulfinylalkyl 
glucosinolates (161) to alkenyl glucosinolates (163), whereas the AOP3 gene product 
controls the formation of hydroxyalkyl glucosinolates (164) from 161 (Kliebenstein et 
al., 2001). Although biosynthesis of glucosinolate esters (165) have been investigated 
160 
161 
162 
163 
164 
165 
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through administration of isotopically labeled precursors and intermediates, no studies 
have been carried out to determine the enzymes involved in their biosynthetic pathways 
(Graser et al., 2001). 
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1.5 Conclusion 
Phytoalexins and glucosinolates are only two components of the complex 
mechanism by which plants respond to various forms of stress including overcoming 
microbial attack. The increased rate of accumulation of glucosinolates in infected or 
stressed plants is an indication of the role that they play in protecting plants against 
subsequent attacks (Agrawal et al., 2002; Mewis et al., 2005; Traw, 2002; van Dam et 
al., 2005). On the other hand, the timing, rate of accumulation and relative amounts of 
phytoalexins have shown their significant role in plant defense against pathogen invasion 
(Dixon, 1986; Dixon and Harrison, 1994; Kuć, 1995; Smith, 1996). Phytoalexins are 
often isolated in insufficient quantities that limit investigating their antimicrobial 
activity. In order to get sufficient amounts, synthetic strategies have been developed and 
the antimicrobial activities of the various phytoalexins have been established against a 
range of plant pathogens (Pedras et al., 2003b; 2007b; 2007c). Although there has been 
tremendous effort to unravel the biosynthetic pathway of glucosinolates, especially with 
the sequencing of Arabidopsis genome (Grubb and Abel, 2006; Halkier and Gershenzon, 
2006), very little has been done in phytoalexin biosynthetic pathway in terms of genetic 
analysis. An increasing number of wild and cultivated plants exhibiting resistance to a 
variety of pathogens are being found and identified (Conn et al., 1988; Gugel et al., 
1990; Lefol et al., 1997; Pedras and Zaharia, 2000). Such resistant species may provide 
good genetic sources to control the devastating effect of various pathogens, and yet most 
remain uninvestigated. By isolation and characterization of phytoalexins, their synthesis 
allows for further investigation of their interaction with various plant pathogens (Pedras 
et al., 2007b). For example, erucalexin (38) isolated as a phytoalexin of Erucastrum 
gallicum (dog mustard), a wild crucifer known to be resistant to Sclerotinia 
sclerotiorum, exhibited remarkable antifungal activity against this pathogen (Pedras et 
al., 2006a). To date, the phytoalexin caulilexin A (42) has exhibited the strongest 
antifungal activity against S. sclerotiorum (Pedras et al., 2006b), plants producing 
caulilexin A such as cauliflower are therefore good genetic sources for controlling S. 
sclerotiorum. Many more phytoalexins with unique skeletal structures such as rapalexins 
A (53) and B (54) (Pedras et al., 2007a), and brussalexin (55) (Pedras et al., 2007c) have 
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been isolated, synthesized and their antifungal activities against a range of pathogens 
established. Identification of phytoalexins from the resistant species also provides an 
opportunity for the synthesis of various biosynthetic intermediates that can be used to 
investigate their biosynthetic pathways (Pedras et al., 2003b; 2007b). An understanding 
of the biosynthetic pathways will allow for genetic manipulation of the susceptible 
species, to make them produce metabolites similar to those of resistant plants, thus 
enhancing their disease resistance with a result in improved crop production. 
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CHAPTER 2  
2. Results 
2.1 Analysis of antifungal secondary metabolites from 
Eruca sativa (rocket) 
The search for phytoalexins from cruciferous plants resistant to economically 
important fungal diseases led to the investigation of rocket (Eruca sativa), a wild 
crucifer reported to exhibit resistance against Alternaria brassicae (Conn et al., 1988). 
Although a number of glucosinolates and their degradation products (isothiocyanates) 
have been isolated from rocket (Bennett et al., 2002; Cataldy et al., 2007; Cerny et al., 
1996; Kim and Ishii, 2006), no phytoalexins have been reported to date. Previous 
investigations involving administration of destruxin B (a host-selective toxin produced 
by the pathogen A. brassicae) to petiolated leaves of rocket did not induce detectable 
amounts of phytoalexins (Pedras et al., 2003c). Since cruciferous plants produce 
different secondary metabolites depending on the type of stress (Pedras et al., 2007b; 
2007e), the current investigation has undertaken abiotic elicitation of rocket with 
copper(II) chloride, followed by HPLC-DAD analyses and TLC biodetection of 
bioactive compounds employing spores of Cladosporium cucumerinum. 
2.1.1 Time-course analysis 
In preliminary experiments, time course analyses were conducted by spraying 14-
and 21-day-old plants with copper(II) chloride to the point of run-off. After incubation 
for 24 hours, leaves were excised, extracted and subjected to HPLC-DAD analyses. 
Additional leaves were harvested every 24 hours up to 168 hours; control leaves were 
sprayed with water, were extracted and analyzed similarly. Comparison of the 
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metabolite profiles of elicited and control leaf extracts indicated that a peak in the 
chromatograms of elicited extracts was absent in those of control extracts. This peak 
with tR =14.2 min was identified as arvelexin (51) by comparison of its retention time 
and UV spectra with those of an authentic sample. The amount of arvelexin in leaf 
extracts was determined by HPLC-DAD using calibration curves (Table 2.1). Amounts 
of arvelexin were generally higher in 21-day-old plants than in 14-day-old plants. The 
highest amount of arvelexin was detected in 21-day-old leaf extracts obtained after a 24-
hour incubation period. Gradual decrease of arvelexin amounts was noted from 48 to 
168-hour incubation periods (Table 2.1). 
 
N
H
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Table 2.1 Time-course HPLC analyses of production of arvelexin in rocket (Eruca 
sativa) 
 
Phytoalexin Incubation time 
(h) 
Total amount of phytoalexin 
(µmole/100 g of fresh tissue ± 
STD)a 
Arvelexin (51) 24 6.7 ± 1.2 
 48 6.7 ± 2.3 
 72 2.6 ± 0.8 
 96 1.9 ± 1.0 
 120 1.4 ± 0.3 
 144 1.0 ± 0.6 
 168 0.9 ± 0.8 
aAmounts of arvelexin (51) determined by HPLC-DAD using calibration curves. Total 
amount ± standard deviation (STD); average of three independent experiments 
conducted in triplicate. 
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Since arvelexin (51) was the only induced metabolite of rocket detected by HPLC-
DAD, an alternative method for detection of antifungal compounds (TLC biodetection) 
was used to supplement HPLC-DAD analyses. TLC biodetection was conducted using 
spores of Cladosporium cucumerinum to detect additional antifungal compounds present 
in the extracts (Pedras and Sorensen, 1998). Extracts from elicited and control leaves 
were spotted on TLC plates strips (developed with EtOAc-hexane, 60:40, followed by 
air drying). The dried plates were sprayed with a suspension of C. cucumerinum spores 
in double strength PDB and incubated for 36 hours in darkness; control plates were 
similarly developed and sprayed with a spore suspension. The TLC plates containing 
elicited or control extracts indicated three spots that appeared white on a gray 
background indicating the presence of antifungal compounds. The white spots were due 
to inhibition of spore germination on a gray background of fungal mycelia. Since HPLC-
DAD analyses of these extracts indicated that arvelexin (51) was the only induced 
compound, the antifungal spots observed were likely due to constitutive secondary 
metabolites. 
2.1.2 Isolation and identification of antifungal metabolites 
In order to carry out isolation and identification of antifungal metabolites, 21-day-
old plants were elicited and were extracted following experimental procedures similar to 
those of time course analyses. Extraction was carried out sequentially with n-hexane, 
ethyl acetate and methanol. The extracts were analyzed by HPLC-DAD and antifungal 
metabolites were detected by spore germination inhibition assays employing 
Cladosporium cucumerinum spores. Multiple chromatographic separations using FCC 
and PTLC were conducted; fractions obtained were subjected to HPLC-DAD analysis 
and TLC-biodetection. Two compounds with tR = 22.5 (166) and 34.7 (167) min (HPLC-
DAD) were purified from elicited and control leaf extracts. These two compounds 
inhibited spore germination in TLC-biodetection assays, suggesting that they are 
constitutive antifungal components of rocket. The third bioactive spot did not yield 
sufficient amount of compound for bioassays or for characterization. The two 
metabolites (166 and 167) were characterized by 1H NMR, 13C NMR, and HRMS-EI, as 
follows. 
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The HRMS-EI of compound 166 with tR = 22.5 min indicated a molecular ion at 
m/z 161.0333 that was consistent with the molecular formula C6H11NS2. The 1H NMR 
spectrum showed 11 protons (four methylene protons at δH 1.77, 1.84, 2.56, 3.58, and a 
singlet at δH 2.12 indicating presence of a SCH3 group) as suggested by HRMS. The 13C 
NMR spectroscopic data corroborated the structural assignment based on 1H NMR. 
From these data, the structure of compound 166 was assigned as 4-methylthiobutyl 
isothiocyanate. Compound 166 was previously isolated and identified from rocket 
extracts (Bennett et al., 2002); the spectroscopic data obtained were consistent with that 
reported (Vermeulen et al., 2003). 
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The HRMS-EI of compound 167 with tR = 34.7 min (HPLC-DAD) indicated a 
molecular ion at m/z 292.0196 which was consistent with the molecular formula 
C10H16N2S4, and a fragment ion at m/z 146.0095 which was consistent with the 
molecular formula C5H8NS2. 1H NMR spectrum showed 8 protons (four methylene 
groups at δH 1.85, 2.74, and 3.59) whereas the 13C NMR spectrum indicated the presence 
of 5 carbons (four methylene carbons at δC 45.1, 38.3, 29.0, 26.4, and a broad singlet at 
130.9) thus suggesting a symmetrical structure. The structure of compound 167 was 
therefore assigned as bis(4-isothiocyanatobutyl)disulfide. Compound 167 was previously 
isolated and identified from rocket extracts; the spectroscopic data obtained were 
consistent with that reported (Cerny et al., 1996). 
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2.2 Biosynthesis of phytoalexins and glucosinolates 
Phytoalexins and glucosinolates play a vital role in plant defense systems. 
Cultivated crucifers are susceptible to various fungal diseases such as blackleg, 
blackspot, and Sclerotinia stem rot among others. A few wild species have been reported 
to be resistant to some of these fungal diseases. Production of crops with enhanced 
disease resistance can be achieved through genetic manipulation by, for example, 
making them capable of producing metabolites involved in defense mechanisms (Dixon, 
2005). The transfer of such positive traits will require an understanding of the 
biosynthetic pathways of these metabolites. The study of biosynthetic pathways requires 
synthesis of potential biosynthetic precursors containing isotopes that allow 
measurements of their incorporation. 
2.2.1 Syntheses of compounds 
The use of perdeuterated compounds in biosynthetic studies is invaluable as 
extremely small amounts of deuterated metabolites can be detected unambiguously by 
mass spectrometry, e.g. ESI-HRMS or APCI-HRMS (Pedras and Okinyo, 2006a). The 
indole derivatives of immediate interest needed to contain at least three deuterium atoms, 
as this number can allow the unambiguous detection and assignment of labeled 
phytoalexins using HRMS analysis of m/z [M + 3]+/─ and corresponding fragment ions 
m/z [M ─ X + 3]+/−. Potential precursors containing different amounts of deuterium were 
synthesized: [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a), [4',5',6',7'-2H4]1-
methoxyindolyl-3-acetaldoxime (116b), [1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-
acetaldoxime (116c), [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a), 
[4',5',6',7'-2H4]1-methoxybrassinin (18b), [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c), 
[4',5',6',7'-2H4]sinalbin B (31a), [4',5',6',7'-2H4]cyclobrassinin (28a), and 
[SC2H3]brassicanal A (39b). 
In addition compounds (non-isotopically labeled) that would lead to non-natural 
products if incorporated, i.e. substrates used for precursor-directed biosynthesis 
(Glaswischnig et al., 2004; Xu et al., 2007), were prepared: 1-methylindolyl-3-
acetaldoxime (170), 1-methylindolyl-3-acetothiohydroxamic acid (178), 1-(t-
butoxycarbonyl)indol-3-ylmethyl-isothiocyanate (180) and 1-acetylindol-3-
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ylmethylisothiocyanate (183). Incorporation of such precursors can be determined by 
comparison of HPLC-DAD chromatograms of fed and control extracts. Synthesis of 
non-natural phytoalexin derivatives followed by HPLC-DAD and HPLC-MS-ESI 
analyses can be employed to unambiguously identify the phytoalexins incorporating the 
non-natural precursors. 
2.2.1.1 Synthesis of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
and derivatives 
This section covers the synthesis of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a), 
[4',5',6',7'-2H4]1-methoxyindolyl-3-acetaldoxime (116b), [1",1",1",4',5',6',7'-2H7]1-
methoxyindolyl-3-acetaldoxime (116c), and 1-methylindolyl-3-acetaldoxime (170) 
[4',5',6',7'-2H4]Indolyl-3-acetaldoxime (112a) 
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Scheme 2.1 Reagents and conditions: i) ClCH2CN, NaOH, DMSO, 40%; ii) 10% 
Pd/C, H2, EtOAc, 61%; iii) Mg, ICH3, BrCH2CN, Et2O, 57%; iv) DIBAH; v) 
HONH2·HCl, NaOAc, EtOH, 33% from 49a (Pedras and Okinyo, 2006a). 
 
[3,4,5,6-2H4]2-Nitrophenylacetonitrile was prepared from [2,3,4,5,6-
2H5]nitrobenzene (168a) through vicarious nucleophilic substitution of hydrogen with 
168a 105a 49a 
112a 
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chloroacetonitrile (Makosza and Winiarski, 1984). This procedure provided a mixture of 
[3,4,5,6-2H4]2-nitrophenylacetonitrile and [2,3,5,6-2H4]4-nitrophenylacetonitrile in a 
10:1 ratio at 40% yield in one step (Pedras and Okinyo, 2006a). Hydrogenation of the 
mixture under balloon pressure at room temperature yielded [4,5,6,7-2H4]indole (105a) 
and [2,3,5,6-2H4]4-aminophenylacetonitrile; [2,3,5,6-2H4]4-aminophenylacetonitrile was 
separated from the reaction mixture as a hydrochloride salt upon treatment of the 
reaction mixture with HCl (1 M), yielding [4,5,6,7-2H4]indole in 61% (Pedras and 
Okinyo, 2006a). [4',5',6',7'-2H4]Indolyl-3-acetonitrile (49a) was prepared by reacting 
indolylmagnesium iodide (prepared from [4,5,6,7-2H4]indole, and Mg/methyl iodide) 
with bromoacetonitrile (Pedras et al., 2003a). Reduction of [4',5',6',7'-2H4]indolyl-3-
acetonitrile to the unstable [4',5',6',7'-2H4]indolyl-3-acetaldehyde with 
diisobutylaluminium hydride (DIBAH), followed by hydrolysis with HCl (2 M, 
Miyashita et al., 1997) and immediate treatment with hydroxylamine hydrochloride and 
sodium acetate yielded [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a, Scheme 2.1) in 
33% over two steps (Pedras and Okinyo, 2006a). 
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[4',5',6',7'-2H4]1-Methoxyindolyl-3-acetaldoxime (116b) and 
[1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime (116c) 
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Scheme 2.2 Reagents and conditions: i) 10% Pd/C, H2, Ac2O; ii) NaBH3CN, AcOH; 
iii) Na2WO4·2H2O, H2O2, CH3OH; iv) (CH3O)2SO2, K2CO3; v) (C2H3O)2SO2, K2CO3, 
CH3OH; vi) NaOH, CH3OH, reflux; vii) Na2WO4·2H2O, H2O2, CH3OH, 5% from 49a 
(Pedras and Okinyo, 2006a); viii) Na2WO4·2H2O, H2O2, CH3OH, 4% from 49a (Pedras 
and Okinyo, 2006a). 
 
[4',5',6',7'-2H4]1-Methoxyindolyl-3-acetaldoxime and [1",1",1",4',5',6',7'-2H7]1-
methoxyindolyl-3-acetaldoxime were synthesized as shown in Scheme 2.2. [4',5',6',7'-
2H4]Nb-Acetyltryptamine was prepared in one step by hydrogenation of [4',5',6',7'-
2H4]indolyl-3-acetonitrile in acetic anhydride at room temperature. Reduction of 
[4',5',6',7'-2H4]Nb-acetyltryptamine with sodium cyanoborohydride in glacial acetic acid 
yielded [4',5',6',7'-2H4]Nb-acetyl-2,3-dihyroindolyl-3-ethylamine (114a). Oxidation of 
114a with hydrogen peroxide followed by methylation of the 1-hydroxyindolyl 
intermediate with dimethylsulphate or hexadeuterated dimethylsulphate (Somei and 
Kawasaki, 1989) yielded [4',5',6',7'-2H4]Nb-acetyl-1-methoxytryptamine (115b) or 
[1",1",1",4',5',6',7'-2H7]Nb-acetyl-1-methoxytryptamine (115c), respectively. Sodium 
hydroxide hydrolysis of the Nb-acetyl groups of 115b and 115c yielded [4',5',6',7'-2H4]1-
49a 114a 115b 
116b 115c 116c 
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methoxytryptamine and [1",1",1",4',5',6',7'-2H7]1-methoxytryptamine, respectively. 
Hydrogen peroxide oxidation of [4',5',6',7'-2H4]1-methoxytryptamine in the presence of 
sodium tungstate (Burckard et al., 1965) yielded [4',5',6',7'-2H4]1-methoxyindolyl-3-
acetaldoxime (116b) in 5% over five steps. [1",1",1",4',5',6',7'-2H7]1-Methoxytryptamine 
was similarly oxidized to yield [1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime 
(116c) in 4% over five steps (Scheme 2.2, Pedras and Okinyo, 2006a). [1",1",1"-2H3]1-
Methoxyindolyl-3-acetaldoxime (116a) and 1-methoxyindolyl-3-acetaldoxime (116) 
were similarly prepared. 
1-Methylindolyl-3-acetaldoxime (170) 
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Scheme 2.3 Reagents and conditions: i) NaH, ICH3, 96%; ii) DIBAH; iii) 
HONH2·HCl, NaOAc, EtOH, 66%. 
 
1-Methylindolyl-3-acetonitrile (169) was obtained in 96% yield via methylation of 
indolyl-3-acetonitrile (49) with methyl iodide in the presence of sodium hydride. 
Reduction of 1-methylindolyl-3-acetonitrile with diisobutylaluminium hydride followed 
by hydrolysis with 5 % HCl (Pedras and Okinyo 2006a) provided 1-methylindolyl-3-
acetaldehyde. Reacting 1-methylindole-3-acetaldehyde with hydroxylamine 
hydrochloride and sodium acetate yielded 1-methylindolyl-3-acetaldoxime (170) in 66% 
(Scheme 2.3). 
 
 
49 169 170 
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2.2.1.2 Synthesis of [4',5',6',7'-2H4]indolyl-3-[34S]acetothio-
hydroxamic acid (174a) and 1-methyl derivative 
This section covers the synthesis of 34S-hexamethyldisilathiane (171a), [4',5',6',7'-
2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a), and 1-methylindolyl-3-
acetothiohydroxamic acid (178). 
[4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) 
 
i ii
 
34S8   +   2 Na [Na234S] (CH3)3Si34SSi(CH3)31 8
 
 
Scheme 2.4 Reagents and conditions: i) Naphthalene, THF, reflux; ii) (CH3)3SiCl, r.t., 
60% based on 34S. 
 
Preparation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a, 
Scheme 2.5) required an 34S-labeled reagent to introduce the labeled sulfur atom. 34S-
Hexamethyldisilathiane (171a) was therefore synthesized by a modification of the 
procedure by So and Boudjouk (1989; 1992) as shown in Scheme 2.4. Thus, sodium was 
cut into small pieces under n-hexane and was introduced into a flask charged with sulfur 
and naphthalene in dry tetrahydrofuran under atmosphere of argon. After 2 hours of 
sonication and 2 hours of refluxing, the reaction flask was cooled in an ice-bath followed 
by drop wise addition of chlorotrimethylsilane. The reaction mixture was stirred for 10 
minutes in ice-bath and 3 hours at room temperature after which excess tetrahydrofuran 
and chlorotrimethylsilane were distilled off at atmospheric pressure, followed by 
vacuum distillation to yield 34S-hexamethyldisilathiane (171a, b.p. 68-71 ºC at 510 torr) 
as a vile smelling colorless liquid in 60% yield based on 34S. The 34S-
hexamethyldisilathiane (171a) was analyzed by GC and GC-MS-EI. Non-labeled 
hexamethyldisilathiane (171) was similarly prepared and analyzed by GC-MS-EI which 
was consistent with that reported by So and Boudjouk (1989; 1992). 
 
171a 
 70 
N
H
2H
2H
2H
2H NH
2H
2H
2H
2H
CHO
N
H
2H
2H
2H
2H
NO2
N
H
2H
2H
2H
2H
NO2
N
H
2H
2H
2H
2H
NHOH
34S
i ii
iii
iv
 
 
Scheme 2.5 Reagents and conditions: i) POCl3, DMF, 87%; ii) NH4OAc, CH3NO2, 
reflux 128-130 ºC, 99%; iii) NaBH4, i-PrOH, SiO2, CHCl3, 42%; iv) KH, (Me3Si)234S 
(171a), THF, 76%. 
 
Vilsmeier-Haack formylation of [4,5,6,7-2H4]indole (105a) provided [4,5,6,7-
2H4]indole-3-carboxaldehyde (106a) in good purity to be used in the next step without 
further purification (Pedras et al., 1998). Knöevenagel type condensation between 
[4,5,6,7-2H4]indole-3-carboxaldehyde with excess nitromethane in presence of catalytic 
amount of ammonium acetate under reflux conditions (Canoira et al., 1989) yielded 
[4,5,6,7-2H4]-3-(2'-nitrovinyl)indole (172a) in near quantitative yield. [4,5,6,7-2H4]-3-
(2'-Nitroethyl)indole (173a) was prepared in 42% yield via sodium borohydride 
reduction of 172a in the presence of silica gel and using chloroform and isopropanol as 
solvent (Sinhababu and Borchardt, 1983). In order to prepare thiohydroxamic acid 174a, 
a solution of [4,5,6,7-2H4]-3-(2'-nitroethyl)indole in dry tetrahydrofuran was added drop 
wise to potassium hydride powder at 0 ºC under argon atmosphere, the reaction mixture 
was allowed to warm up to room temperature. Addition of 34S-hexamethyldisilathiane 
(171a) to the resulting nitronate (Hwu and Tsay, 1990) yielded [4,5,6,7-2H4]indolyl-3-
[34S]acetothiohydroxamic acid (174a) in 76% (Scheme 2.5). 
105a 106a 172a 
173a 174a 
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1-Methylindolyl-3-acetothiohyrodroxamic acid (178) 
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Scheme 2.6 Reagents and conditions: i) NaH, ICH3, 98%; (ii) NH4OAc, CH3NO2, 
reflux 128-130 ºC, 98%; (iii) NaBH4, i-PrOH, SiO2, CHCl3, 63%; (iv) KH, (Me3Si)2S 
(171), THF, 67%. 
 
Preparation of 1-methylindolyl-3-acetothiohydroxamic acid (178, Scheme 2.6) 
began with methylation of indole-3-carboxaldehyde (106) using methyl iodide in the 
presence of sodium hydride. Knoevangel type condensation of the resulting 1-
methylindole-3-carboxaldehyde (175) with excess nitromethane in the presence of 
catalytic amount of ammonium acetate (Canoira et al., 1989) provided 1-methyl-3-(2-
nitrovinyl)indole (176) in 98% yield. Sodium borohydride reduction of 176 in the 
presence of silica gel (Sinhababu and Borchardt, 1983) gave 1-methyl-3-(2-
nitroethyl)indole (177) in 63% yield. Reaction of 177 with potassium hydride followed 
by treatment of the resulting nitronate with hexamethyldisilathiane (171, Hwu and Tsay, 
1990) afforded 1-methylindolyl-3-acetothiohydroxamic acid (178) in 67 % yield. 
 
106 175 176 
177 178 
 72 
2.2.1.3 Synthesis of N-protected-indolyl derivatives of indolyl-3-
methylisothiocyanate 
This section covers the synthesis of (tert-butoxycarbonyl)indolyl-3-methyl-
isothiocyanate (180), and 1-acetylindolyl-3-methylisothiocyanate (183) as probes for the 
role of indolyl-3-methylisothiocyanate (123) in the biosynthetic pathway of crucifer 
phytoalexins. 
1-(tert-Butoxycarbonyl)indolyl-3-methyl isothiocyanate (180) 
 
N
H
CHO
i, ii, iii iv
N
NH
SCH3
S
O OH3C
H3C CH3
N
O OH3C
H3C CH3
NH2
N
NCS
O OH3C
H3C CH3
v
 
 
Scheme 2.7 Reagents and conditions: i) Boc2O, DMAP, THF, quant.; ii) HONH2·HCl, 
Na2CO3, EtOH, 48-50 ºC, quant.; iii) NiCl2·6H2O, NaBH4, CH3OH; iv) Cl2CS, CaCO3, 
CH2Cl2-H2O, 56 % from oxime (Kutschy et al., 1997; 1998); v) Pyridine, Et3N, CS2, 
ICH3, 72% from oxime. 
 
Indole-3-carboxaldehyde (106) was treated with di-tert-butyl dicarbonate (Boc2O) 
and 4-(dimethylamino)pyridine (DMAP) in tetrahydrofuran to yield 1-(tert-
butoxycarbonyl)indole-3-carboxaldehyde in quantitative yield. Standard oximation 
procedure employing hydroxylamine hydrochloride and sodium carbonate afforded 1-
106 
181 
179 180 
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(tert-butoxycarbonyl)indolyl-3-carboxaldehyde oxime that after sodium borohydride and 
nickel(II) chloride reduction yielded amine 179. Reaction of amine 179 with 
thiophosgene in the presence of calcium carbonate yielded 1-(tert-
butoxycarbonyl)indolyl-3-methyl isothiocyanate (180) in 56% (Scheme 2.7, Kutschy et 
al., 1997; 1998). 
1-Acetylindolyl-3-methyl isothiocyanate (183) 
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Scheme 2.8 Reagents and conditions: i) Ac2O, pyridine, 96%; ii) HONH2·HCl, 
NaOAc, EtOH, 45-50 ºC, 88%; iii) NiCl2·6H2O, NaBH4, CH3OH; iv) Cl2CS, CaCO3, 
CH2Cl2-H2O, 31% from oxime; v) Et3N, CS2, then ICH3, pyridine, 41 % from oxime. 
 
1-Acetylindole-3-carboxaldehyde was obtained in 96% yield from indole-3-
carboxaldehyde (106) and acetic anhydride in pyridine. Heating 1-acetylindole-3-
carboxaldehyde with sodium carbonate and hydroxylamine hydrochloride at 
temperatures above 50 ºC resulted in loss of acetyl group with formation of indolyl-3-
carboxaldehyde oxime. Thus, 1-acetylindolyl-3-carboxaldehyde oxime was prepared in 
84% yield by heating 1-acetylindole-3-carboxaldehyde with hydroxylamine 
hydrochloride and sodium acetate at 50 ºC for 10 minutes. Sodium borohydride and 
nickel(II) chloride reduction (Kutschy et al., 1997; 1998) of 1-acetylindolyl-3-
carboxaldehyde oxime at 0 °C provided amine 182, which was reacted with 
106 182 
183 
184 
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thiophosgene in the presence of calcium carbonate (Kutschy et al., 1997; 1998) to give 
1-acetylindolyl-3-methyl isothiocyanate (183) in 31% yield (Scheme 2.8). 
 
2.2.1.4 Synthesis of [4',5',6',7'-2H4]brassinin (16a), [4',5',6',7'-
2H4]cyclobrassinin (28a), [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a) 
and derivatives 
This section covers the synthesis of [4',5',6',7'-2H4]brassinin (16a), [4',5',6',7'-
2H4]1-methoxybrassinin (18b), [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c), 1-
methylbrassinin (192), 1-(t-butoxycarbonyl)brassinin (181), 1-acetylbrassinin (184), 
[4',5',6',7'-2H4]cyclobrassinin (28a), 1-methylcyclobrassinin (193), [4',5',6',7'-
2H4]sinalbin B (31a), [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a), 1-
methylspirobrassinin (194), 1-acetylspirobrassinin (195), and 1-(t-
butoxycarbonyl)spirobrassinin (196). 
[4',5',6',7'-2H4]Brassinin (16a) and [4',5',6',7'-2H4]cyclobrassinin (28a) 
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Scheme 2.9 Reagents and conditions: i) HONH2·HCl, Na2CO3, EtOH, reflux, 87%; ii) 
NaOH, Devarda’s alloy, CH3OH; iii) Pyridine, Et3N, CS2, 60 min, 0 ºC; iv) ICH3, 50%; 
v) pyridine/HBr/Br2, THF; vi) DBU, 58% (Pedras et al., 1998). 
 
106a 185a 117a 
28a 16a 
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[4',5',6',7'-2H4]Cyclobrassinin (28a) was synthesized following previously 
established procedure (Pedras et al., 1998). [4,5,6,7-2H4]Indole-3-carboxaldehyde (106a) 
was transformed to the corresponding oximes 185a upon treatment with hydroxylamine 
hydrochloride and sodium carbonate. Reduction of 185a yielded [4',5',6',7'-2H4]indole-3-
methanamine (117a), which was treated with triethylamine and carbon disulfide in 
pyridine, followed by addition of methyl iodide to yield [4',5',6',7'-2H4]brassinin (16a) in 
50%. [4',5',6',7'-2H4]Cyclobrassinin (28a), was prepared by treating 16a with pyridinium 
bromide perbromide, followed by alkalynation with 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) to yield [4',5',6',7'-2H4]cyclobrassinin in 58% (Scheme 2.9). 
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[4',5',6',7'-2H4]1-Methoxybrassinin (18b) and [4',5',6',7'-2H4]sinalbin B 
(31a) 
 
N
H
2H
2H
2H
2H NOCH3
2H
2H
2H
2H
N
OCH3
2H
2H
2H
2H
NH
SC2H3
S
N
OCH3
2H
2H
2H
2H
N OH
N
OCH3
2H
2H
2H
2H
NH2
N
OCH3
2H
2H
2H
2H
NH
SCH3
S
N
OCH3
2H
2H
2H
2H
S
N
SCH3
1
1'
3' 4'
7'
1'
1'
3'
3'
4'
4'
7'
7'
1
1
2
3
2
3
N
H
2H
2H
2H
2H
i ii,iii
iv, v
vi
vii, viii
ix, x
xi, xii
x
N
OCH3
2H
2H
2H
2H
O
S
N SCH3
 
 
Scheme 2.10 Reagents and conditions: i) NaBH3CN, AcOH, 82%; ii) Na2WO4·H2O, 
H2O2; iii) (CH3O)2SO2, K2CO3, CH3OH, 52%; iv) POCl3, DMF, 93%; v) HONH2·HCl, 
Na2CO3, EtOH, reflux, 99%; vi) NaBH3CN, TiCl3, NH4OAc, CH3OH; vii) Pyridine, 
Et3N, CS2, 60 min, 0 ºC; viii) ICH3, 67%; ix) Pyridine, Et3N, CS2, 60 min, 0 ºC; x) 
IC2H3, 68% (Pedras and Okinyo, 2006a); xi) NBS, CH2Cl2; xii) Et3N, 47% (adapted 
from Pedras and Zaharia, 2000); xiii) PCC, CH2Cl2, 41% (adapted from Pedras et al., 
2006a). 
 
[4',5',6',7'-2H4]1-Methoxybrassinin (18b) was obtained from [4,5,6,7-2H4]indole 
(Scheme 2.10). First [4,5,6,7-2H4]indole was reduced with sodium cyanoborohydride in 
acetic acid to provide [4,5,6,7-2H4]indoline (186a) which was obtained in 82%. 
Hydrogen peroxide oxidation of [4,5,6,7-2H4]indoline to 1-hydroxyindole intermediate 
followed by dimethylsulphate methylation (Somei and Kawasaki, 1989) yielded [4,5,6,7-
105a 186a 187a 
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189a 
18b 
18c 
31a 35a 
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2H4]1-methoxyindole (187a) in 52%. Standard Vilsmeier-Haack formylation of 187a 
yielded [4,5,6,7-2H4]1-methoxyindole-3-carboxaldehyde, which was transformed to 
[4',5',6',7'-2H4]1-methoxyindolyl-3-carboxaldehyde oxime (188a) on treatment with 
hydroxylamine hydrochloride and sodium carbonate. Reduction of the oxime 188a 
employing sodium cyanoborohydride and titanium (III) chloride in presence of 
ammonium acetate (Pedras and Zaharia, 2000) yielded [4',5',6',7'-2H4]1-methoxyindolyl-
3-methanamine (189a) which was used in the next step without further purification. 
Triethylamine and carbon disulfide treatment of a solution of amine 189a in pyridine 
yielded dithiocarbamate intermediate in situ, which was reacted with methyl iodide to 
afford [4',5',6',7'-2H4]1-methoxybrassinin in 67% yield over two steps from the oxime 
188a (Pedras and Okinyo, 2006a). By adapting experimental procedure for preparation 
of sinalbin B (31, Pedras and Zaharia, 2000), [4',5',6',7'-2H4]1-methoxybrassinin was 
reacted with N-bromosuccinimide (NBS) followed by triethylamine to yield [4',5',6',7'-
2H4]sinalbin B (31a, Scheme 2.10) in 47%. 
[3,3,3,4',5',6',7'-2H7]1-Methoxybrassinin (18c) 
[3,3,3,4',5',6',7'-2H7]1-Methoxybrassinin (18c) was prepared following similar 
experimental procedure as that for [4',5',6',7'-2H4]1-methoxybrassinin (Scheme 2.10). 
Methylation of the dithiocarbamate intermediate was conducted with deuterated methyl 
iodide to provide [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin in 68% yield over two steps 
from oxime 188a (Pedras and Okinyo, 2006a). 
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1-Methylbrassinin (192) 
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Scheme 2.11 Reagents and conditions: i) HONH2·HCl, Na2CO3, EtOH, reflux, 93%; ii) 
NaOH, Devarda’s alloy, CH3OH; iii) Pyridine, Et3N, CS2, 60 min, 0 ºC; iv) ICH3, 52%. 
 
Reaction of 1-methylindole-3-carboxaldehyde (175) with hydroxylamine 
hydrochloride in the presence of sodium carbonate provided 1-methylindolyl-3-
carboxaldehyde oxime (190) in 93% yield. Devarda’s alloy reduction of oxime 190 
provided 1-methylindolyl-3-methanamine (191) which was transformed to 1-
methylbrassinin (192) in 52% yield following established experimental procedure for 
synthesis of brassinin (Pedras et al., 2000; 2003b). 
1-(tert-Butoxycarbonyl)brassinin (181) 
1-(tert-Butoxycarbonyl)brassinin (181) was previously prepared in 97% yield from 
1-(tert-butoxycarbonyl)indolyl-3-methylisothiocyanate and sodium methane thiolate 
(Kutschy et al., 1997; 1998); however, in my work, this route provided 181 in only 40% 
yield. Thus, the traditional route for brassinin synthesis was used (Pedras et al., 2003b). 
Freshly prepared amine 179 was treated with triethylamine and carbon disulfide to 
afford a dithiocarbamate intermediate in situ, methylation of this intermediate with 
methyl iodide yielded 1-(tert-butoxycarbonyl)brassinin in 72% (Scheme 2.7). 
175 190 191 
192 
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1-Acetylbrassinin (184) 
1-Acetylbrassinin (184) was synthesized from the freshly prepared amine 182 
(Scheme 2.8) by slight modification of procedure used for preparation of brassinin. 
Addition of triethylamine and carbon disulfide to a solution of freshly prepared amine 
182 at room temperature with stirring for 90 minutes provided intermediate 1-
acetylindolyl-3-methyl dithiocarbamate in situ, which was reacted with methyl iodide to 
give 1-acetylbrassinin (184, Scheme 2.8) in 41% yield. 
1-Methylcyclobrassinin (193) 
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Scheme 2.12 Reagents and conditions: i) NaH, ICH3, THF, 0 ºC, 82%. 
 
1-Methylcyclobrassinin (193) was obtained from a reaction of cyclobrassinin (28) 
with methyl iodide at 0 ºC (Scheme 2.12). 1-Methylcyclobrassinin (193) was previously 
prepared from 1-methylbrassinin (192) (Kutschy et al., 1998). 
[4',5',6',7'-2H4]1-Methoxyspirobrassinin (35a) 
[4',5',6',7'-2H4]1-Methoxyspirobrassinin (35a) was prepared from [4',5',6',7'-2H4]1-
methoxybrassinin ((18b, Scheme 2.10) following previously set route (Pedras et al., 
2006a). Thus, a solution of [4',5',6',7'-2H4]1-methoxybrassinin in dichloromethane was 
treated with pyridinium chlorochromate to provide [4',5',6',7'-2H4]1-
methoxyspirobrassinin in 41% yield. 
 
 
 
28 193 
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1-Methylspirobrassinin (194) 
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Scheme 2.13 Reagents and conditions: i) NaH, ICH3, THF, 0 ºC, 91% (Pedras and 
Hossain, 2006). 
 
1-Methylspirobrassinin (194) was obtained in 91% yield via methylation of 
spirobrassinin (34) with methyl iodide and sodium hydride at 0 °C (Pedras and Hossain, 
2006, Scheme 2.13). 
1-Acetylspirobrassinin (195) 
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Scheme 2.14 Reagents and conditions: i) Pyridine, Ac2O, 80%. 
 
1-Acetylspirobrassinin (195) was obtained in 80% yield from reaction of 
spirobrassinin (34) with acetic anhydride in pyridine. 
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1-(tert-Butoxycarbonyl)spirobrassinin (196) 
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Scheme 2.15 Reagents and conditions: i) Boc2O, DMAP, THF, Quant. 
 
1-(tert-Butoxycarbonyl)spirobrassinin (196) was prepared in 99% yield from 
spirobrassinin (34) and Boc2O in the presence of DMAP (Scheme 2.15). 
2.2.1.5 Synthesis of [SC2H3]brassicanal A (39b) 
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Scheme 2.16 Reagents and conditions: i) NaHCO3, P4S10, THF, 72%; ii) NaH, HCO2Et 
(Pedras and Okanga, 1999); iii) Et3N, IC2H3, Et2O, 56%. 
 
2-Mercaptoindole-3-carboxaldehyde (135) was synthesized following previously 
established procedure (Pedras and Okanga, 1999). Reaction of 135 with deuterated 
197 198 135 
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methyl iodide in the presence of triethylamine afforded [SC2H3]brassicanal A (39b) in 
56 % isolated yield. 
2.2.2 Incorporation experiments using synthetic compounds 
The present biosynthetic studies involved administration of perdeuterated 
precursors and 34S containing indolyl-3-acetothiohydroxamic acid to different plant 
tissues that were known to produce a variety of phytoalexins and glucosinolates. Non-
natural compounds containing methyl, acetyl and Boc groups at the indole nitrogen were 
also administered to these plant tissues. The N-substituents served as non-isotopic labels 
to probe biosynthetic pathway(s) of phytoalexins and glucosinolates. The main plant 
tissues used were Brassica napus (rutabaga), B. rapa (turnip), and Erucastrum gallicum 
(dog mustard). 
2.2.2.1 Brassica napus L. ssp. rapifera (rutabaga) and B. rapa 
(turnip) 
Rutabaga and turnip are two examples of tuberous brassicas that produce a variety 
of indole phytoalexins and indole glucosinolates (Monde et al., 1994; Pedras et al., 2004; 
Pedras and Montaut, 2004). The incorporation of phytoalexin precursors was established 
to be more efficient in tubers than in leaves or stems of brassicas (Pedras and Montaut, 
2004). For this reason, these plant tissues were used to investigate biosynthetic 
pathway(s) of crucifer phytoalexins and glucosinolates. 
In feeding experiments, rutabaga and turnip tubers were sliced horizontally after 
which cylindrical holes were made on one surface. Following overnight incubation at 20 
°C in darkness, the slices were irradiated with UV on the surface with holes for 20 
minutes, and further incubated for 24 hours. The slices were then incubated separately 
with (i) labeled precursors (5 × 10-4 M), (ii) non-labeled precursors (5 × 10-4 M), and (iii) 
carrier solution. The aqueous phase was collected (24, 48, 72 or 96 hours after 
administration), was extracted and was subjected to preliminary clean up to yield 
fractions containing phytoalexins (established by HPLC-DAD and HPLC-MS-ESI). The 
percentage of isotope (2H, and/or 34S) incorporation was established from analysis of 
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data obtained by HPLC-HRMS-ESI (positive or negative ion modes) according to the 
equation: 
 
% of (2H, and/or 34S) incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 
3, 4, 5), n is the number of deuterium atoms, and M is the peak area or relative 
intensity of the molecular ion peak. 
 
The HPLC-HRMS-ESI data indicated that the ions [M + n]+/− were not present in 
natural abundance samples. 
Extracts containing indolyl glucosinolates were obtained by cutting tissue around 
the holes, soaking in methanol, and grinding (mortar and pestle), followed by overnight 
extraction with aqueous methanol solution. The tissue extracts were subjected to RP-
FCC to yield a fraction that contained indolyl glucosinolates (established by HPLC-
DAD and HPLC-MS-ESI). The percentage of isotope (2H, and 34S) incorporation was 
established from HPLC-HRMS-ESI (negative ion mode) data similar to phytoalexins. 
Incorporation of L-[2',4',5',6',7'-2H5]tryptophan (78b) 
Rutabaga slices were prepared as previously described. Commercially available L-
[2',4',5',6',7'-2H5]tryptophan (78b) was administered to UV-elicited slices followed by 
72-hour incubation. The aqueous solution was collected, was extracted, and was 
subjected to preliminary clean up to yield fraction A that contained the phytoalexins 
cyclobrassinin (28), rutalexin (33), brassicanate A (43), rapalexin A (53), and fraction B 
that contained spirobrassinin (34) (established by HPLC-DAD and HPLC-MS-ESI) 
(Figure 2.1). Control slices were incubated with L-tryptophan (78) or with carrier 
solution and were treated similarly. HPLC-HRMS-ESI analyses (positive ion mode) of 
the phytoalexin fraction resulting from feeding L-[2',4',5',6',7'-2H5]tryptophan displayed 
the cyclobrassinin peak at tR = 30.5 min containing two ions at m/z 235.0358 and 
239.0609, that were consistent with the molecular formulae C11H11N2S2 and 
C11H72H4N2S2, respectively. The ion at m/z 239.0609 was not detected in control 
samples incubated with non-labeled L-tryptophan. Based on the peak area of each ion, 
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the percentage of deuterium incorporation was found to be 7% {[1/(14 + 1)] × 100} 
(Table 2.2). 
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Figure 2.1 HPLC-HRMS-ESI chromatograms of rutabaga phytoalexins: 
cyclobrassinin (28), rutalexin (33), spirobrassinin (34), brassicanate A (43), and 
rapalexin A (53). Chromatogram 1 = fraction A, positive ion mode; Chromatogram 2 = 
fraction A negative ion mode; Chromatogram 3 = fraction B, positive ion mode. 
 
The rutalexin peak at tR = 15.9 min (negative ion mode) indicated two ions at m/z 
231.0233 and 235.0484 that were consistent with the molecular formulae C11H7N2O2S 
and C11H32H4N2O2S, respectively. Based on the peak area of each ion, the percentage of 
deuterium incorporation was found to be 32% {[47/(99 + 47)] × 100} (Table 2.2). The 
brassicanate A peak at tR = 17.5 min (negative ion mode) indicated two ions at m/z 
220.0437 and 224.0688 that were consistent with the molecular formulae C11H10NO2S 
and C11H62H4NO2S, respectively. The percentage of deuterium incorporation was 
calculated based on the peak area of each ion and was found to be 4% {[0.5/(11 + 0.5)] × 
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100} (Table 2.2). The rapalexin A peak at tR = 25.7 min (negative ion mode) indicated 
two ions at m/z 203.0284 and 207.0535 that were consistent with the molecular formulae 
C10H7N2OS and C10H32H4N2OS, respectively. Based on the peak area of each ion, the 
percentage of deuterium incorporation was found to be 12% {[12/(85 + 12)] × 100}. The 
spirobrassinin peak at tR = 14.7 min (positive ion mode) indicated two molecular ions at 
m/z 251.0307 and 255.0558 that were consistent with the molecular formulae 
C11H11N2OS2 and C11H72H4N2OS2, respectively. The percentage of deuterium 
incorporation was calculated based on the peak area of each ion and was found to be 
17% {[19/(90 + 19)] × 100}(Table 2.2, Figure 2.2). 
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Figure 2.2 Incorporation of L-[2H5]tryptophan (78b) into rutabaga phytoalexins: 
[2H4]cyclobrassinin (28a, 7%), [2H4]rutalexin (33a, 32%), [2H4]spirobrassinin (34b, 
17%), [2H4]brassicanate A (43a, 4%), and [2H4]rapalexin A (53a, 12%). 
 
Incorporation of L-[2',4',5',6',7'-2H5]tryptophan (78b) into indole glucosinolates 
was investigated in rutabaga tissues as well. After cutting tissue around the holes from 
slices incubated with L-[2',4',5',6',7'-2H5]tryptophan, grinding, and extracting, RP-FCC 
yielded a fraction that contained glucosinolates glucobrassicin (70), 4-
methoxyglucobrassicin (156), and neoglucobrassicin (199) (established by HPLC-DAD 
78b 
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and HPLC-MS-ESI) (Figure 2.3). Control tissues incubated with non-labeled L-
tryptophan or with carrier solution were treated similarly. 
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Figure 2.3 HPLC-HRMS-ESI chromatogram of rutabaga glucosinolates: 
glucobrassicin (70), methoxyglucobrassicin (156), and neoglucobrassicin (199). 
 
HPLC-HRMS-ESI analyses (negative ion mode) of the glucosinolate fraction 
resulting from feeding of L-[2',4',5',6',7'-2H5]tryptophan displayed the glucobrassicin 
peak at tR = 12.0 min to contain two ions at m/z 447.0537 and 452.0851 that were 
consistent with the molecular formulae C16H19N2O9S2 and C16H142H5N2O9S2, 
respectively. The ion at m/z 452.0851 was not detected in control samples incubated with 
non-labeled L-tryptophan. The percentage of deuterium incorporation was calculated 
based on the peak area of each ion and was found to be 17 ± 1% (Table 2.2). The 4-
methoxyglucobrassicin peak at tR = 14.5 min indicated two ions at m/z 477.0643 and 
481.0894 that were consistent with molecular formulae C17H21N2O10S2 and 
C17H172H4N2O10S2, respectively. Based on the peak area of each ion, the percentage of 
deuterium incorporation was found to be 7 ± 2 %. The neoglucobrassicin peak at tR = 
16.1 min indicated two ions at m/z 477.0643 and 482.0956 that were consistent with 
molecular formulae C17H21N2O10S2 and C17H162H5N2O10S2, respectively. The percentage 
of deuterium incorporation was calculated from the peak area of each ion and was found 
to be 12 ± 1 % (Table 2.2). 
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Figure 2.4 Incorporation of L-[2H5]tryptophan (78b) into rutabaga glucosinolates: 
[2H5]glucobrassicin (70b, 17 ± 1%), [2H4]-4-methoxyglucobrassicin (156a, 7 ± 2 %) and 
[2H5]neoglucobrassicin (199a, 12 ± 1 %). 
 
Table 2.2 Incorporation of L-[2',4',5',6',7'-2H5]tryptophan (78b) into rutabaga 
phytoalexins and glucosinolates 
Compound % Incorporation 
[4',5',6',7'-2H4]Cyclobrassinin (28a) a,c7 
[4',5',6',7'-2H4]Rutalexin (33a) a,d32 
[4',5',6',7'-2H4]Spirobrassinin (34a) a,c17 
[4',5',6',7'-2H4]Brassicanate A (43a) a,d4 
[2',5',6',7'-2H4]Rapalexin A (53a) a,d12 
[2',4',5',6',7'-2H5]Glucobrassicin (70b) b,d17 ± 1 
[2',5',6',7'-2H4]4-Methoxyglucobrassicin (156a) b,d7 ± 2 
[2',4',5',6',7'-2H5]Neoglucobrassicin (199a) b,d12 ± 1 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 5). 
aIncorporation determined from a single feeding experiment. 
bIncorporation determined from average of two independent experiments ± standard 
deviation (STD). 
cPositive ion mode. 
dNegative ion mode. 
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The biosynthetic pathways of 1-substituted rutabaga metabolites 1-
methoxybrassinin (18) and neoglucobrassicin (199) were probed with 1-methyl-L-
tryptophan (200), a non-natural compound. Rutabaga root slices were prepared as 
previously described. After incubation with 1-methyl-L-tryptophan (24, 48, 72, and 96 
hours), the aqueous phase was collected, was extracted, and was subjected to preliminary 
clean up to yield fraction A that contained the phytoalexins cyclobrassinin (28), rutalexin 
(33), brassicanate A (43), rapalexin A (53), and fraction B that contained spirobrassinin 
(34) (established by HPLC-DAD and HPLC-MS-ESI). Tissues around the holes were 
cut, were ground (mortar and pestle), and were extracted. The extracts were subjected to 
RP-FCC to yield a fraction that contained the glucosinolates glucobrassicin (70), 4-
methoxyglucobrassicin (156), and neoglucobrassicin (199) (established by HPLC-DAD 
and HPLC-MS-ESI). Control slices were incubated with carrier solution and were 
similarly treated. From HPLC-DAD and HPLC-MS-ESI analyses, no 1-methyl 
containing phytoalexins or indole glucosinolates were detected under various feeding 
conditions and incubation periods (Figure 2.5). It was also surprising that no 1-methyl-
L-tryptophan was recovered, neither was any of its metabolic products detected in the 
extracts.  
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Figure 2.5 Administration of 1-methyl-L-tryptophan (200) to rutabaga tubers. 
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Incorporation of [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a) 
The biogenesis of neoglucobrassicin (199) from 1-methoxyindolyl-3-acetaldoxime 
(116) was investigated. Rutabaga root slices were prepared as previously described and 
were incubated with [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a) for 96 
hours; control slices were incubated separately with 1-methoxyindolyl-3-acetaldoxime 
(116) and with carrier solution. Following incubation and extraction, RP-FCC of the 
extracts yielded a fraction that contained the glucosinolates glucobrassicin (70), 4-
methoxyglucobrassicin (156), and neoglucobrassicin (199) (established by HPLC-DAD 
and HPLC-MS-ESI). HPLC-HRMS-ESI analyses (negative ion mode) of the 
glucosinolate fraction resulting from feeding of [1",1",1"-2H3]1-methoxyindolyl-3-
acetaldoxime displayed the neoglucobrassicin peak at tR = 13.8 min containing two ions 
at m/z 477.0643 and 480.0831 that were consistent with molecular formulae 
C17H21N2O10S2 and C17H182H3N2O10S2, respectively. The ion at m/z 480.0831 was absent 
in control samples incubated with 1-methoxyindolyl-3-acetaldoxime. Based on the peak 
area of each ion, the percentage of deuterium incorporation was found to be 6% {[3/(48 
+ 3)] × 100} (Figure 2.6). 
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Figure 2.6 Incorporation of [2H3]1-methoxyindolyl-3-acetaldoxime (116b) into 
[2H3]neoglucobrassicin (199b, 6%). 
 
Incorporation of 1-methylindolyl-3-acetaldoxime (170) 
The biosynthetic pathway(s) of 1-substituted phytoalexins and glucosinolates was 
further probed with 1-methylindolyl-3-acetaldoxime (170). No 1-methyl containing 
metabolite has been identified from rutabaga or turnip extracts, incorporation of 1-
methylindolyl-3-acetaldoxime into phytoalexins or glucosinolates can therefore be 
116a 199b 
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determined by comparing HPLC-DAD chromatograms of fed and control extracts, 
followed by HPLC-HRMS-ESI analyses to confirm the compound structure. In the 
present studies, 1-methylindolyl-3-acetaldoxime was administered separately to UV-
irradiated rutabaga and turnip root slices. After incubation and extraction, preliminary 
clean up of the extracts yielded fractions containing phytoalexins and glucosinolates 
(established by HPLC-DAD and HPLC-MS-ESI); similar experiments were conducted 
for root slices incubated with carrier solution. Surprisingly, no 1-methyl containing 
phytoalexin was detected from phytoalexin fractions, but chromatograms of polar 
fractions indicated a new peak that was absent in those of control fractions. HPLC-
HRMS-ESI analyses (negative ion mode) of the new metabolite peak at tR = 13.5 min 
indicated an ion at m/z 461.0693 that was consistent with molecular formula 
C17H21N2O9S2. The new metabolite structure was deduced to be 1-methylglucobrassicin 
(Figure 2.7). Both rutabaga and turnip root slices metabolized 1-methylindolyl-3-
acetaldoxime (170) to 1-methylglucobrassicin (201). 
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Figure 2.7 Incorporation of 1-methylindolyl-3-acetaldoxime (170) into 1-
methylglucobrassicin (201). 
 
Incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) 
The potential involvement of indolyl-3-acetothiohydroxamic acid in the 
biosynthetic pathway of indole phytoalexins and glucosinolates was investigated in 
rutabaga root tubers. Thus, [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) was administered to UV-irradiated rutabaga root slices followed by 72-hour 
incubation. Control experiments were conducted similarly by incubating rutabaga root 
170 201 
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slices with non-labeled indolyl-3-acetothiohydroxamic acid or with carrier solution. 
Extraction of the aqueous phase and preliminary clean up of the extracts yielded fraction 
A that contained the phytoalexins cyclobrassinin (28), rutalexin (33), brassicanate A 
(43), rapalexin A (53), and fraction B that contained spirobrassinin (34) (established by 
HPLC-DAD, HPLC-MS-ESI, and HPLC-HRMS-ESI) (Figure 2.8). HPLC-HRMS-ESI 
analyses (positive ion mode) of the phytoalexin fraction resulting from feeding of 
[4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid displayed the cyclobrassinin 
peak at tR = 30.1 min containing two ions at m/z 235.0358 and 241.0567 that were 
consistent with the molecular formulae C11H11N2S2 and C11H72H4N2S34S, respectively. 
Based on the peak area of each ion, the percentage of 34S and deuterium incorporation 
was found to be 5% {[1/(19 + 1)] × 100}. The rutalexin peak at tR = 15.9 min (negative 
ion mode) indicated two ions at m/z 231.0233 and 235.0484 that were consistent with the 
molecular formulae C11H7N2O2S and C11H32H4N2O2S, respectively. The percentage of 
deuterium incorporation was calculated based on the peak areas of each ion and was 
found to be 11 ± 2 % (Table 2.3). The brassicanate A peak at tR = 17.5 min (negative ion 
mode) indicated two ions at m/z 220.0437 and 224.0688 that were consistent with the 
molecular formulae C11H10NO2S and C11H62H4NO2S, respectively. Based on the peak 
area of each ion, the percentage of deuterium incorporation was found to be 3% 
{[0.3/(10 + 0.3)] × 100} (Table 2.3). The rapalexin A peak at tR = 25.8 min (negative 
ion mode) indicated four ions at m/z 203.0284, 205.0242, 206.0472 and 208.0446 that 
were consistent with the molecular formulae C10H7N2OS, C10H7N2O34S, C10H42H3N2OS, 
and C10H42H3N2O34S, respectively. The ion at m/z 205.0242 with formula C10H7N2O34S 
suggested incorporation of 34S into rapalexin A (53d) which was calculated based on 
peak area of each ion at m/z 203.0284 and 205.0242 and was found to be 57 ± 10 % 
(Table 2.3). The ion at m/z 206.0472 consistent with the molecular formula 
C10H42H3N2OS indicated incorporation of deuterium from indole ring of [4',5',6',7'-
2H4]indolyl-3-[34S]acetothiohydroxamic acid into rapalexin A (53b). Based on the peak 
area of each ion at m/z 203.0284 and 206.0472 the percentage of deuterium 
incorporation was found to be 14 ± 9 % (Table 2.3). The ion at m/z 208.0446 consistent 
with the molecular formula C10H42H3N2O34S suggested incorporation of 34S and 
deuterium into rapalexin A (53c), the percentage of incorporation was calculated based 
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on peak area of each ion at m/z 203.0284 and 208.0446 and was found to be 4 ± 3 % 
(Table 2.3). The spirobrassinin peak at tR = 14.6 min (positive ion mode) contained two 
ions at m/z 251.0307 and 257.0516 that were consistent with the molecular formulae 
C11H11N2OS2 and C11H72H4N2OS34S, respectively. The percentage of 34S and deuterium 
incorporation was calculated based on the peak area of each ion and was found to be 8% 
{[5/(59 + 5)] × 100} (Table 2.3). 
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Figure 2.8 Incorporation of [2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) 
into rutabaga phytoalexins: 34S-[2H4]cyclobrassinin (28c, 5%), [2H4]rutalexin (33a, 11 ± 
2 %), 34S-[2H4]spirobrassinin (34c, 8%), [2H4]brassicanate A (43a, 3%), [2H3]rapalexin 
A (53b, 14 ± 9 %), 34S-[2H3]rapalexin A (53c, 4 ± 3 %), and [34S]rapalexin A (53d, 57 ± 
10 %). 
 
The incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) into rutabaga glucosinolates was investigated in the polar extracts as well. Thus, 
tissue around the holes was cut and was extracted. Preliminary clean up of the extract 
yielded a fraction that contained the glucosinolates glucobrassicin (70), 4-
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53b 53c 53d 
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methoxyglucobrassicin (156), and neoglucobrassicin (199) (established by HPLC-DAD 
and HPLC-MS-ESI). Control slices were treated similarly. HPLC-HRMS-ESI analyses 
(negative ion mode) of the glucosinolate fraction resulting from feeding [4',5',6',7'-
2H4]indolyl-3-[34S]acetothiohydroxamic acid displayed the glucobrassicin peak at tR = 
12.0 min containing two ions at m/z 447.0537 and 453.0746 that were consistent with the 
molecular formulae C16H19N2O9S2 and C16H152H4N2O9S34S, respectively. These results 
suggested intact incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
into glucobrassicin (70c). The percentage of 34S and deuterium incorporation was 
calculated based on the peak area of each ion and was found to be 2 ± 1 % (Figure 2.9, 
Table 2.3). HPLC-HRMS-ESI analyses of 4-methoxyglucobrassicin peak at tR = 14.5 
min indicated an ion at m/z 477.0643 that was consistent with molecular formulae 
C17H21N2O10S2, whereas neoglucobrassicin peak at tR = 16.1 min indicated an ion at m/z 
477.0643 that was consistent with the molecular formulae C17H21N2O10S2. The absence 
of incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid into 4-
methoxyglucobrassicin and neoglucobrassicin suggested that indolyl-3-
acetothiohydroxamic acid is not a biogenetic precursor in the biosynthetic pathway of 
these two glucosinolates. 
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Figure 2.9 Incorporation of [2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) 
into 34S-[2H4]glucobrassicin (70c, 2 ± 1 %). 
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Table 2.3 Incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) into rutabaga phytoalexins and glucobrassicin (70c) 
Compound % Incorporation 
34S-[4',5',6',7'-2H4]Cyclobrassinin (28c) a,c5 
[4',5',6',7'-2H4]Rutalexin (33a) b,d11 ± 2 
34S-[4',5',6',7'-2H4]Spirobrassinin (34c) a,c8 
[4',5',6',7'-2H4]Brassicanate A (43a) a,d3 
[5',6',7'-2H4]Rapalexin A (53b) b,d14 ± 9 
34S-[5',6',7'-2H4]Rapalexin A (53c) b,d4 ± 3 
34S-Rapalexin A (53d) b,d57 ± 10 
34S-[2',4',5',6',7'-2H5]Glucobrassicin (70c) b,d2 ± 1 
% of 2H and 34S incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 4). 
aIncorporation determined from a single feeding experiment. 
bIncorporation determined from average of two independent experiments ± standard 
deviation (STD). 
cPositive ion mode. 
dNegative ion mode. 
 
Incorporation of 1-methylindolyl-3-acetothiohydroxamic acid (178) 
The incorporation of 1-methylindolyl-3-acetothiohydroxamic acid (178) into 
indole phytoalexins and glucosinolates was investigated. 1-Methylindolyl-3-
acetothiohydroxamic acid was separately administered to UV-irradiated rutabaga and 
turnip slices followed by 48- and 72-hour incubations. The aqueous phase was collected, 
was extracted, and the resulting extract was subjected to preliminary clean up to yield 
fraction A that contained the phytoalexins cyclobrassinin (28), rutalexin (33), 
brassicanate A (43), rapalexin A (53), and fraction B that contained spirobrassinin (34) 
(established by HPLC-DAD and HPLC-MS-ESI). Control slices were incubated with 
carrier solution and were treated similarly. After cutting tissue around the holes, 
grinding, and extracting, preliminary clean up of the extracts yielded a fraction that 
contained the glucosinolates glucobrassicin (70), 4-methoxyglucobrassicin (156), and 
neoglucobrassicin (199) (established by HPLC-DAD and HPLC-MS-ESI). The HPLC-
DAD and HPLC-MS-ESI analyses of phytoalexin fractions did not indicate the presence 
of 1-methyl containing phytoalexins, whereas a new metabolite peak was detected in 
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glucosinolate extracts. HPLC-HRMS-ESI analyses (negative ion mode) of the new peak 
at tR = 13.5 min indicated an ion at m/z 461.0693 that was consistent with molecular 
formula C17H21N2O9S2, similar to that obtained from administration of 1-methylindolyl-
3-acetaldoxime. The structure of 1-methylglucobrassicin (201) was deduced (Figure 
2.10). 
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Figure 2.10 Incorporation of 1-methylindolyl-3-acetothiohydroxamic acid (178) into 
1-methylglucobrassicin (201). 
 
Incorporation of [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a) 
[4',5',6',7'-2H4]Indolyl-3-[34S]acetothiohydroxamic acid (174a) decomposes to 
[4',5',6',7'-2H4]indolyl-3-acetonitrile (49a) under feeding conditions (in carrier solution). 
Therefore it was important to determine the metabolic products of [4',5',6',7'-2H4]indolyl-
3-acetonitrile and their potential relationship with other rutabaga phytoalexins. A time-
course feeding experiment was conducted to determine the metabolism of 49a in 
rutabaga tissues (Figure 2.11). Firstly, non-isotopically labeled indolyl-3-acetonitrile 
(49) was administered to rutabaga slices that were prepared as previously described. 
Following incubation for 4, 8, 16, and 24 hours the aqueous phase was collected, was 
extracted and was subjected to preliminary clean up to yield non-polar fractions. HPLC-
DAD analyses of the non-polar fractions after 4-hour incubation indicated two new 
peaks at tR = 4.8 and 5.5 min that showed increasing amounts between 4- and 16-hour 
incubations, then gradual decrease after 16-hour incubation. Between 8- and 16-hour 
incubation a new metabolite peak with increasing intensity was detected at tR = 12.3 
min. After 24-hour incubation indolyl-3-acetonitrile was completely metabolized, the 
intensity of the peaks at tR = 4.8 and 5.5 min decreased significantly whereas that at tR = 
178 201 
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12.3 min increased. The three new peaks were absent in extracts incubated with carrier 
solution only, suggesting that they were metabolic products of indolyl-3-acetonitrile 
(49). The three metabolites were identified by comparison of their UV spectra and 
retention times with those of compounds in the HPLC-DAD library. Thus, the 
metabolites at tR = 4.8, 5.5, and 12.3 min were identified as indole-3-acetic acid (202), 
indole-3-carboxylic acid (203), and methyl indole-3-carboxylate (121), respectively. A 
similar experiment was conducted with [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a). The 
aqueous phase was extracted after 16-hour incubation to allow for the detection of the 
three new peaks. No deuterium labeling was detected in any of the phytoalexins 
cyclobrassinin (28), rutalexin (33), brassicanate A (43), rapalexin A (53), and 
spirobrassinin (34) (established HPLC-MS-ESI). The HPLC-HRMS-ESI analyses 
(negative ion mode) of the three new compounds with peaks at tR = 4.8, 5.5, and 12.3 
min indicated the masses at m/z 164.0655, 178.0811, and 178.0811 that were consistent 
with the molecular formulae C9H22H4NO2, C10H42H4NO2 and C10H42H4NO2, 
respectively. The peaks at tR = 4.8, 5.5, and 12.3 min were consistent with [4',5',6',7'-
2H4]indolyl-3-acetic acid (202a), [4,5,6,7-2H4]indole-3-carboxylic acid (203a), and 
methyl [4,5,6,7-2H4]indole-3-carboxilate (121a), respectively (Figure 2.11). HPLC-MS-
ESI analyses (negative ion mode) of fractions from tissue extracts did not show other 
deuterium labeled metabolic products. It was therefore concluded that indolyl-3-
acetonitrile in not a precursor of phytoalexins or glucosinolates that are produced in 
rutabaga tissues. 
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Figure 2.11 Incorporation of [2H4]indolyl-3-acetonitrile (49a) into [2H4]indolyl-3-
acetic acid (202a), [2H4]indole-3-carboxylic acid (203a) and methyl [4,5,6,7-2H4]indole-
3-carboxylate (121a). 
 
1-(tert-Butoxycarbonyl)indolyl-3-methylisothiocyanate (180) and 1-(tert-
butoxycarbonyl)brassinin (181) as potential intermediates 
Potential involvement of indolyl-3-methylisothiocyanate (123) in the biosynthetic 
pathway of indole phytoalexins was investigated using 1-(tert-butoxycarbonyl)indolyl-3-
methyl-isothiocyanate (180). Due to instability of indolyl-3-methylisothiocyanate 
(Hanley et al., 1990; Hanley and Parsley, 1990), the stable 1-(tert-
butoxycarbonyl)indolyl-3-methyl-isothiocyanate (Kutchy et al., 1997; 1998) was used in 
the present investigations with 1-Boc group serving as the label. Rutabaga slices were 
prepared as previously described and were incubated with 180; control experiments were 
conducted by incubating slices with carrier solution. After 72-hour incubation the 
aqueous phase was collected, was extracted and was subjected to preliminary clean up to 
yield fraction A that contained phytoalexins cyclobrassinin (28), rutalexin (33), 
brassicanate A (43), rapalexin A (53), and fraction B that contained spirobrassinin (34) 
(established by HPLC-DAD and HPLC-MS-ESI). Two new metabolite peaks were 
detected at tR = 30.1 and 34.1 min that were absent in chromatogram of control extracts. 
HPLC-MS-ESI analyses (positive ion mode) of the metabolite with peak at tR = 34.1 min 
49a 202a 
203a 
121a 
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contained an ion at m/z 337 and fragment ions at m/z 230, 174 and 130. The metabolite 
with peak at tR = 30.1 min contained an ion at m/z 351 and a fragment ion at m/z 251. 
The retention times, UV spectra, and fragmentation patterns of the metabolites at tR = 
30.1 and tR = 34.1 min were comparable with those of synthetic standards, 1-(tert-
butoxycarbonyl)spirobrassinin (196) and 1-(tert-butoxycarbonyl)brassinin (181), 
respectively, (Figure 2.12). These results were consistent with the expected involvement 
of indolyl-3-methylisothiocyanate in the biosynthetic pathway of indole phytoalexins. 
Additional experiments were conducted by incubating rutabaga root slices with 1-(tert-
butoxycarbonyl)brassinin (181). After 72-hour incubation the aqueous phase was 
collected, was extracted and was subjected to preliminary clean up to yield a fraction 
that contained phytoalexins; control experiments were prepared similarly by incubating 
slices with carrier solution. HPLC-DAD analysis of the phytoalexin fraction displayed a 
new peak at tR = 30.1 min that was absent in chromatogram of control extract. The new 
metabolite was identified as 1-(tert-butoxycarbonyl)spirobrassinin (196) by comparison 
of retention time, UV spectra, and fragmentation pattern (established by HPLC-DAD 
and HPLC-MS-ESI) (Figure 2.12). 
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Figure 2.12 Incorporation of 1-(tert-butoxycarbonyl)indol-3-ylmethylisothiocyanate 
(180) into 1-(tert-butoxycarbonyl)brassinin (181) and 1-(tert-
butoxycarbonyl)spirobrassinin (196). 
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1-Acetylindolyl-3-methylisothiocyanate (183) as a potential intermediate 
Boc is a large group that does not occur in natural products whereas the acetyl 
group is comparatively smaller and occurs in some natural products. 1-Acetylindolyl-3-
methylisothiocyanate (183) was therefore used to establish the involvement of 
isothiocyanates in the biosynthetic pathway of indole phytoalexins. Rutabaga and turnip 
root slices (prepared as previously described) were incubated with 183; control 
experiments were conducted similarly by incubating slices with carrier solution. 
Following 48- and 72-hour incubations, the aqueous phase was extracted and was 
fractionated to yield fraction A that contained the phytoalexins cyclobrassinin (28), 
rutalexin (33), brassicanate A (43), rapalexin A (53), and fraction B that contained 
spirobrassinin (34) (established by HPLC-DAD and HPLC-MS-ESI). A new peak was 
detected at tR = 22.2 min that was absent in the chromatogram of control extracts. 
HPLC-MS-ESI analyses (positive ion mode) of the phytoalexin fractions indicated ions 
at m/z 172 and 130. The new metabolite was identified as 1-acetylbrassinin (184) by 
comparison of retention time, UV spectra, and fragmentation pattern with those of 
authentic sample (Figure 2.13). The phytoalexin fractions, however, did not yield 1-
acetylspirobrassinin (195) or any 1-acetyl containing phytoalexins. Incubation of turnip 
and rutabaga root slices separately with 1-acetylbrassinin (183) did not yield any 1-
acetly-containing metabolites following 96 hours of incubation. 
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Figure 2.13 Incorporation of 1-acetylindol-3-ylmethylisothiocyanate (183) into 1-
acetylbrassinin (184). 
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Incorporation of [4',5',6',7'-2H4]cyclobrassinin (28a) 
The biogenetic relationship between cyclobrassinin (28) and spirobrassinin (34) 
was investigated in rutabaga and turnip root slices that produce both metabolites. Thus, 
[4',5',6',7'-2H4]cyclobrassinin (28a) was administered to UV-irradiated rutabaga and 
turnip slices (prepared as previously described); control experiments were prepared 
similarly and incubated with cyclobrassinin (28) or with carrier solution only. Following 
incubation for 24, 48, and 72 hours, the aqueous phase was collected, was extracted, and 
was subjected to preliminary clean up to yield fraction A that contained phytoalexins 
cyclobrassinin (28), rutalexin (33), brassicanate A (43), rapalexin A (53), and fraction B 
that contained spirobrassinin (34) (established by HPLC-DAD and HPLC-MS-ESI). 
Rutabaga root slices did not produce detectable amounts of spirobrassinin after 24 hours 
of incubation, but both tissues showed increasing amounts of spirobrassinin from 48- to 
72-hour incubations. HPLC-MS-ESI analyses (positive ion mode) of the phytoalexin 
fractions resulting from feeding [4',5',6',7'-2H4]cyclobrassinin displayed the 
spirobrassinin peak at tR = 13.2 min to contain two ions at m/z 251 and 255. The ion at 
m/z 255 was absent in control samples incubated with non-labeled cyclobrassinin. Based 
on the relative intensity of each molecular ion, deuterium incorporation was found to be 
10% {[2/(18 + 2)] × 100} after 24-hour incubation, but 15% {[4/(22 + 4)] × 100} and 
6% {[1/(16 + 1)] × 100} after 48- and 72-hour incubations, respectively in turnip root 
slices (Figure 2.14). In rutabaga tissues, deuterium incorporations were 7% {[6/(77 + 6)] 
× 100} and 4% {[0.9/(24 + 0.9)] × 100} for 48- and 72-hour incubations, respectively 
(Table 2.4). The decrease in incorporations with longer incubation period could result 
from pool dilution with increasing amount of natural abundant spirobrassinin. 
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Figure 2.14 Incorporation of [2H4]cyclobrassinin (28a) into [2H4]spirobrassinin (34b). 
 
Table 2.4 Biosynthetic incorporation of [4',5',6',7'-2H4]cyclobrassinin (28a) into 
[4',5',6',7'-2H4]spirobrassinin (34b) in rutabaga and turnip tissues 
% Deuterium incorporation into spirobrassinina,b  
Incubation (h) Rutabaga Turnip 
24 Nd 10 
48 7 15 
72 4 6 
Nd = Not detected. 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 4). 
aIncorporation determined from a single feeding experiment. 
bPositive ion mode. 
 
Incorporation of [SC2H3]brassicanal A (39b) 
The biogenetic relationship between brassicanal A (39) and brassicanate A (43) 
was investigated in rutabaga tissues that produce both metabolites. UV-irradiated root 
slices (prepared as previously described) were incubated with [SC2H3]brassicanal A 
(39b). Following 72-hour incubation, the aqueous phase was extracted and was 
subjected to preliminary clean up to yield fraction A that contained phytoalexins 
cyclobrassinin (28), rutalexin (33), brassicanate A (43), rapalexin A (53), and fraction B 
that contained spirobrassinin (34) (established by HPLC-DAD and HPLC-MS-ESI).; 
control experiments were prepared similarly and incubated with brassicanal A and with 
carrier solution. HPLC-MS-ESI analyses (negative ion mode) of the phytoalexin fraction 
resulting from feeding [SC2H3]brassicanal A displayed the brassicanate A peak at tR = 
15.2 min to contain two ions at m/z 220 and 223. The ion at m/z 223 was not detected in 
28a 34b 
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control samples incubated with non-labeled brassicanal A. Based on the relative 
intensity of the molecular ion the percentage of deuterium incorporation was found to be 
≥ 99%, suggesting that brassicanal A could be the last biogenetic intermediate in the 
biosynthetic pathway of brassicanate A. 
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Figure 2.15 Incorporation of [SC2H3]brassicanal A (39b) into [SC2H3]brassicanate A 
(43b ≥ 99%). 
 
2.2.2.2 Erucastrum gallicum (dog mustard) 
Dog mustard is a wild crucifer that was reported to exhibit resistance against the 
plant pathogen, S. sclerotiorum (Lefol et. al, 1997). Biotic (S. sclerotiorum) and abiotic 
[copper(II) chloride] elicitation of dog mustard leaves led to isolation and identification 
of four phytoalexins: indolyl-3-acetonitrile (49), arvelexin (51), erucalexin (38), and 1-
methoxyspirobrassinin (35) (Pedras and Ahiahonu 2004; Pedras et al., 2006a). The 
occurrence of erucalexin and its regioisomer 1-methoxyspirobrassinin in elicited leaves 
of dog mustard suggested a possible biogenetic relationship between these two 
metabolites. Toward this end, the biosynthetic pathway of erucalexin and 1-
methoxyspirobrassinin, and other dog mustard phytoalexins were investigated. 
Time course analyses and feeding experiments 
In order to investigate biosynthesis of erucalexin (38) and 1-methoxyspirobrassinin 
(35), time course analyses were conducted with detached dog mustard leaves to establish 
suitable plant age and incubation period for feeding experiments. Plants of different 
ages, 21, 28 and 35 days were sprayed with a solution of copper(II) chloride (2 × 10-3 M) 
to induce phytoalexin production. The petiolated leaves were incubated for 24 to 120 
hours under continuous light followed by extraction, preliminary clean up and HPLC-
39b 43b 
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DAD analyses to determine production of phytoalexins; control experiments were 
prepared similarly from dog mustard leaves sprayed with water. The amounts of 
erucalexin and 1-methoxyspirobrassinin in leaf extracts were determined by HPLC-DAD 
using calibration curves (Table 2.5). From these analyses, it was established that leaves 
from 21-day-old plants exhibited a slow uptake of carrier solution, and most of the 
detached leaves wilted before the end of the experiment period. Plant leaves older than 
35 days exhibited faster uptake of carrier solution, but elicitation levels were not as 
efficient as was observed with 21- and 28-day-old plants. The 28-day-old plants 
therefore proved more suitable for feeding experiments since their leaf extracts 
contained higher amounts of erucalexin and 1-methoxyspirobrassinin than the 21-day-
old plants, and exhibited efficient uptake of carrier solution. The 28-day-old plant 
extracts were used to establish a suitable incubation period for feeding experiments. 
These analyses revealed that the amounts of erucalexin increased from 24-hour 
incubation to a maximum at 48-hour incubation, after which a decrease was noted from 
72- to 120-hour incubations (Table 2.5). The amounts of 1-methoxyspirobrassinin were 
not significantly different between 24- and 48-hour incubations; a significant decrease 
was noted from 72- to 120-hour incubations. It was also noted that the amounts of 
erucalexin were consistently higher than those of 1-methoxyspirobrassinin through out 
the time course analyses. Since maximum production of erucalexin and 1-
methoxyspirobrassinin was at 48-hour incubation, this time was used to conduct feeding 
experiments. 
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Table 2.5 Production of 1-methoxyspirobrassinin (35) and erucalexin (38) in 28-
day-old detached leaves of dog mustard (Pedras and Okinyo, 2006b) 
Phytoalexin Incubation time 
(h) 
Total amount of phytoalexin 
(µmole/100 g of fresh tissue ± 
STD)a 
Erucalexin 24 5.9 ± 1.2 
 48 14.9 ± 2.4 
 72 5.8 ± 2.7 
 96 5.4 ± 0.1 
 120 2.7 ± 1.2 
1-Methoxyspirobrassinin 24 3.7 ± 0.2 
 48 3.4 ± 0.5 
 72 1.1 ± 0.6 
 96 2.0 ± 0.9 
 120 0.7 ± 0.01 
aAmounts of erucalexin and 1-methoxyspirobrassinin ± standard deviation (STD) were 
determined from duplicate experiments. In each experiment, three leaves were extracted 
and subjected to preliminary clean up, followed by HPLC-DAD analysis. 
 
In feeding experiments, 28-day-old dog mustard plants were sprayed with 
copper(II) chloride (2 × 10-3 M) to the point of run off. After 24-hour incubation the 
leaves were excised at the petiole and were incubated with perdeuterated compounds (5 
× 10-4 M) followed by a second copper(II) chloride spray. Following 48 hours of 
incubation, the leaves were extracted. The extracts were subjected to preliminary clean 
up to yield a fraction that contained the phytoalexins 1-methoxyspirobrassinin (35), 
erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin (51) (established by HPLC-
DAD and HPLC-MS-ESI). Control experiments were conducted using: (i) doubly-
elicited leaves of dog mustard incubated with non-labeled compounds (5 × 10-4 M), (ii) 
doubly-elicited leaves incubated with carrier solution, (iii) non-elicited leaves incubated 
with carrier solution. 
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The percentage of deuterium (2H) incorporation was established according to the 
equation: 
 
% of 2H incorporation = [M + n]+/([M]+ + [M + n]+) × 100 (n = 3, 4, 7), n is the 
number of deuterium atoms, and M is the peak area or relative intensity of each 
molecular ion. 
 
The HPLC-HRMS-ESI data indicated that [M + n]+ was not present in natural 
abundance samples. 
Incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
The origin of indole group in erucalexin and 1-methoxyspirobrassinin was 
established through administration of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) to 
doubly elicited detached dog mustard leaves. After 48 hours of incubation the leaves 
were extracted and extracts subjected to preliminary clean up to yield a fraction that 
contained the phytoalexins 1-methoxyspirobrassinin (35), erucalexin (38), indolyl-3-
acetonitrile (49), and arvelexin (51) (established by HPLC-DAD and HPLC-MS-ESI); 
control experiments were conducted similarly by incubating doubly elicited leaves with 
non-labeled indolyl-3-acetaldoxime and with carrier solution. HPLC-HRMS-ESI 
analyses (positive ion mode) of the phytoalexin fraction resulting from feeding 
[4',5',6',7'-2H4]indolyl-3-acetaldoxime displayed the erucalexin and 1-
methoxyspirobrassinin peaks at tR = 14.5 and 18.2 min, respectively, to contain two ions 
at m/z 281.0412 and 285.0664 corresponding to the molecular formulae C12H13N2O2S2 
and C12H92H4N2O2S2, respectively. The ion at m/z 285.0664 was not detected in control 
samples incubated with non-labeled indolyl-3-acetaldoxime (112). Based on the peak 
area of each ion, the percentage of deuterium incorporation was found to be 15 ± 3 % for 
erucalexin and 46 ± 6 % for 1-methoxyspirobrassinin (Figure 2.16, Table 2.6). 
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Figure 2.16 Incorporation of [2H4]indolyl-3-acetaldoxime (112a) into [2H4]erucalexin 
(38a, 15 ± 3 %) and [2H4]1-methoxyspirobrassinin (35a, 46 ± 6 %). 
 
Biogenetic relationship between indolyl-3-acetaldoxime (112) with other dog 
mustard phytoalexins, indolyl-3-acetonitrile (49) and arvelexin (51) was investigated 
(Figure 2.17). These phytoalexins are not detectable by HPLC-MS-ESI and HPLC-
HRMS-ESI, but they can be detected by HRMS-EI. In order to carry out this study, dog 
mustard extracts [(i) incubated with [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a); (ii) 
incubated with indolyl-3-acetaldoxime (112); (iii) incubated with carrier solution] were 
subjected to preparative HPLC purification. HRMS-EI analysis of a fraction resulting 
from feeding [4',5',6',7'-2H4]indolyl-3-acetaldoxime displayed the indolyl-3-acetonitrile 
peak to contain two molecular ions at m/z 156.0687 and 160.0938 which were consistent 
with molecular formulae C10H8N2 and C10H42H4N2, respectively (Figure 2.17). The 
molecular ion at m/z 160.0938 was not detected in indolyl-3-acetonitrile fractions from 
control extract incubated with non-labeled indolyl-3-acetaldoxime. Based on the relative 
intensity of each molecular ion, the percentage of deuterium incorporation was found to 
be 89 % {[93/(11 + 93)] × 100}. HRMS-EI analyses of arvelexin (51) fraction from 
feeding [4',5',6',7'-2H4]indolyl-3-acetaldoxime displayed two molecular ions at m/z 
186.0793 and 189.0981 that were consistent with molecular formulae C11H10N2O and 
C11H72H3N2O, respectively (Figure 2.17). The molecular ion at m/z 189.0981 was not 
detected in arvelexin fractions from control extract incubated with non-labeled indolyl-
3-acetaldoxime. Percentage of deuterium incorporation was calculated from the relative 
intensity of each molecular ion and was found to be 41% {[69/(100 + 69)] × 100} 
(Figure 2.17, Table 2.6). 
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Figure 2.17 Incorporation of [2H4]indolyl-3-acetaldoxime (112a) into [2H4]indolyl-3-
acetonitrile (49a, 89%) and [2H3]arvelexin (51a, 41%). 
 
Table 2.6 Incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) into dog 
mustard phytoalexins 
Compound % Incorporation 
[4',5',6',7'-2H4]1-Methoxyspirobrassinin (35a) a,c46 ± 6 
[4',5',6',7'-2H4]Erucalexin (38a) a,c15 ± 3 
[4',5',6',7'-2H4]Indolyl-3-acetonitrile (49a) b89 
[4',5',6',7'-2H4]Arvelexin (51a) b41 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 4). 
aIncorporation determined from average of two independent experiments ± standard 
deviation (STD). 
bIncorporation determined from a single feeding experiment. 
cPositive ion mode. 
Incorporation of 1-methoxyindolyl-3-acetaldoximes 
Biogenetic origin of 1-methoxy group in erucalexin and 1-methoxyspirobrassinin 
was investigated using perdeuterated 1-methoxyindolyl-3-acetaldoximes: [1",1",1"-
2H3]1-methoxyindolyl-3-acetaldoxime (116a), [4',5',6',7'-2H4]1-methoxyindolyl-3-
acetaldoxime (116b), and [1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime 
(116c). 
First, doubly elicited dog mustard leaves were incubated with [1",1",1"-2H3]1-
methoxyindolyl-3-acetaldoxime (116a) for 48 hours. The leaves were extracted and 
subjected to preliminary clean up to yield a fraction that contained the phytoalexins 1-
methoxyspirobrassinin (35), erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin 
(51) (established by HPLC-DAD and HPLC-MS-ESI); control experiments were 
prepared similarly by incubating doubly elicited leaves with 1-methoxyindolyl-3-
112a 49a 51a 
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acetaldoxime (116) and with carrier solution. HPLC-HRMS-ESI analyses (positive ion 
mode) of the phytoalexin fraction from feeding [1",1",1"-2H3]1-methoxyindolyl-3-
acetaldoxime displayed the erucalexin and 1-methoxyspirobrassinin peaks at tR = 14.5 
and 18.2 min, respectively, to contain two ions at m/z 281.0412 and 284.061 
corresponding to the molecular formulae C12H13N2O2S2 and C12H102H3N2O2S2, 
respectively (Figure 2.18, Table 2.7). The ion at m/z 284.061 was not detected in 
control fractions incubated with non-labeled 1-methoxyindolyl-3-acetaldoxime. 
Deuterium incorporation was calculated based on the peak area of each molecular ion 
and was found to be 5 ± 3 % for erucalexin and 7 ± 3 % for 1-methoxyspirobrassinin 
(Figure 2.18, Table 2.7). 
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Figure 2.18 Incorporation of [2H3]1-methoxyindolyl-3-acetaldoxime (116a) into 1-
methoxyspirobrassinin (35b, 7 ± 3 %) and erucalexin (38b, 5 ± 3 %). 
 
Next, doubly elicited dog mustard leaves were incubated with [4',5',6',7'-2H4]1-
methoxyindolyl-3-acetaldoxime (116b) for 48 hours. The leaves were extracted and 
subjected to preliminary clean up to yield a fraction that contained the phytoalexins 1-
methoxyspirobrassinin (35), erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin 
(51) (established by HPLC-DAD and HPLC-MS-ESI); control experiments were 
prepared similarly by incubating doubly elicited leaves with 1-methoxyindolyl-3-
acetaldoxime (116) and with carrier solution. HPLC-HRMS-ESI analyses (positive ion 
mode) of the phytoalexin fraction from feeding [4',5',6',7'-2H4]1-methoxyindolyl-3-
acetaldoxime displayed the erucalexin and 1-methoxyspirobrassinin peaks at tR = 14.5 
and 18.2 min, respectively, to contain two ions at m/z 281.0412 and 285.0664 that were 
consistent with the molecular formulae C12H13N2O2S2 and C12H92H4N2O2S2, respectively 
(Figure 2.19). The ion at m/z 285.0664 was not detected in control fractions that were 
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incubated with 1-methoxyindolyl-3-acetaldoxime. Based on the peak area of each ion, 
deuterium incorporation was found to be 6 ± 4 % for erucalexin and 7 ± 2 % for 1-
methoxyspirobrassinin (Figure 2.19, Table 2.7). 
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Figure 2.19 Incorporation of [2H4]1-methoxyindolyl-3-acetaldoxime (116b) into 
[2H4]1-methoxyspirobrassinin (35a, 7 ± 2 %) and [2H4]erucalexin (38a, 6 ± 4 %). 
 
Lastly, [1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime (116c) was 
administered to doubly elicited dog mustard leaves. Following 48-hour incubation and 
extraction, preliminary clean up yielded a fraction that contained the phytoalexins 1-
methoxyspirobrassinin (35), erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin 
(51) (established by HPLC-DAD and HPLC-MS-ESI); control experiments were 
prepared similarly by incubating doubly elicited leaves with 1-methoxyindolyl-3-
acetaldoxime (116) and with carrier solution. HPLC-HRMS-ESI analyses (positive ion 
mode) of the phytoalexin fraction resulting from feeding [1",1",1",4',5',6',7'-2H7]1-
methoxyindolyl-3-acetaldoxime displayed the erucalexin and 1-methoxyspirobrassinin 
peaks at tR = 14.5 and 18.2 min, respectively, to contain two ions at m/z 281.0412 and 
288.0852 that were consistent with the molecular formulae C12H13N2O2S2 and 
C12H62H7N2O2S2, respectively (Figure 2.20). The ion at m/z 288.0852 was absent in 
control extracts incubated with non-labeled 1-methoxyindolyl-3-acetaldoxime. The 
percentage of deuterium incorporation was calculated based on the peak area of each ion 
and was found to be 3 ± 2 % for erucalexin and 4 ± 3 % for 1-methoxyspirobrassinin 
(Figure 2.20, Table 2.7). 
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Figure 2.20 Incorporation of [2H7]1-methoxyindolyl-3-acetaldoxime (116c) into 
[2H7]1-methoxyspirobrassinin (35c, 4 ± 3 %) and [2H7]erucalexin (38c, 3 ± 2 %). 
 
Deuterium labeling of erucalexin and 1-methoxyspirobrassinin indicated only [M + 
7]+ suggesting intact incorporation of [2H7]1-methoxyindolyl-3-acetaldoxime without 
loss of 1-methoxy group (Figure 2.20). 
 
Table 2.7 Incorporation of 1-methoxyindolyl-3-acetaldoximes (116a, 116b, and 
116c) into erucalexin and 1-methoxyspirobrassinin 
% Incorporation  
Precursor Erucalexin 1-Methoxyspirobrassinin 
[1",1",1"-2H3]1-methoxyindolyl-3-
acetaldoxime (116a) 
a,c5 ± 3 a,c7 ± 3 
[4',5',6',7'-2H4]1-methoxyindolyl-3-
acetaldoxime (116b) 
b,c6 ± 4 b,c7 ± 2 
[1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-
3-acetaldoxime (116c) 
b,c3 ± 2 b,c4 ± 3 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 3, 4, 7). 
aIncorporation determined from average of five independent experiments ± standard 
deviation (STD). 
bIncorporation determined from average of three independent experiments ± standard 
deviation (STD). 
cPositive ion mode. 
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Incorporation of 1-methoxybrassinins 
Biosynthetic pathway of erucalexin and 1-methoxyspirobrassinin was studied with 
perdeuterated 1-methoxybrassinins; [3,3,3-2H3]1-methoxybrassinin (18a), and 
[3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c) which are advanced precursors in the 
biosynthetic pathway. Thus, doubly elicited dog mustard leaves were incubated with 
[3,3,3-2H3]1-methoxybrassinin (18a) for 48 hours followed by extraction. Preliminary 
clean up of the extract yielded a fraction that contained the phytoalexins 1-
methoxyspirobrassinin (35), erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin 
(51) (established by HPLC-DAD and HPLC-MS-ESI); control experiments were 
prepared similarly by incubating doubly elicited leaves with 1-methoxybrassinin (18) 
and with carrier solution only. HPLC-HRMS-ESI analyses (positive ion mode) of the 
phytoalexin fraction resulting from feeding [3,3,3-2H3]1-methoxybrassinin displayed the 
erucalexin and 1-methoxyspirobrassinin peaks at tR = 14.5 and 18.2 min, respectively, to 
contain two ions at m/z 281.0412 and 284.0601 which were consistent with molecular 
formulae C12H13N2O2S2 and C12H102H3N2O2S2, respectively (Figure 2.21). The ion at 
m/z 284.0601 was not detected in control fractions incubated with non-labeled 1-
methoxybrassinin. Based on the peak area of each molecular ion, deuterium 
incorporation was found to be 7 ± 3 % for erucalexin and 53 ± 2 % for 1-
methoxyspirobrassinin (Figure 2.21, Table 2.8). 
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Figure 2.21 Incorporation of [2H3]1-methoxybrassinin (18a) into [2H3]1-
methoxyspirobrassinin (35d, 53 ± 2 %) and [2H3]erucalexin (38d, 7 ± 3 %) (Pedras and 
Okinyo, 2006b). 
 
Next, doubly elicited dog mustard leaves were incubated with [3,3,3,4',5',6',7'-
2H7]1-methoxybrassinin (18c). After 48 hours the leaves were extracted followed by 
preliminary clean up to yield a fraction that contained the phytoalexins 1-
18a 38d 35d 
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methoxyspirobrassinin (35), erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin 
(51) (established by HPLC-DAD and HPLC-MS-ESI); control experiments were 
prepared similarly by incubating doubly elicited leaves with 1-methoxybrassinin (18) 
and with carrier solution. HPLC-HRMS-ESI analyses (positive ion mode) of the 
phytoalexin fraction resulting from feeding [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin 
displayed the erucalexin and 1-methoxyspirobrassinin peaks at tR = 14.5 and 18.2 min, 
respectively, to contain two ions at m/z 281.0412 and 288.0852 that were consistent with 
the molecular formulae C12H13N2O2S2 and C12H62H7N2O2S2, respectively (Figure 2.22). 
The ion at m/z 288.0852 was not detected in control extracts incubated with non-labeled 
1-methoxybrassinin. Based on the peak area of each ion, deuterium incorporation was 
found to be 4 ± 2 % for erucalexin and 64 ± 11 % for 1-methoxyspirobrassinin (Figure 
2.22, Table 2.8). 
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Figure 2.22 Incorporation of [2H7]1-methoxybrassinin (18c) into 1-
methoxyspirobrassinin (35e, 64 ± 11 %) and erucalexin (38e, 4 ± 2 %) (Pedras and 
Okinyo, 2006b). 
 
HPLC-DAD chromatograms of leaf extracts incubated with 1-methoxybrassinins 
(18, 18a, 18c) indicated a new metabolite peak at tR = 8.9 min that was absent in leaf 
extracts incubated with carrier solution only. The new metabolite was identified as 
caulilexin B (48) by comparison of retention time and UV spectra with those of an 
authentic sample. In order to determine deuterium incorporation, fed and control leaf 
extracts were separated by preparative HPLC to yield caulilexin B at tR = 8.9 min and 1-
methoxybrassitin at 18.1 min in less than 0.1 mg each. 
HPLC-HRMS-ESI analysis of caulilexin B (purified from leaf extracts incubated 
with [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin) indicated a fragment ion at m/z 164.1007 
that was consistent with the molecular formula C10H62H4NO, suggesting a 1-
18c 35e 38e 
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methoxyindole-3-methine fragment. The fragmentation pattern is characteristic of 1-
methoxy containing phytoalexins such as 1-methoxybrassinin (18), 1-methoxybrassitin 
(20), and wasalexins A (23) and B (24) (Pedras et al., 2006c). HRMS-EI analysis of 
caulilexin B resulting from extracts fed [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin 
displayed an ion at m/z 208.1149 that was consistent with the molecular formula 
C11H82H4N2O2. These data suggested deuterium incorporation into [4',5',6',7'-
2H4]caulilexin B (48a) to be ≥ 99.9% (Figure 2.23, Table 2.9). 
The amount of 1-methoxybrassitin (20) increased 5 fold in extracts incubated with 
1-methoxybrassinin compared to those incubated with carrier solution only. The HRMS-
EI analysis of 1-methoxybrassitin fraction obtained from leaf extracts incubated with 
[3,3,3,4',5',6',7'-2H7]1-methoxybrassinin displayed two ions at m/z 250.0776 and 
257.1215 that were consistent with the molecular formulae C12H14N2O2S and 
C12H72H7N2O2S, respectively (Figure 2.23). Based on the relative intensity of each 
molecular ion, percentage of deuterium incorporation was found to be 99.6% {[100/(0.4 
+ 100)] × 100} (Figure 2.23, Table 2.9), suggesting that 1-methoxybrassinin is 
immediate precursor of 1-methoxybrassitin. 
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Figure 2.23 Incorporation of [2H7]1-methoxybrassinin (18c) into [2H7]1-
methoxybrassitin (20a, 99.6%) and [2H4]caulilexin B (48a, ≥ 99.9%). 
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Table 2.8 Incorporation of 1-methoxybrassinins into erucalexin and 1-
methoxyspirobrassinin 
% Incorporationa,b  
Precursor Erucalexin 1-Methoxyspirobrassinin 
[3,3,3-2H3]1-Methoxybrassinin (18a) 7 ± 3 53 ± 2 
[3,3,3,4',5',6',7'-2H7]1-Methoxybrassinin 
(18c) 
4 ± 2 64 ± 11 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 3, 7). 
aIncorporation determined from average of three independent experiments ± standard 
deviation (STD). 
bPositive ion mode. 
 
Table 2.9 Incorporation of [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c) into 1-
methoxybrassitin (20a) and caulilexin B (48a) 
Compound % Incorporationa 
[1",1",1",4',5',6',7'-2H7]1-Methoxybrassitin (20a) 99.6 
[4',5',6',7'-2H4]Caulilexin B (48a) ≥99.9 
% of 2H incorporation = {[M + n]+/([M]+ + [M + n]+)} × 100 (n = 4, 7). 
aIncorporation determined from one set of experiments. 
 
Incorporation of sinalbins B 
Sinalbin B (31) was detected in stem extracts of white mustard (Sinapis alba) 
elicited with L. maculans and was suggested to be a biosynthetic precursor of sinalbin A 
(30). Since sinalbin B contains a 1-methoxy group, its biogenetic relationship with 
erucalexin was investigated. Thus, doubly elicited dog mustard leaves were incubated 
with [3,3,3-2H3]sinalbin B (31b) for 48 hours. Following extraction, preliminary clean 
up yielded a fraction that contained the phytoalexins 1-methoxyspirobrassinin (35), 
erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin (51) (established by HPLC-
DAD and HPLC-MS-ESI); control experiments were prepared similarly by incubating 
doubly elicited leaves with sinalbin B (31) and with carrier solution. HPLC-HRMS-ESI 
analyses (positive ion mode) of the phytoalexin fraction resulting from feeding [3,3,3-
2H3]sinalbin B displayed the erucalexin (38d) and 1-methoxyspirobrassinin (35d) peaks 
at tR = 14.5 and 18.2 min, respectively, to contain two ions at m/z 281.0412 and 284.061 
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that were consistent with molecular formulae C12H13N2O2S2 and C12H102H3N2O2S2, 
respectively. The ion at m/z 284.061 was not detected in control extracts incubated with 
non-labeled sinalbin B. The percentage of deuterium incorporation was calculated from 
the peak area of each ion and was found to be 2 ± 0.2 % for erucalexin and 10 ± 1 % for 
1-methoxyspirobrassinin (Figure 2.24, Table 2.10). 
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Figure 2.24 Incorporation of [2H3]sinalbin B (31b) into [2H3]1-methoxyspirobrassinin 
(35d, 10 ± 1 %) and [2H3]erucalexin (38d, 2 ± 0.2 %) (Pedras and Okinyo, 2006b). 
 
Next, doubly elicited dog mustard leaves were incubated with [4',5',6',7'-
2H4]sinalbin B (31a). After 48 hours, the leaves were extracted followed by preliminary 
clean up to yield a fraction that contained phytoalexins 1-methoxyspirobrassinin (35), 
erucalexin (38), indolyl-3-acetonitrile (49), and arvelexin (51) (established by HPLC-
DAD and HPLC-MS-ESI); control experiments were prepared similarly by incubating 
doubly elicited leaves with sinalbin B (31) and with carrier solution. HPLC-HRMS-ESI 
analyses (positive ion mode) of the phytoalexin fraction resulting from feeding of 
[4',5',6',7'-2H4]sinalbin B displayed the erucalexin and 1-methoxyspirobrassinin peaks at 
tR = 14.5 and 18.2 min, respectively, to contain two ions at m/z 281.0412 and 285.0664 
that were consistent with the molecular formulae C12H13N2O2S2 and C12H92H4N2O2S2, 
respectively (Figure 2.25). The ion at m/z 285.0664 was not detected in control fractions 
incubated with non-labeled sinalbin B. The percentage of deuterium incorporation was 
calculated from the peak area of each ion and was found to be 5 ± 0.1 % for erucalexin 
and 19 ± 7 % for 1-methoxyspirobrassinin (Figure 2.25, Table 2.10). These results were 
consistent with those obtained from incorporation of [3,3,3-2H3]sinalbin B (31b). 
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Figure 2.25 Incorporation of [2H4]sinalbin B (31a) into [2H4]1-methoxyspirobrassinin 
(35a, 19 ± 7 %) and [2H4]erucalexin (38a, 5 ± 0.1 %) (Pedras and Okinyo, 2006b). 
 
Table 2.10 Incorporation of sinalbins B (31a and 31b) into erucalexin and 1-
methoxyspirobrassinin 
% Incorporation  
Precursor Erucalexin 1-Methoxyspirobrassinin 
[4',5',6',7'-2H4]sinalbin B (31a) a,c5 ± 0.1 b,c19 ± 7 
[3,3,3-2H3]sinalbin B (31b) a,c2 ± 0.2 b,c10 ± 1 
% of 2H incorporation = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 3,4). 
aIncorporation determined from average of two independent experiments ± standard 
deviation (STD). 
bIncorporation determined from average of three independent experiments ± standard 
deviation (STD). 
cPositive ion mode. 
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CHAPTER 3  
3. Discussion 
3.1 Secondary metabolites from Eruca sativa (rocket) 
Rocket (Eruca sativa) was previously reported to exhibit resistance against the 
phytopathogenic fungus Alternaria brassicae (Conn et al., 1988). Considering the role of 
phytoalexins in plant disease resistance, investigation of phytoalexin production in 
rocket was carried out. Phytoalexin elicitation followed by analysis of leaf extracts 
showed arvelexin (51) (Pedras et al.,  2003a) as the only elicited compound. Bioassay 
guided isolation using spores of Cladosporium cucumerinum, however, led to the 
isolation of two antifungal metabolites, 4-methylthiobutyl isothiocyanate (166) and 
bis(4-isothiocyanatobutyl)disulfide (167). Compounds, 166 and 167 inhibited 
germination of C. cucumerinum spores in TLC biodetection assays. Both 
metabolites 166 and 167 were previously isolated from rocket and suggested to derive 
from their respective glucosinolates (Bennett et al., 2002; Cerney et al., 1996). The 
bis(4-isothiocyanatobutyl)disulfide was proposed to be formed via oxidation of the 
unstable 4-(mercaptobutyl) isothiocyanate (Cerney et al., 1996), whereas 4-
methylthiobutyl isothiocyanate derived from myrosinase hydrolysis of 4-methylthiobutyl 
glucosinolate (Bennett et al., 2002). 
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Figure 3.1 Antifungal metabolites from rocket (Eruca sativa). 
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In general, crucifers produce a mixture of phytoalexins, whose composition and 
amounts depend on the type of stress (Pedras et al., 2007b). It was therefore surprising to 
find that rocket seems to produce only one phytoalexin upon elicitation with copper(II) 
chloride. Perhaps it would be of interest to analyze tissues infected with different 
pathogens. In fact, recent results have shown that canola and rapeseed produced 
phytoalexin mixtures related to the virulence of the pathogen (Pedras et al., 2007e). 
3.2 Syntheses of compounds 
Preparation of perdeuterated compounds such as [4',5',6',7'-2H4]indolyl-3-
acetaldoxime (112a), [4',5',6',7'-2H4]brassinin (16a), [4',5',6',7'-2H4]cyclobrassinin (28a), 
and [4',5',6',7'-2H4]sinalbin B (31a) required the starting material, [4,5,6,7-2H4]indole 
(105a), to be at least 99% deuterated. Because the commercially available indoles did 
not offer this percentage of deuteration at specific sites or were very expensive, a shorter 
procedure was used to prepare [4,5,6,7-2H4]indole (105a) in two steps and 24% overall 
yield starting from the readily available NMR solvent [2,3,4,5,6-2H5]nitrobenzene (168a, 
99%, 2H5) and 2-chloroacetonitrile (Pedras and Okinyo, 2006a) (Scheme 3.1). Indole 
was previously prepared from 2-nitrophenylacetonitrile which was obtained from 
toluene in three steps, requiring a chromatographic separation for each step (Van den 
Berg et al., 1988). Makosza and Winiarski (1984), however, developed a one step 
reaction in the preparation of 2-nitrophenylacetonitrile and derivatives by employing 
vicarious nucleophilic substitution of stabilized R-chlorocarbanions with nitrobenzene. 
This method (Makosza and Winiarski, 1984) was therefore adapted to the preparation of 
[4,5,6,7-2H4]indole (105a) as shown in Scheme 3.1. Next [4',5',6',7'-2H4]indolyl-3-
acetonitrile (49a) was prepared from [4,5,6,7-2H4]indolylmagnesium iodide and 
bromoacetonitrile (Pedras et al., 2003; Pedras and Okinyo, 2006a). Subsequent reduction 
of [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a) with DIBAH followed by hydrolysis and 
treatment with HONH2·HCl and NaOAc yielded [4',5',6',7'-2H4]indolyl-3-acetaldoxime 
(112a) (Pedras and Okinyo, 2006) (Scheme 3.1). Non-isotopically labeled indolyl-3-
acetaldoxime (112), and 1-methylindolyl-3-acetaldoxime (170) were similarly prepared. 
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Scheme 3.1 Reagents and conditions: i) ClCH2CN, NaOH, DMSO, 40%; ii) 10% 
Pd/C, H2, EtOAc, 61%; iii) Mg, ICH3, BrCH2CN, Et2O, 57%; iv) DIBAH; v) 
HONH2·HCl, NaOAc, EtOH, 33%; vi) 10% Pd/C, H2, Ac2O; vii) NaBH3CN, AcOH; 
viii) Na2WO4·2H2O, H2O2, CH3OH; ix) (C2H3O)2SO2, K2CO3, CH3OH; x) NaOH, 
CH3OH, reflux; xi) Na2WO4·2H2O, H2O2, CH3OH, 4% from 49a; xii) Na2WO4·2H2O, 
H2O2, CH3OH; xiii) (CH3O)2SO2, K2CO3; xiv) NaOH, CH3OH, reflux; xv) 
Na2WO4·2H2O, H2O2, CH3OH, 5% from 49a (Pedras and Okinyo, 2006a). 
 
Preparation of perdeuterated 1-methoxyindolyl-3-acetaldoximes 116b and 116c 
(Scheme 3.1) needed [4',5',6',7'-2H4]tryptamine as the starting material. Attempts to 
synthesize [4',5',6',7'-2H4]tryptamine via hydrogenation of [4',5',6',7'-2H4]indolyl-3-
acetonitrile (49a) in ethyl acetate or ethanol were unsuccessful. Hydrogenation of 49a in 
acetic anhydride thus provided [4',5',6',7'-2H4]Nb-acetyltryptamine that was reduced with 
NaBH3CN to yield [2H4]Nb-acetyl-2,3-dihyroindolyl-3-ethylamine (114a) (Pedras and 
Okinyo, 2006a). Oxidation of 114a with Na2WO4/H2O2 (Somei and Kawasaki, 1989) 
and subsequent methylation with (C2H3O)2SO2 or (CH3O)2SO2 yielded 
[1",1",1",4',5',6',7'-2H7]Nb-acetyl-1-methoxytryptamine (115c) and [4',5',6',7'-2H4]Nb-
acetyl-1-methoxytryptamine (115b), respectively. The oxidation of the amines proved 
difficult mostly due to decomposition of the products under the reaction conditions used 
168a 105a 49a 112a 
115b 
115c 116c 
114a 
116b 
 120 
(Pedras and Okinyo, 2006a) but were accomplished in 4 – 5% yield (Scheme 3.1). 
Simple and efficient methods of oxidation of aliphatic amines to oximes are however not 
available. For example, CH3ReO3/H2O2 catalyzed oxidation of primary alkylamines 
possessing the α-C-H bond was found to yield mixtures of oximes, nitroso dimers, and 
azoxy compounds (Yamazaki, 1997). 
A number of synthetic strategies have been developed for the preparation of free 
thiohydroxamic acids as described in the Introduction section (Chimiak et al., 2002; 
Walter and Schaumann, 1971). The simplest and most efficient preparation involves 
conversion of primary nitro compounds (alkyl or benzyl) to their respective 
thiohydroxamic acids using hexamethyldisilathiane (171) (Hwu and Tsay, 1990). 
Indolyl-3-acetothiohydroxamic acid (174) or its derivatives were however not reported. 
In addition, the biosynthetic investigations employing indolyl-3-acetothiohydroxamic 
acid required labeling of the sulfur and the indolyl ring. Sulfur 34 and deuterium were 
chosen for labeling experiments since metabolites incorporating them could 
unambiguously be detected by mass spectrometry (HRMS-ESI). In this work, a simple 
three step preparation was developed starting from indole-3-carboxaldehyde (106) 
(Scheme 3.2). 1-Methylindolyl-3-acetothiohydroxamic acid (178) was similarly 
prepared starting from 1-methylindole-3-carboxaldehyde (175). The use of sodium 
hydride instead of potassium hydride to prepare 174 provided only indolyl-3-acetonitrile 
(49) and indolyl-3-acetaldoxime (112) in a 1:1 ratio (Scheme 3.2). The 13C NMR data 
indicated that indolyl-3-acetothiohydroxamic acid (174), and not indolyl-3-
acetothiohydroximic acid (204), is the most likely tautomer present in solution since the 
C-1 is 189.0 ppm. In general the C-1 of thiohydroximates has lower value (ca 162-172 
ppm) (Pedras and Okinyo, 2008). 
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Scheme 3.2 Synthesis of indolyl-3-acetothiohydroxamic acid (174). Reagents and 
conditions: i) CH3NO2, NH4OAc, 128-130 °C, 98%; ii) NaBH4, i-PrOH, SiO2, CHCl3, 
71%; iii) KH, (Me3Si)2S (171), THF, 74%; . iv) NaH, (Me3Si)2S, THF (Pedras and 
Okinyo, 2008). 
 
Once the synthesis of indolyl-3-acetothiohydroxamic acid (174) was established 
(Scheme 3.2), the [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) was 
synthesized for the first time following steps in Scheme 3.2 and using [4,5,6,7-
2H4]indole-3-carboxaldehyde (106a) as the starting material. The 34S-
hexamethyldisilathiane (171a) was not commercially available, and was therefore 
prepared (from sulfur 34, sodium, and chlorotrimethylsilane) as described in the Result 
and Experimental sections. With 171a in hand, [4',5',6',7'-2H4]indolyl-3-
[34S]acetothiohydroxamic acid (174a) was prepared following steps in Scheme 3.2 
(Pedras and Okinyo, 2008). 
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The indolyl-3-methylisothiocyante (123) was proposed to be an intermediate in the 
biosynthetic pathway of brassinin (16) (Pedras et al., 2003b; Pedras and Okinyo, 2008). 
Attempts to synthesize 123 were unsuccessful (Kutchy et al., 1997; 1998) due to its 
instability (Hanley et al., 1990; Hanley and Parsley, 1990). The synthesis of the stable 1-
(t-butoxycarbonyl)indolyl-3-methylisothiocyanate (180) was reported (Kutchy et al., 
1997; 1998). In this thesis, 1-acetylindolyl-3-methylisothiocyanate (183) was prepared 
for the first time (Scheme 3.3). The 1-acetylbrassinin (184) was obtained from freshly 
prepared amine 182 following previously established procedures for the preparation of 
brassinin (16) (Scheme 3.3, Pedras et al., 2003b) and is described in Result and 
Experimental sections. 
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Scheme 3.3 Reagents and conditions: i) Ac2O, pyridine, 96%; ii) HONH2·HCl, 
NaOAc, EtOH, 45-50 ºC, 88%; iii) NiCl2·6H2O, NaBH4, CH3OH; iv) Cl2CS, CaCO3, 
CH2Cl2-H2O, 31% from oxime; v) Et3N, CS2, ICH3, pyridine, 41 % from oxime. 
 
[4',5',6',7'-2H4]Cyclobrassinin (28a) was prepared from [4,5,6,7-2H4]indole (105a) 
following previously established procedure (Pedras et al., 1998) (Scheme 3.4). 
Perdeuterated 1-methoxybrassinins 18b and 18c were obtained from [4,5,6,7-2H4]indole 
(105a) as shown in Scheme 3.4 (Pedras and Okinyo, 2006a). [4',5',6',7'-2H4]Sinalbin B 
(31a) was prepared from [4',5',6',7'-2H4]1-methoxybrassinin (18b) following the 
established synthesis for sinalbin B (31) (Pedras and Zaharia, 2000), whereas [4',5',6',7'-
183 182 106 
184 
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2H4]1-methoxyspirobrassinin (35a) was prepared from 18b following the established 
synthesis for 1-methoxyspirobrassinin (35) (Scheme 3.4, Pedras et al., 2006a). 
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Scheme 3.4 Reagents and conditions: i) POCl3, DMF, 87%; ii) HONH2·HCl, Na2CO3, 
EtOH, reflux, 87%; iii) NaOH, Devarda’s alloy, CH3OH; iv) Pyridine, Et3N, CS2, 60 
min, 0 ºC; v) ICH3, 50%; vi) pyridine/HBr/Br2, THF, vii) DBU, 58% (Pedras et al., 
1998); viii) NaBH3CN, AcOH, 82%; ix) Na2WO4·2H2O, H2O2; x) (CH3O)2SO2, K2CO3, 
CH3OH, 52%; xi) POCl3, DMF, 93%; xii) HONH2·HCl, Na2CO3, EtOH, reflux, 99%; 
xiii) NaBH3CN, TiCl3, NH4OAc, CH3OH; xiv) Pyridine, Et3N, CS2, 60 min, 0 ºC; xv) 
ICH3, 67%; xvi) Pyridine, Et3N, CS2, 60 min, 0 ºC; xvii) IC2H3, 68% (Pedras and 
Okinyo, 2006a); xviii) NBS, CH2Cl2; xix) Et3N, 47% (adapted from Pedras and Zaharia, 
2000); xx) PCC, CH2Cl2, 41% (adapted from Pedras et al., 2006a). 
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2-Mercaptoindole-3-carboxaldehyde (135) was prepared following the established 
synthetic procedures (Pedras and Okanga, 1999). The 135 was then used to synthesize 
[SC2H3]brassicanal A (39b) (Scheme 3.5). 
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Scheme 3.5 Synthesis of [SC2H3]brassicanal A (39b). Reagents and conditions: i) 
Et3N, IC2H3, Et2O, 56%. 
 
3.3 Biosyntheses of phytoalexins and glucosinolates 
Most phytoalexins (Pedras et al., 2003b; 2007b) and glucosinolates were shown to 
derive from L-tryptophan (78) (Josefsson, 1972; Kutáček and Králová, 1972; Mikkelsen 
et al., 2002; Rausch et al., 1983). A number of new phytoalexins with diverse chemical 
structures have been recently isolated from crucifers (Pedras et al., 2007b; 2007c). 
Rutabaga tubers, for example, were shown to produce a variety of previously unknown 
phytoalexins (Pedras et al., 2004), as well as three indolyl glucosinolates, glucobrassicin 
(70), 4-methoxyglucobrassicin (156) and neoglucobrassicin (199) (Pedras and Montaut., 
2004). Rutabaga tubers therefore, provided a good tissue for biosynthetic studies of 
phytoalexins and glucosinolates, and to determine the biosynthetic precursors common 
to these metabolites. To date, dog mustard (Erucastrum gallicum) is the only plant 
known to produce erucalexin (38), the first and only phytoalexin known so far to possess 
a carbon substitution at C-2 of the indolyl group (Pedras et al., 2006a). Deuterium 
labeling of potential precursors was chosen since small amounts of deuterated 
metabolites can be detected unambiguously by mass spectrometry (ESI-HRMS or APCI-
HRMS or EI). The majority of crucifer phytoalexins can be detected by HPLC-MS-ESI 
in crude extracts without sample purification (Pedras et al., 2006c). HPLC-HRMS-ESI 
and EI analyses were therefore carried out to determine the levels of isotope (2H and 34S) 
incorporation into various phytoalexins and glucosinolates. In addition, non-isotopically 
39b 135 
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labeled compounds containing non-natural groups such as methyl, acetyl, and Boc 
groups were also used in biosynthetic investigations. The resulting metabolites (from 
feeding non-isotopically labeled compounds) were identified by comparing their UV 
spectra, retention time and fragmentation patterns from HPLC-MS-ESI analyses with 
those of authentic standards.  
The phytoalexins produced by rutabaga, cyclobrassinin (28a), rutalexin (33a), 
spirobrassinin (34b), brassicanate A (43a), and rapalexin A (53a) incorporated L-
[2',4',5',6',7'-2H5]tryptophan (78b) in different amounts (established by HPLC-HRMS-
ESI). Rutalexin (33), previously shown to derive from cyclobrassinin (28) in rutabaga 
root tissues showed the most efficient incorporation of 78b. Other biosynthetic 
experiment showed a 99% incorporation of [SC2H3]brassicanal A (39b) into brassicanate 
A (43b), suggesting that 39 could be the last precursor in the biosynthetic pathway of 43. 
Of the three indolyl glucosinolates, glucobrassicin (70b) showed the most efficient 
incorporation of L-[2',4',5',6',7'-2H5]tryptophan (78b), followed by neoglucobrassicin 
(199a), and 4-methoxyglucobrassicin (156a). The difference in incorporation may result 
from additional intermediates (steps involve oxidation and methylation at C-4 and N-1) 
leading to 4-methoxyglucobrassicin and neoglucobrassicin, respectively. 
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Figure 3.2 Incorporation of L-[2H5]tryptophan (78b) into rutabaga phytoalexins and 
glucosinolates, and cyclobrassinin (28a) into spirobrassinin (34b). 
 
Previously, absence of incorporation of cyclobrassinin (28) into spirobrassinin (34) 
led to a conclusion that 28 is not a biosynthetic precursor of 34 (Monde et al., 1994). On 
the contrary, the present biosynthetic experiments showed incorporation of 
cyclobrassinin (28) into spirobrassinin (34) on incubation with either rutabaga or turnip 
root slices. Spirobrassinin was not detected in rutabaga after 24 hour incubation, but 
deuterium incorporation after 48- and 72-hour incubation was 7 and 4%, respectively. In 
turnip root slices, cyclobrassinin incorporation for 24-, 48- and 72-hour incubation was 
10, 15, and 6%, respectively. The incorporation levels in both tissues decreased after 72-
hour incubation, perhaps due to dilution with natural abundant spirobrassinin. These 
results suggested that cyclobrassinin is an intermediate in the biosynthetic pathway of 
33a 
53a 
70b R = R1 = 2H 
156a R = H, R1 = OCH3 
199a R = OCH3, R1 = 2H 
28a 
34b 
78b 
43a 
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spirobrassinin, albeit with low incorporation levels compared to brassinin (Pedras et al., 
2004). The low incorporation levels of cyclobrassinin may imply that this biosynthetic 
pathway operates in parallel with direct oxidation of brassinin to spirobrassinin, which is 
the most favored pathway. Rutabaga and turnip tubers metabolize cyclobrassinin to 
unidentified products. This metabolism possibly depletes the cyclobrassinin available for 
the spirobrassinin biosynthesis. 
Incubation of rutabaga root slices with 1-methyl-L-tryptophan (200) under various 
feeding conditions did not produce detectable amounts of 1-methylated metabolites; 
neither was 200 recovered from the extracts. Perhaps 1-methyl-L-tryptophan (200) is 
metabolized into several polar metabolites. 
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Figure 3.3 Lack of metabolism of 1-methyl-L-tryptophan (200) into rutabaga 
phytoalexins and glucosinolates 
 
Although indolyl-3-acetaldoxime (112) and 1-methoxyindolyl-3-acetaldoxime 
(116) show incorporation into indolyl phytoalexins and glucosinolates (Pedras et al., 
2007b), 112 and 116 have not been detected in any plant tissues, and 1-methoxyindolyl-
3-acetaldoxime is not as stable as indolyl-3-acetaldoxime (Pedras and Montaut, 2004). In 
the biosynthetic experiments using dog mustard (Erucastrum gallicum), the 
incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) into arvelexin (51a, 
Figure 3.4) suggested oxidation and methylation at C-4 of 112 to give 4-
methoxyindolyl-3-acetaldoxime. These results suggest that possibly 4-methoxy-
containing phytoalexins are derived from 4-methoxyindolyl-3-acetaldoxime. The natural 
occurrence of 4-methoxyindolyl-3-acetaldoxime is not known; it has neither been 
isolated nor identified from any plant tissue. In this thesis, the biosynthesis of a 4-
methoxy-containing phytoalexin from indoyl-3-acetaldoxime is being reported for the 
200 170 
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first time. The efficient incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
into [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a, 89%) suggested that 112 is an immediate 
precursor in the biosynthetic pathway of 49. 
 
N
H
CN2H
2H
2H
2H
N
H
CNOCH3
2H
2H
2H
N
H
2H
2H
2H
2H
N OH
 
 
Figure 3.4 Incorporation of [2H4]indolyl-3-acetaldoxime (112a) into [2H3]arvelexin 
(51a) and [2H4]indolyl-3-acetonitrile (49a). 
 
Other biosynthetic experiments using dog mustard showed that the indolyl and 1-
methoxy groups of erucalexin (38) and 1-methoxyspirobrassinin (35) are derived from 
indolyl-3-acetaldoxime (112) and 1-methoxyindolyl-3-acetaldoxime (116). The HPLC-
HRMS-ESI data indicated incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) 
into 1-methoxyspirobrassinin (35a, 46 ± 6 %) and erucalexin (38a, 15 ± 3 %) (Figure 
3.5). 1-Methoxyindolyl-3-acetaldoxime (116) is a more advanced precursor than indolyl-
3-acetaldoxime (112) and was therefore expected to exhibit higher incorporation levels 
since it is closer to erucalexin and 1-methoxyspirobrassinin in the biosynthetic pathway. 
Contrary to these expectations, [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a) 
incorporation into 1-methoxyspirobrassinin (35b) and erucalexin (38b) were 7 ± 3 % 
and 5 ± 3, respectively. Additional experiments employing [4',5',6',7'-2H4]1-
methoxyindolyl-3-acetaldoxime (116b) indicated 7 ± 2 and 6 ± 4 % incorporations into 
1-methoxyspirobrassinin (35a) and erucalexin (38a), respectively (Figure 3.5). These 
incorporation levels were still lower that those of [4',5',6',7'-2H4]indolyl-3-acetaldoxime 
(112a). In order to confirm if the low incorporation of 116 into erucalexin and 1-
methoxyspirobrassinin was due to loss of the 1-methoxy groups from 116a and 116b, 
[1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime (116c) was used in the next 
biosynthetic experiments. It was expected that loss of 1-methoxy group from 116c would 
result in metabolites containing four and seven deuterium. HPLC-HRMS-ESI data 
49a 112a 51a 
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however indicated intact incorporation of [1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-
acetaldoxime into 1-methoxyspirobrassinin (35c, 4 ± 3 %) and erucalexin (38c, 3 ± 2 %) 
since only [M + 7]+/- peak was detected. These results suggested that the low levels of 
incorporation of 1-methoxyindolyl-3-acetaldoxime were not due to loss of 1-methoxy 
group, but likely due to its decomposition since it is not as nearly as stable as indolyl-3-
acetaldoxime. Even though low incorporation levels were recorded, 1-methoxyindolyl-3-
acetaldoxime appears to be an intermediate in the biosynthetic pathway of both 
erucalexin and 1-methoxyspirobrassinin. Thus, oxidation and biological methylation of 
indolyl-3-acetaldoxime gives 1-methoxyindolyl-3-acetaldoxime, which is the 
biosynthetic precursor of 1-methoxy-containing metabolites (Figure 3.5, Pedras et al., 
2007b). 
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Figure 3.5 Incorporation of [2H4]indolyl-3-acetaldoxime (112a) and [2H4]1-
methoxyindolyl-3-acetaldoxime (116b) into [2H4]1-methoxyspirobrassinin (35a) and 
[2H4]erucalexin (38a). 
 
In rutabaga and turnip tissues, 1-methylindolyl-3-acetaldoxime (170) was not 
incorporated into phytoalexins, but was metabolized into 1-methylglucobrassicin (201, 
Figure 3.6). In other biosynthetic experiments using rutabaga tissues, [1",1",1"-2H3]1-
methoxyindolyl-3-acetaldoxime (116a) was incorporated into neoglucobrassicin (199b, 
Figure 3.6). 
35a 
38a 
116b 112a 
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Figure 3.6 Metabolism of 1-methylindolyl-3-acetaldoxime (170) and [2H3]1-
methoxyindolyl-3-acetaldoxime (116) in rutabaga root slices. 
 
Indolyl-3-acetothioihydroxamic acid (174) is one of the plausible biosynthetic 
precursors between indolyl-3-acetaldoxime (112) and brassinin (16). [4',5',6',7'-
2H4]Indolyl-3-[34S]acetothiohydroxamic acid (174a) was synthesized for the first time 
and was incubated with rutabaga root slices. The HPLC-HRMS-ESI data indicated that 
the phytoalexins cyclobrassinin (28c, 5%) and spirobrassinin (34c, 8%), as well as the 
glucosinolate glucobrassicin (70c, 2 ± 1 %), incorporated 174a intact since only [M + 
6]+/- peak was detected (Figure 3.7). The other phytoalexins rutalexin (33a, 11 ± 2 %) 
and brassicanate A (43a, 3%) incorporated only four deuterium from the indolyl group 
since only the [M + 4]+/- peak was detected (Figure 3.7). Since rutalexin (33) is 
biosynthesized from cyclobrassinin (28), lack of intact incorporation of 174a suggested 
that rutalexin does not derive directly from cyclobrassinin, but through an unidentified 
intermediate, hence the resulting exchange of sulfur-34. The HPLC-HRMS-ESI analyses 
of rapalexin A showed incorporation of [M + 2]+/- (53d, 57 ± 10 %), [M + 3]+/- (53b, 14 
± 9 %), and [M + 5]+/- (53c, 4 ± 3 %) ions. The peaks [M + 2]+/-, [M + 3]+/-, and [M + 
5]+/- indicated incorporation of sulfur-34, three deuterium, and sulfur-34 and three 
deuterium, respectively (Figure 3.7). The sulfur-34 incorporated into 53c and 53d could 
possibly be resulting from enzyme-catalyzed exchange of rapalexin A (53) S with 34S 
extruded from decomposed [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid. 
Since rapalexin A consists of 4-methoxyindole that is directly attached to an 
isothiocyanate, the incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic 
acid (174a) into 53b and 53c (Figure 3.7) suggested a degradation of the 
170 R = CH3 
116 R = OCH3 
201 R = CH3 
199 R = OCH3 
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acetothiohydroxamic side chain of 174a to possibly yield [4',5',6',7'-2H4]indole. 
Oxidation and methylation at C-4 gives 4-methoxyindole, the plausible biosynthetic 
precursor of rapalexin A (53b and 53c, Figure 3.7). In the case of glucosinolates, the 
intact incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) 
into glucobrassicin (70c, 2 ± 1%), and its lack of incorporation into 4-
methoxyglucobrassicin (156) and neoglucobrassicin (199) suggested that 174 is not a 
biosynthetic precursor of 156 and 199. Overall, these results suggested that the N-1 and 
C-4 methoxy groups are introduced before formation of indolyl-3-acetothiohydroxamic 
acid. Previous biosynthetic studies showed 1-methoxyindolyl-3-acetaldoxime (116) to be 
the first 1-methoxy-containing intermediate between indolyl-3-acetaldoxime (112) and 
1-methoxybrassinin (18). In the present biosynthetic studies, indolyl-3-acetaldoxime 
(112) was incorporated into arvelexin (51) whereas 1-methoxyindolyl-3-acetaldoxime 
(116) was incorporated into neoglucobrassicin (199). These results showed that 
oxidation and methylation (N-1 and C-4) occurred at the indolyl-3-acetaldoxime stage, 
and that 1-methoxyindolyl-3-acetaldoxime and 4-methoxyindolyl-3-acetaldoxime are the 
first methoxy-containing intermediates in the biosynthesis of 1- or 4-methoxy-containing 
phytoalexins and glucosinolate. 
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Figure 3.7 Incorporation of [2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) 
into rutabaga phytoalexins and into glucobrassicin (70c). 
 
The metabolism of 1-methylindolyl-3-acetothiohydroxamic acid (178) into 1-
methylglucobrassicin (201, Figure 3.8) in rutabaga root slices indicated that 1-methoxy 
containing metabolites such as neoglucobrassicin (199) must then be deriving from 1-
methoxyindolyl-3-acetothiohydroxamic acid. The metabolism of 1-methylindolyl-3-
acetaldoxime (170) (Figure 3.6) and 1-methylindolyl-3-acetothiohydroxamic acid (178) 
(Figure 3.12) into 1-methylglucobrassicin (201) and not into phytoalexins produced by 
turnip and rutabaga tissues suggested that the post-aldoxime enzymes in the biosynthetic 
pathway of indolyl glucosinolates are not substrate-specific compared to those in the 
biosynthetic pathway of phytoalexins. As described in the Introduction section, many 
174a 
34c 
43a 
28c 33a 
70c 
53c 53d 53b 
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post-aldoxime enzymes in the biosynthetic pathway of glucosinolates recognize the 
functional groups but not the side chain (aliphatic, aromatic, indolyl) (Grubb and Abel, 
2006; Halkier and Gershenzon, 2006), hence the results obtained with 170 (Figure 3.6) 
and 178 (Figure 3.8). 
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Figure 3.8 Metabolism of 1-methylindolyl-3-acetothiohydroxamic acid (178) in 
rutabaga and turnip root slices. 
 
On standing in the carrier solution, indolyl-3-acetothiohydroxamic acid (174) 
decomposes to indolyl-3-acetonitrile (49) with extrusion of sulfur. Since phytoalexins 
such as rutalexin (33) and brassicanate A (43) did not incorporate 34S from 174a, the 
biogenetic relationship between indolyl-3-acetonitrile with rutabaga phytoalexins was 
investigated. Incubation of rutabaga root slices with [4',5',6',7'-2H4]indolyl-3-acetonitrile 
(49a) yielded as metabolic products, [4,5,6,7-2H4]indolyl-3-acetic acid (202a), [4,5,6,7-
2H4]indole-3-carboxylic acid (203a), and [4',5',6',7'-2H4]methyl indole-3-carboxylate 
(121a) (Figure 3.9). Since the phytoalexins or indole glucosinolates did not show 
deuterium incorporation from [4',5',6',7'-2H4]indolyl-3-acetonitrile, the previous detected 
deuterium incorporations were therefore from [4',5',6',7'-2H4]indolyl-3-
[34S]acetothiohydroxamic acid (174a) or a derivative. 
 
201 
 
178 
 
 134 
N
H
CN2H
2H
2H
2H
N
H
CO2H
2H
2H
2H
2H
N
H
CO2H
2H
2H
2H
2H
N
H
COOCH3
2H
2H
2H
2H
 
 
Figure 3.9 Metabolism of [2H4]indolyl-3-acetonitrile (49a) in rutabaga root slices. 
 
The metabolism of 1-(tert-butoxycarbonyl)indolyl-3-methylisothiocyanate (180) 
(by rutabaga root slices) to 1-(tert-butoxycarbonyl)brassinin (181) and 1-(tert-
butoxycarbonyl)spirobrassinin (196), and additional experiments showing metabolism of 
1-(tert-butoxycarbonyl)brassinin (181) to 1-(tert-butoxycarbonyl)spirobrassinin (196) 
were consistent with the proposed biosynthetic pathway of indole phytoalexins (Pedras 
et al., 2003b) (Figure 3.10). Similar to 180, 1-acetylindolyl-3-methylisothiocyanate 
(183) was metabolized to 1-acetylbrassinin (184), and not into 1-acetylspirobrassinin 
(195) (Figure 3.10). Incubation of either rutabaga or turnip root slices with 1-
acetylbrassinin (184) for 96 hours did not yield detectable amount of 1-
acetylspirobrassinin (195) or any 1-acetyl-contanining phytoalexin. Perhaps 1-
acetylspirobrassinin (195) is readily hydrolyzed in the plant tissue unlike 1-(tert-
butoxycarbonyl)spirobrassinin (196). 
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Figure 3.10 Metabolism of 1-(tert-butoxycarbonyl)indolyl-3-methylisothiocyanate 
(181) and 1-acetylindolyl-3-methylisothiocyanate (183) in rutabaga and turnip root 
tissues. 
 
The biosynthetic pathways of 1-methoxyspirobrassinin (35) and erucalexin (38) 
were studied using deuterium labeled 1-methoxybrassinin (18) and sinalbin B (31) 
(Figure 3.11). The HPLC-HRMS-ESI data indicated incorporation of [3,3,3-2H3]1-
methoxybrassinin (18a) into 1-methoxyspirobrassinin (35d, 53 ± 2 %) and erucalexin 
(38d, 7 ± 3 %) in detached dog mustard leaves (Pedras et al., 2007b; Pedras and Okinyo, 
2006b). Incorporation of [3,3,3-2H3]1-methoxybrassinin (18a) into erucalexin suggested 
a possible C-3 to C-2 side chain migration in 1-methoxybrassinin to yield 1-
methoxyisobrassinin that undergoes spirocyclization to give erucalexin. Additional 
experiments employing [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c) indicated intact 
incorporation into 1-methoxyspirobrassinin (35e, 64 ± 11 %) and erucalexin (38e, 4 ± 2 
%) since only [M + 7]+/- peaks were detected from HPLC-HRMS-ESI analyses. These 
observations supported the proposed side chain migration in the biosynthesis of 
erucalexin, and also showed that the rearrangement is intramolecular. The occurrence of 
intramolecular rearrangement was further demonstrated by incorporation of [3,3,3-
2H3]sinalbin B (31b) into both 1-methoxyspirobrassinin (35d, 10 ± 1 %) and erucalexin 
(38d, 2 ± 0.2 %). Additional biosynthetic experiments with [4',5',6',7'-2H4]sinalbin B 
(31a) indicated incorporation of four deuterium into both 1-methoxyspirobrassinin (35a, 
19 ± 7 %) and erucalexin (38a, 5 ± 0.1 %) (Pedras et al., 2007b; Pedras and Okinyo, 
2006b). Sinalbin B derives from 1-methoxybrassinin and is therefore a closer precursor 
to erucalexin and 1-methoxyspirobrassinin in the biosynthetic pathway. The 
incorporation levels of sinalbin B into erucalexin were however closer to those obtained 
from 1-methoxybrassinin, but much lower in 1-methoxyspirobrassinin. An efficient 
180 R = Boc 
183 R = Acetyl 
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184 R = Acetyl 
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incorporation of sinalbin B was expected since it is an advanced precursor in the 
biosynthetic pathway. The low levels of incorporation of sinalbin B into 1-
methoxyspirobrassinin (compared to 1-methoxybrassinin) possibly indicates that 
sinalbin B is not a direct precursor, but serves as additional pathway to 1-
methoxyspirobrassinin, or perhaps sinalbin B is not efficiently taken up by the plant 
tissues. In chemical stability studies, sinalbin B (31) was shown to decompose to 
undetermined products (Pedras and Zaharia, 2000). In the present biosynthetic studies, 
the instability of 31 in the precursor solution may have contributed to the low 
incorporation levels observed in erucalexin (38) and 1-methoxyspirobrassinin (35). 
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Figure 3.11 Incorporation of [2H3]1-methoxybrassinin (18a) and [2H3]sinalbin B 
(31b) into 1-methoxyspirobrassinin (35d) and erucalexin (38d). 
 
Erucalexin yields undetermined products upon standing at room temperature (in 
CH3CN) due to its instability. In general, the incorporation levels of most of the 
precursors administered were higher in 1-methoxyspirobrassinin than in erucalexin. The 
observed difference could in part be attributed to different rates of transportation of these 
precursors to different compartments where these metabolites are biosynthesized. On the 
other hand, biosynthesis of erucalexin involves a molecular rearrangement with 
concomitant spirocyclization, whereas that of 1-methoxyspirobrassinin goes through a 
18a 31b 
38d 
35d 
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one step oxidative spirocyclization. Possibly the additional step(s) in the biosynthetic 
pathway(s) of erucalexin may be contributing to pool dilution with the natural 
abundance. More so, production of erucalexin is about 4-5 times that of 1-
methoxyspirobrassinin, this further suggests pool dilution in the biosynthetic pathway of 
erucalexin with a resultant low level of incorporation.  
[3,3,3,4',5',6',7'-2H7]1-Methoxybrassinin (18c) was efficiently incorporated into 
[3,3,3,4',5',6',7'-2H7]1-methoxybrassitin (20a, 99.6%) suggesting that 18 could be the 
immediate precursor (Figure 3.12). Caulilexin B (48) was detected in extracts of dog 
mustard leaves incubated with 1-methoxybrassinin. The EI data indicated deuterium 
composition of [4',5',6',7'-2H4]caulilexin B (48a) to be ≥ 99.9% suggesting that the 
indolyl ring was solely derived from [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c, 
Figure 3.12). It, however, remains to be established whether caulilexin B (48) is directly 
derived from 1-methoxybrassinin (18), or through 1-methoxybrassitin (20). Although 
caulilexin B was not detected in extracts not fed 1-methoxybrassinin, it appears that the 
enzyme(s) involved in its biosynthesis are expressed in the presence of this precursor. 
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Figure 3.12 Incorporation of [2H7]1-methoxybrassinin (18c) into [2H7]1-
methoxybrassitin (20a) and [2H4]caulilexin B (48a). Dashed arrow shows proposed 
biosynthetic pathway. 
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3.4 Conclusion 
The incorporation of L-[2',4',5',6',7'-2H5]tryptophan (78b) into the phytoalexins 
cyclobrassinin (28a), rutalexin (33a), spirobrassinin (34b), brassicanate A (43a), and 
rapalexin A (53a), as well as glucosinolates, glucobrassicin (70b), 4-
methoxyglucobrassicin (156a) and neoglucobrassicin (199a) show that the indolyl 
moiety of these metabolites derives from L-tryptophan (78) (Pedras et al., 2007b). 
The incorporation of [4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) and 
perdeuterated 1-methoxyindolyl-3-acetaldoximes into 1-methoxyspirobrassin (35) and 
erucalexin (38) was consistent with previous studies (Pedras et al., 2004). These 
observations suggested oxidation and methylation of indolyl-3-acetaldoxime to gives 1-
methoxyindolyl-3-acetaldoximes in the biosynthesis of 1-methoxybrassinin (Pedras et 
al., 2004), the advanced precursor of 1-methoxy-containing phytoalexins such as 1-
methoxyspirobrassin (35) and erucalexin (38) (Pedras and Okinyo, 2006b). 1-
Methoxyindolyl-3-acetaldoxime (116) is a biosynthetic precursor of 1-methoxy-
containing phytoalexins (Pedras et al., 2007b) as well as indolyl glucosinolate 
neoglucobrassicin (199). The metabolism of 1-methylindolyl-3-acetaldoxime (170) and 
1-methylindolyl-3-acetothiohydroxamic acid (178) into 1-methylglucobrassicin (201) 
and not into indolyl phytoalexins suggested that the enzymes in the biosynthetic pathway 
of indolyl glucosinolates are specific to the functional groups, but not the indolyl side 
chain, unlike enzymes in the biosynthetic pathway of phytoalexins. Incorporation of 
[4',5',6',7'-2H4]indolyl-3-acetaldoxime (112a) into arvelexin (51) indicated oxidation and 
methylation of C-4 of indolyl-3-acetaldoxime, and that 4-methoxy-containing 
phytoalexins and 4-methoxyglucobrassicin could be derived from 4-methoxyindolyl-3-
acetaldoxime. Indolyl-3-acetaldoxime (112) is a biogenetic precursor of indolyl-3-
acetonitrile (49), but 49 is not a precursor of phytoalexins produced by rutabaga. 
The intact incorporation of [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) into phytoalexins cyclobrassinin (28c) and spirobrassinin (34c), and glucosinolate 
glucobrassicin (70c) suggested that 174a could be the last common intermediate between 
brassinin and glucobrassicin (Pedras and Okinyo, 2008). Lack of incorporation of 174a 
into 4-methoxyglucobrassicin (156) and neoglucobrassicin (199) indicated that oxidation 
and methylation occurs before the formation of indolyl-3-acetothiohydroxamic acid. 
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The metabolism of 1-(tert-butoxycarbonyl)indolyl-3-methylisothiocyanate (180) 
by rutabaga root slices into 1-(tert-butoxycarbonyl)brassinin (181) and 1-(tert-
butoxycarbonyl)spirobrassinin (196) was consistent with the previously proposed 
biosynthetic pathway (Pedras et al., 2003b). The metabolism of 1-acetylindolyl-3-
methylisothiocyanate (183) into 1-acetylbrassinin (184) in both rutabaga and turnip root 
slices supported the previous results from metabolism of 180. 
The incorporation of cyclobrassinin (28a) into spirobrassinin (34b) was shown in 
rutabaga and turnip root slices. Although the levels of incorporation were much lower 
than those of brassinin (16) (Monde et al., 1994; Pedras et al., 2004), this pathway 
appears to contribute to the biosynthesis of spirobrassinin contrary to earlier reports 
(Monde et al., 1994). In addition, similar to the biogenetic relationship of NH-containing 
phytoalexins (cyclobrassinin and spirobrassinin), sinalbin B (31) incorporation into 1-
methoxyspirobrassinin (35) was much lower than that of 1-methoxybrassinin (18) 
(Pedras and Okinyo, 2006b). Intact incorporation of [3,3,3,4',5',6',7'-2H7]1-
methoxybrassinin (18c) into erucalexin (38e) suggested an intramolecular 
rearrangement. Caulilexin B (48) appeared to be derived from 1-methoxybrassinin (18), 
although its biosynthesis from 1-methoxybrassitin (20) is a likely pathway. 
A map of the biosynthetic pathways studied in this thesis is shown in Figure 3.13. 
L-tryptophan (78) is transformed to indolyl-3-acetaldoxime (112). Dehydration of 112 
gives indolyl-3-acetonitrile (49), whereas oxidation and methylation at C-4 followed by 
dehydration gives arvelexin (51). Oxidation of indolyl-3-acetaldoxime (112), 
conjugation with cysteine, followed by C-S lyase catalyzed hydrolysis of the C-S bond 
yields indolyl-3-acetothiohydroxamic acid (174) (Halkier and Gershenzon, 2006; Pedras 
and Okinyo, 2008), possibly the last common intermediate between brassinin (16) and 
glucobrassicin (70) (Pedras and Okinyo, 2008). Lossen-type rearrangement of 174 
would give indolyl-3-methylisothiocyanate (123) that is thiomethylated to yield 
brassinin (16) (Pedras and Okinyo, 2008), the precursor of many other NH-containing 
indolyl phytoalexins (Pedras et al., 2007b). In the present biosynthetic studies, indolyl-3-
acetothiohydroxamic acid (174) was incorporated into the phytoalexins cyclobrassinin 
(28), spirobrassinin (34), rutalexin (33) and brassicanate A (43) (Pedras and Okinyo, 
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2008), all previously shown to derive from brassinin (16) (Pedras et al., 2004), as well as 
the new phytoalexin rapalexin A (53). 
The 1-methoxy-containing phytoalexins 20, 31, 35, 38, and 48 are derived from 1-
methoxybrassinin (18), their biosynthesis from 1-methoxyindolyl-3-acetaldoxime (116) 
possibly follows a similar pathway as that of NH-containing phytoalexins. 1-
Methoxyspirobrassinin (35) and erucalexin (38) were also shown to be biosynthesized 
from sinalbin B (31) (Pedras and Okinyo, 2006b). 
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Figure 3.13 Map of biosynthetic pathway of crucifer phytoalexins and glucosinolates 
70, 156, 199, and 201. 
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CHAPTER 4  
4. Experimental 
4.1 General 
All chemicals were purchased from Sigma-Aldrich Canada Ltd., Oakville, ON, 
except for isotope-labeled compounds that were purchased from Cambridge Isotope 
Laboratories Inc., Andover, MA, and C/D/N Isotopes Inc., Pointe-Claire, Quebec. All 
solvents were HPLC grade and were used as such, except chloroform and 
dichloromethane that were redistilled. The solvents used in the syntheses were dried and 
freshly distilled before use. The following drying agents were used: DMF over 
molecular sieves, Et2O and THF over Na/benzophenone, and CH2Cl2 over CaH2. 
Analytical TLC was performed on precoated silica gel TLC plates (Merck, 
Kieselgel 60 F254, 5 × 2 cm × 0.2 mm layer thickness) aluminum sheets. The compounds 
were eluted with suitable solvent systems, then visualized under UV light (254/366 nm), 
and by dipping the plates in a 5% (w/v) aqueous phosphomolybdic acid solution 
containing 1% (w/v) cerium(IV) sulfate and 4% (v/v) H2SO4, followed by heating at 200 
ºC. 
PTLC was performed on precoated silica gel, (Merck, Kieselgel 60 F254, 20 × 20 
cm × 0.25 mm thickness). The compounds were eluted with suitable solvent systems 
(v/v), then visualized under UV light (254/366 nm). 
FCC was performed on silica gel, Merck grade 60, mesh size 230-400, 60 Å or on 
J. T. Baker reversed phase C-18 silica gel, 40 µm, 275 Å. 
HPLC analysis was carried out with an Agilent 1100 series or Hewlett Packard 
HPLC systems equipped with quaternary pump, autosampler and diode array detector 
(wavelength range 190-600 nm), degasser and a Hypersil octadecylsilane (ODS) column 
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(5 µm particle size silica, 200 × 4.6 mm I.D.), equipped with an in-line filter. The mobile 
phase consisted; Method A: linear gradient of water-acetonitrile (75:25 to 25:75 in 35 
min, to 0:100 in 5 min) and a flow rate of 1 mL/min; Method B: linear gradient of water-
acetonitrile (100:0 to 50:50 in 25 min, to 100:0 in 5 min) and a flow rate of 1 mL/min. 
Samples were dissolved in acetonitrile for Method A, and in methanol-water (50:50) for 
Method B. 
HPLC-MS-ESI analysis was carried out with an Agilent 1100 series HPLC system 
equipped with an autosampler, binary pump, degasser, and a diode array detector 
connected directly to a mass detector (Agilent G2440A MSD-Trap-XCT ion trap mass 
spectrometer) with an ESI source. Chromatographic separation was carried out at room 
temperature using an Eclipse XSB C-18 column (5 µm particle size silica, 150 × 4.6 mm 
I.D.). The mobile phase consisted of a linear gradient of; Method A: 0.2% formic acid in 
water and 0.2% formic acid in acetonitrile (75:25 to 25:75 in 35 min, to 0:100 in 5 min) 
and a flow rate of 1 mL/min; Method B: 0.2% formic acid in water and 0.2% formic acid 
in acetonitrile (90:10 to 50:50 in 25 min, to 90:10 in 5 min) and a flow rate of 1 mL/min. 
Data acquisition was carried out in positive and negative polarity modes in a single LC 
run. Data processing was carried out by Agilent Chemstation Software. Samples were 
dissolved in acetonitrile for Method A, and in methanol-water (50:50) for Method B. 
HPLC-HRMS-ESI was performed on an Agilent HPLC 1100 series directly 
connected to QSTAR XL Systems Mass Spectrometer (Hybrid Quadrupole-TOF 
LC/MS/MS) with turbo spray ESI source. Chromatographic separation was carried out at 
room temperature using a Hypersil ODS C-18 column (5 µm particle size silica, 200 × 
2.1 mm I.D.) or a Hypersil ODS C-18 column (5 µm particle size silica, 100 × 2.1 mm 
I.D.). The mobile phase consisted of a linear gradient of; Method A: 0.1% formic acid in 
water and 0.1% formic acid in acetonitrile (75:25 to 25:75 in 35 min, to 0:100 in 5 min) 
and a flow rate of 0.25 mL/min; Method B: 0.1% formic acid in water and 0.1% formic 
acid in acetonitrile (97:3 to 50:50 in 25 min, to 97:3 in 10 min) and a flow rate of 0.25 
mL/min. Data acquisition was carried out in either positive or negative polarity mode per 
LC run. Data processing was carried out by Analyst QS Software. Samples were 
dissolved in acetonitrile for Method A and in methanol-water (50:50) for Method B. 
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GC analysis was performed on a Varian CP-3800 GC equipped with a split (30:1) 
capillary autosampler, 30 m × 0.25 mm (I.D.) VF-5ms (front) and VF-17ms (back) (0.25 
µm film thickness) capillary columns and FID. The carrier gas was helium at a flow rate 
of 1 mL/min. The temperature program comprised of an initial temperature of 80 ºC (2 
min) to 300 ºC at 10 ºC/min and a hold at this temperature for 5 min. 
GC-MS analysis was performed on a Fisons GC 8000 series model 8060 equipped 
with a split (30:1) capillary injector directly connected to a VG 70 SE Mass 
Spectrometer. The MS was operated in the EI mode at 70 eV and a trap current of 100 
µA. The source temperature was held at 200 ºC and the multiplier voltage at 250 V. The 
mass range was set at 25 – 350. The GC-MS column used was DB-5ms, 30 m × 0.20 
mm (I.D.) and 0.25 µm film thickness. The carrier gas was helium at a flow rate of 1 
mL/min. The temperature program involved initial temperature of 40 ºC (5 min) to 200 
ºC at 10 ºC/min and a hold at this temperature for 15 min. 
NMR spectra were recorded on 500 MHZ Bruker Avance spectrometer. For 1H 
NMR (500 MHz), the chemical shifts (δ) values are reported in parts per million (ppm) 
relative to the internal standard TMS. The δ values are referenced to CHCl3 in C2HCl3 at 
7.27 ppm or referenced to CH2H2CN in C2H3CN at 1.94 ppm. Multiplicities are 
indicated by the following symbols: s = singlet, d = doublet, dd = doublet of doublets, m 
= multiplet and br = broad. For 13C NMR (125.8 MHz) the δ values are referenced to 
C2HCl3 (77.23 ppm) or C2H3CN (118.69 ppm). 
MS [high resolution (HR), electron ionization (EI)] were obtained on a VG 70 SE 
mass spectrometer employing a solids probe. 
Seeds of rocket (E. sativa) were purchased from a commercial seed company. Dog 
mustard (E. gallicum) seeds were obtained from Plant Gene Resources, Agriculture and 
Agric-Food Canada Research Station, Saskatoon, Sk. The seeds were sown in 
commercial potting soil mixture, and plants were grown in a growth chamber under 
controlled environmental conditions (22ºC/18ºC, with 16/8 day/night cycle) for 2-5 
weeks. Rutabaga and turnip roots were purchased from Sobeys, Preston Avenue, 
Saskatoon, Sk. 
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4.2 Analysis of antifungal secondary metabolites from 
rocket 
4.2.1 Time-course analysis 
Time course analysis was carried out to determine the production of antifungal 
metabolites by rocket. Three-week old plants were sprayed with CuCl2 (2 × 10-3 M) 
solution to the point of run-off. Leaves were excised at 24-hour intervals up to 168 hours 
(each experiment was carried out in triplicate). Fresh leaf weights were measured and 
the leaves were frozen in liquid nitrogen, were crushed with a glass rod, and then 
extracted in EtOAc (30 mL) overnight. The EtOAc extract was filtered off and the 
solvent was removed under reduced pressure. Non-elicited leaves (control experiment) 
were similarly treated. The HPLC-UV profiles of extracts from both elicited and control 
leaves were recorded. Antifungal compounds were visualized by carrying out TLC 
biodetection with Cladosporium cucumerinum. 
4.2.2 TLC biodetection 
A solution of double strength potato dextrose broth (PDB) was prepared by 
autoclaving a suspension of PDB (4.8 g) in H2O (100 mL), and spores of C. 
cucumerinum were added to make a concentration of 1 × 106 spores/mL. Bioassays were 
conducted following previously established method (Pedras and Sorensen, 1998). 
Samples were spotted on 2 × 20 cm TLC plate strips (aluminum backing), which were 
developed using solvent system, EtOAc-hexane (60:40). The developed plates were air 
dried (60 min), were sprayed with the spore suspension prepared above, and were 
incubated under high humidity in the dark for 36 h. Control plates were similarly 
prepared but without spotting leaf extracts. From these experiments, the antifungal areas 
appeared white (due to inhibition of spore germination) against a dark gray background 
due to fungal growth. The white spots were not observed in control plates. 
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4.2.3 Isolation of secondary metabolites from rocket 
In order to isolate the antifungal compounds, a large scale experiment was carried 
out. Elicited rocket leaves from 40 pots (358 g of fresh leaf weight) were divided into 
three Erlenmeyer flasks, then frozen in liquid nitrogen, crushed with a glass rod, and 
extracted with hexane (250 mL per flask) overnight. The hexane extract was filtered off 
and the remaining residue was sequentially extracted with EtOAc and CH3OH (250 mL 
per flask), respectively. From TLC biodetection experiments, all the three extracts had 
similar inhibition spots and were thus combined for purification purposes. The combined 
crude extracts were purified by FCC (hexane-EtOAc, 80:20 – 0:100, then CH2Cl2-
CH3OH, 95:5 v/v). The resulting fractions were analyzed by HPLC-DAD and TLC 
biodetection. A fraction showing a peak at tR = 34.7 min on HPLC chromatogram 
exhibited inhibition of spore germination on TLC plate and was further purified by FCC 
(hexane-EtOAc, 100:0 - 80:20; then CH2Cl2-CH3OH, 100:0 to 99:1, v/v) to yield bis(4-
isothiocyanatobutyl)disulfide (56.9 mg, 167). 
The next fraction that exhibited antifungal activity showed a peak at a tR = 22.5 
min on HPLC-DAD analysis. This fraction was further purified by a combination of 
FCC (hexane-EtOAc, 100:0 to 90:10, v/v) and PTLC (hexane-EtOAc, 80:20, v/v 
multiple development) to yield 4-methylthiobutyl isothiocyanate (4.9 mg, 166). 
4.2.4 Chemical characterization of metabolites from rocket 
4.2.4.1 4-Methylthiobutyl isothiocyanate (166) 
 
S NCS
 
 
 
Colorless oil. 
HPLC-DAD Method A, tR = 22.5 min. 
1H NMR (C2HCl3) δ 3.58 (dd, J = 6, 6 Hz, 2H), 2.56 (dd, J = 7, 7 Hz, 2H), 1.87 (s, 3H), 
1.85 (m, 2H), 1.76 (m, 2H). 
13C NMR (C2HCl3) δ 131.0, 45.1, 33.7, 29.2, 26.2, 15.8. 
166 
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HR-EIMS m/z measured: 161.0331 (161.0333 calcd. for C6H11NS2). 
EIMS m/z (% relative abundance); 161 [M]+ (100), 146 (52). 
4.2.4.2 Bis(4-isothiocyanatobutyl)disulfide (167) 
 
SCN S S NCS
 
 
 
Yellowish oil. 
HPLC-DAD Method A, tR = 34.7 min. 
1H NMR (C2HCl3) δ 3.59 (dd, J = 6, 6 Hz, 2H), 2.74 (dd, J = 6.5, 6.5 Hz, 2H), 1.85 (m, 
4H). 
13C NMR (C2HCl3) δ 130.9, 45.1, 38.3, 29.0, 26.4. 
HR-EIMS m/z measured: 292.0196 (292.0196 calcd. for C10H16N2S4). 
EIMS m/z (% relative abundance); 292 [M]+ (10), 114 (100), 87 (14), 71 (69), 55 (52). 
 
4.3 Syntheses of compounds 
4.3.1 [4',5',6',7'-2H4]Indolyl-3-acetaldoxime (112a) 
 
N
H
2H
2H
2H
2H
N OH
 
 
 
A solution of DIBAH (850 µL, 1.28 mmol) in toluene was added drop wise to a 
solution of [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a, 100 mg, 0.63 mmol) in dry toluene 
(8 mL) cooled to -78 °C under an atmosphere of argon. The reaction mixture was 
allowed to stir at -78 °C for 10 min, was diluted with ice-cold HCl (10 mL, 2 M) and 
immediately extracted in EtOAc (20 mL × 3) (Miyashita et al., 1997). The combined 
112a 
167 
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organic extract was washed with H2O (10 mL × 2), was dried over Na2SO4, and was 
concentrated under reduced pressure to yield crude [4',5',6',7'-2H4]indolyl-3-
acetaldehyde, which was used for the next step without purification. A solution of 
HONH2·HCl (111 mg, 1.60 mmol) and CH3COONa (131 mg, 1.60 mmol) in H2O (1 
mL) was added to a cooled solution (1 °C) of crude [4',5',6',7'-2H4]indolyl-3-
acetaldehyde in EtOH (8.5 mL). The reaction mixture was allowed to stir at 1 °C for 10 
min, and then at r.t. for 15 min. The reaction mixture was concentrated, the residue was 
taken in H2O (15 mL), was extracted with EtOAc (15 mL × 4), the combined organic 
extract was dried over Na2SO4 and was concentrated under reduced pressure. Separation 
by FCC (CH2Cl2-CH3OH, 97:3, v/v) yielded [4',5',6',7'-2H4]indolyl-3-acetaldoxime 
(112a, 36.8 mg, 33% yield from 49a). Integration of 1H NMR signals indicated the 
presence of syn and anti isomers (1.1:0.9) (Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, two peaks at tR = 11.8 and 12.9 min. 
Major isomer: 1H NMR (500 MHz C2H3CN) δ 9.17 (br s, NH), 8.37 (s, OH), 7.49 (dd, J 
= 6, 6 Hz, 1H), 7.12 (d, J = 2 Hz, 1H), 3.60 (d, J = 6 Hz, 2H). 
Minor isomer: 1H NMR (500 MHz C2H3CN) δ 9.17 (br s, NH), 8.85 (s, OH), 7.15 (d, J = 
1 Hz, 1H), 6.83 (dd, J = 5, 5 Hz, 1H), 3.78 (d, J = 5 Hz, 2H). 
HR-EIMS m/z measured 178.1044 (178.1044 calcd for C10H62H4N2O). 
EIMS m/z (relative abundance) 178 [M]+ (76), 134 (100). 
4.3.2 Indolyl-3-acetaldoxime (112) 
 
N
H
N OH
 
 
 
A solution of DIBAH (850 µL, 1.28 mmol) in toluene was added drop wise to a 
solution of indolyl-3-acetonitrile (49, 100 mg, 0.64 mmol) in dry toluene (8 mL) cooled 
to -78 °C under an atmosphere of argon. The reaction mixture was allowed to stir at -78 
112 
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°C for 10 min, was diluted with ice-cold HCl (10 mL, 2 M) and immediately extracted in 
EtOAc (20 mL × 3) (Miyashita et al., 1997). The combined organic extract was washed 
with H2O (10 mL × 2), was dried over Na2SO4, and was concentrated under reduced 
pressure to yield crude indolyl-3-acetaldehyde. The crude indolyl-3-acetaldehyde was 
treated as reported above for [4',5',6',7'-2H4]indolyl-3-acetaldehyde to yield indolyl-3-
acetaldoxime (112, 35.7 mg, 32% yield from 49, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, two peaks at tR = 11.8 and 12.9 min. 
Major isomer: 1H NMR (500 MHz C2H3CN) δ 9.16 (br s, NH), 8.85 (s, OH), 7.57 (d, J = 
8 Hz, 1H), 7.43 (d, J = 8 Hz, 1H), 7.17 (dd, J = 8 Hz, 1H), 7.15 (s, 1H), 7.08 (dd, J = 
7.5, 7.5 Hz, 1H), 6.84 (dd, J = 5.5 Hz, 1H), 3.78 (d, J = 5.5 Hz, 2H). 
Minor isomer: 1H NMR (500 MHz C2H3CN) δ 9.16 (br s, NH), 8.37 (s, OH), 7.57 (d, J = 
8 Hz, 1H), 7.50 (dd, J = 6 Hz, 1H), 7.43 (d, J = 8 Hz, 1H), 7.17 (dd, J = 8, 8 Hz, 1H), 
7.12 (s, 1H), 7.08 (dd, J = 7.5, 7.5 Hz, 1H), 3.61 (d, J = 6 Hz, 2H). 
HR-EIMS m/z measured 174.0793 (174.0793 calcd for C10H10N2O). 
EIMS m/z (relative abundance) 174 [M]+ (57), 157 (20), 130 (100), 117 (14), 103 (12). 
 
4.3.3 [4',5',6',7'-2H4]1-Methoxyindolyl-3-acetaldoxime (116b) 
 
N
OCH3
2H
2H
2H
2H
N OH
 
 
 
Ten percent Pd/C (80 mg) was added to a solution of [4',5',6',7'-2H4]indolyl-3-
acetonitrile (49a, 80 mg, 0.50 mmol) in Ac2O (4 mL), and the mixture was stirred at r.t. 
under H2 atmosphere (balloon pressure). After 14 h the catalyst was filtered off, the 
filtrate was concentrated under reduced pressure, the residue was dissolved in CH2Cl2 
(15 mL), was washed with a 10% solution of NaHCO3 (8 mL), H2O (8 mL × 2), and was 
116b 
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dried over Na2SO4. After removal of the solvent under reduced pressure, crude 
[4',5',6',7'-2H4]Nb-acetyltryptamine was obtained (87.9 mg, 85%) in sufficient purity to 
use directly in the next step. To a solution of [4',5',6',7'-2H4]Nb-acetyltryptamine (100 
mg, 0.495 mmol) in glacial acetic acid (2 mL) at r.t., NaBH3CN (47 mg, 0.74 mmol) was 
added in portions. The reaction mixture was allowed to stir for 3 h at room temperature, 
was diluted with H2O (5 mL), was basified with NaOH, and was extracted with Et2O (15 
mL × 3). The combined organic extract was dried over Na2SO4 and concentrated under 
reduced pressure to yield crude [4',5',6',7'-2H4]Nb-acetyl-2,3-dihydrotryptamine (114a, 
117 mg, 99%), which was used in the next step without purification. A solution of 
Na2WO4·2H2O (17.2 mg, 0.0943 mmol) in H2O (199 µL) was added to a solution of 
[4',5',6',7'-2H4]Nb-acetyl-2,3-dihydrotryptamine (112.8 mg, 0.542 mmol) in CH3OH (2.2 
mL) cooled to -20 ºC under stirring, followed by drop wise addition of a solution of 
H2O2 (520 µL, 5.42 mmol) in CH3OH (540 µL). After being stirred at r.t. for 10 min, 
K2CO3 (601 mg, 4.44 mmol) and (CH3O)2SO2 (78 µL, 0.87 mmol) were added under 
vigorous stirring at r.t. (Somei and Kawasaki, 1989). After 60 min, the reaction mixture 
was diluted with H2O (12 mL), was extracted with Et2O (20 mL × 3), the combined 
organic extract was dried over Na2SO4 and was concentrated under reduced pressure to 
yield crude [4',5',6',7'-2H4]Nb-acetyl-1-methoxytryptamine (115b, 79.4 mg, 62%). A 
solution of the crude [4',5',6',7'-2H4]Nb-acetyl-1-methoxytryptamine (79.4 mg) in 15% 
methanolic solution of NaOH (20 mL) was allowed to reflux for 24 h. After removing 
the solvent under reduced pressure, the residue was taken in H2O, was extracted with 
CH2Cl2-CH3OH (95:5, v/v), was dried over Na2SO4 and was concentrated under reduced 
pressure to yield crude [4',5',6',7'-2H4]1-methoxytryptamine (41 mg, 63%). An aqueous 
solution of Na2WO4·2H2O (1.4 mg, 0.0042 mmol) in H2O (60 µL) was added to the 
solution of [4',5',6',7'-2H4]1-methoxytryptamine (41 mg, 0.21 mmol) in CH3OH (400 
µL), the mixture was cooled to -15 ºC and H2O2 (48 µL, 0.5 mmol) was added under 
stirring (Burckard et al., 1965). After being stirred for 60 min at r.t., the mixture was 
diluted with H2O (5 mL), was basified with 20% NaOH, was extracted with CH2Cl2 (20 
mL × 3), the combined organic extract was dried over Na2SO4 and the solvent was 
removed under reduced pressure to afford a crude residue (24.3 mg). The crude residue 
was separated by preparative TLC (CH2Cl2-CH3OH, 95:5, v/v) to yield [4',5',6',7'-2H4]1-
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methoxyindolyl-3-acetaldoxime (116b, 4.8 mg, 5% yield over 5 steps). Integration of 1H 
NMR signals indicated the presence of syn and anti isomers (1.1:0.9) (Pedras and 
Okinyo, 2006a). 
 
HPLC-DAD Method A, two peaks at tR = 14.5 and 15.4 min. 
Major isomer: 1H NMR (500 MHz C2HCl3) δ 7.60 (dd, J = 6, 6 Hz, 1H), 7.15 (s, 1H), 
4.08 (s, 3H), 3.64 (d, J = 6 Hz, 2H). 
Minor isomer: 1H NMR (500 MHz C2HCl3) δ 7.17 (s, 1H), 6.93 (dd, J = 5, 5 Hz, 1H), 
4.09 (s, 3H), 3.83 (d, J = 5 Hz, 2H). 
HR-EIMS m/z measured 208.1142 (208.1149 calcd for C11H82H4N2O2). 
EIMS m/z (relative abundance) 208 [M]+ (100), 190 (25), 164 (45), 159 (54), 132 (70). 
4.3.4 [1",1",1",4',5',6',7'-2H7]1-Methoxyindolyl-3-acetaldoxime (116c) 
 
N
OC2H3
2H
2H
2H
2H
N OH
 
 
 
A solution of Na2WO4·2H2O (32.3 mg, 0.098 mmol) in H2O (206 µL) was added to 
a solution of [4',5',6',7'-2H4]Nb-acetyl-2,3-dihydrotryptamine (114a, 117 mg, 0.563 
mmol) in CH3OH (2.3 mL) under stirring. The mixture was cooled to -20 ºC and a 
solution of H2O2 (541 µL, 5.63 mmol) in CH3OH (562 µL) was added drop wise. After 
being stirred for 10 min at r.t., K2CO3 (623 mg, 4.50 mmol) and (C2H3O)2SO2 (85 µL, 
0.90 mmol) were added to the reaction mixture under vigorous stirring (Somei and 
Kawasaki, 1989). After being stirred for 60 min at r.t., the reaction mixture was diluted 
with H2O (12 mL), was extracted with Et2O (20 mL × 3), the combined organic extract 
was dried over Na2SO4 and was concentrated under reduced pressure to yield crude 
[1",1",1",4',5',6',7'-2H7]Nb-acetyl-1-methoxytryptamine (115c, 84.8 mg, 63%). The crude 
[1",1",1",4',5',6',7'-2H7]Nb-acetyl-1-methoxytryptamine (84.8 mg) was treated as reported 
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above for [4',5',6',7'-2H4]Nb-acetyl-1-methoxytryptamine (116b) to yield 
[1",1",1",4',5',6',7'-2H7]1-methoxyindolyl-3-acetaldoxime (116c, 4.2 mg, 4% yield over 5 
steps). Integration of 1H NMR signals indicated the presence of syn and anti isomers 
(1.1:0.9) (Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, two peaks at tR = 14.5 and 15.4 min. 
Major isomer: 1H NMR (500 MHz C2HCl3) δ 7.60 (dd, J = 6, 6 Hz, 1H), 7.15 (s, 1H), 
3.64 (d, J = 6 Hz, 2H). 
Minor isomer: 1H NMR (500 MHz C2HCl3): δ 7.17 (s, 1H), 6.93 (dd, J = 5, 5 Hz, 1H), 
3.83 (d, J = 5 Hz, 2H). 
HR-EIMS m/z measured 211.1335 (211.1338 calcd for C11H52H7N2O2). 
EIMS m/z (relative abundance) 211 [M]+ (100), 193 (29), 167 (48), 159 (51), 132 (61). 
4.3.5 [1",1",1"-2H3]1-Methoxyindolyl-3-acetaldoxime (116a) 
 
N
OC2H3
N OH
 
 
 
Py (0.5 mL) was added to a solution of tryptamine (1 g) in Ac2O (1.5 mL) under 
stirring. After 60 min the reaction mixture was dissolved in CH2Cl2 (10 mL), was 
washed with a 10% solution of NaHCO3 (8 mL), H2O (8 mL × 2), and was dried over 
Na2SO4. The solvent was removed under reduced pressure to yield crude Nb-
acetyltryptamine (quant.) which was used in the next step without purification. To a 
solution of Nb-acetyltryptamine (500 mg, 2.48 mmol) in glacial acetic acid (8 mL) was 
added NaBH3CN (232 mg, 3.72 mmol) in portions. After 3 h at room temperature, the 
reaction mixture was diluted with H2O (5 mL), was basified with 20% NaOH, and was 
extracted with Et2O (30 mL × 3). The combined organic extract was dried over Na2SO4, 
was concentrated under reduced pressure, and the resulting residue was subjected to 
FCC (CH2Cl2-CH3OH, 98:2 and 97:3, v/v) to yield Nb-acetyl-2,3-dihydrotryptamine 
116a 
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(114) (398 mg, 79%). A solution of Na2WO4·2H2O (56.4 mg, 0.171 mmol) in H2O (390 
µL) was added to a stirred solution of Nb-acetyl-2,3-dihydrotryptamine (200 mg, 0.980 
mmol) in CH3OH (3.9 mL) cooled to -20 ºC, followed by drop wise addition of a 
solution of H2O2 (875 µL, 9.10 mmol) in CH3OH (980 µL). After being stirred at r.t. for 
10 min, K2CO3 (18 g, 7.84 mmol) and (C2H3O)2SO2 (135 µL, 1.57 mmol) were added 
under vigorous stirring at r.t. (Somei and Kawasaki, 1989). After 60 min the reaction 
mixture was diluted with H2O (20 mL), was extracted with Et2O (30 mL × 3), the 
combined organic extract was dried over Na2SO4 and was concentrated under reduced 
pressure. The residue was subjected to FCC (CH2Cl2-CH3OH, 98:2 v/v) to yield 
[1",1",1"-2H3]Nb-acetyl-1-methoxytryptamine (140.5 mg, 61%). A solution of [1",1",1"-
2H3]Nb-acetyl-1-methoxytryptamine (140.5 mg) in 15% methanolic solution of NaOH 
(28 mL) was allowed to reflux for 24 h. After removing the solvent under reduced 
pressure, the residue was dissolved in water (20 mL), was extracted with CH2Cl2-
CH3OH (95:5, v/v, 40 mL × 3), was dried over Na2SO4 and was concentrated under 
reduced pressure to yield crude [1",1",1"-2H3]1-methoxytryptamine (115a, 101.6 mg, 
88%). An aqueous solution of Na2WO4·2H2O (2.24 mg, 0.00680 mmol) in H2O (95 µL) 
was added to the solution of [1",1",1"-2H3]1-methoxytryptamine (66 mg, 0.34 mmol) in 
CH3OH (630 µL). The mixture was cooled to -15 ºC and H2O2 (79 µL, 0.82 mmol) was 
added under stirring (Burckard et al., 1965). After being stirred for 60 min at r.t., the 
mixture was diluted with H2O (8 mL), was basified with 20 % NaOH, was extracted 
with CH2Cl2 (20 mL × 3), the combined organic extract was dried over Na2SO4 and the 
solvent was removed under reduced pressure. The residue was subjected to FCC 
(CH2Cl2-CH3OH, 100:0, 98:2 and 90:10 v/v), followed by PTLC (CH2Cl2-CH3OH, 98:2 
v/v) to yield [1",1",1"-2H3]1-methoxyindolyl-3-acetaldoxime (116a, 28.1 mg, 40% yield, 
Pedras and Montaut, 2004). 
 
HPLC-DAD Method A, two peaks at tR = 14.5 and 15.4 min. 
1H NMR (500 MHz C2HCl3) δ 7.58-7.61 (m, 2H), 7.43-7.46 (m, 2H), 7.26-7.30 (m, 2H), 
7.18 (s, 1H), 7.13-7.17 (m, 2H), 6.95 (dd, J = 5, 5 Hz, 1H), 3.84 (d, J = 5 Hz, 2H), 3.65 
(d, J = 6 Hz, 2H). 
HR-EIMS m/z measured 207.1082 (207.1087 calcd for C11H92H3N2O2). 
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EIMS m/z (relative abundance) 207 [M]+ (100), 163 (36), 129 (40), 102 (17).
 
4.3.6 1-Methoxyindolyl-3-acetaldoxime (116) 
 
N
OCH3
N OH
 
 
 
A solution of Na2WO4·2H2O (56.4 mg, 0.171 mmol) in H2O (390 µL) was added to 
a stirred solution of Nb-acetyl-2,3-dihydrotryptamine (114, 200 mg, 0.980 mmol) in 
CH3OH (3.9 mL) cooled to -20 ºC. The mixture was treated with drop wise addition of a 
solution of H2O2 (875 µL, 9.10 mmol) in CH3OH (980 µL). After being stirred at r.t. for 
10 min, K2CO3 (18 g, 7.84 mmol) and (CH3O)2SO2 (145 µL, 1.60 mmol) were added 
under vigorous stirring at r.t. (Somei and Kawasaki, 1989). After 60 min the reaction 
mixture was diluted with H2O (20 ml), was extracted with Et2O (30 mL × 3), the 
combined organic extract was dried over Na2SO4 and was concentrated under reduced 
pressure. The residue was subjected to FCC (CH2Cl2-CH3OH, 98:2 v/v) to yield Nb-
acetyl-1-methoxytryptamine (152.6 mg, 67%). The Nb-acetyl-1-methoxytryptamine (100 
mg) was treated as reported above for [1",1",1"-2H3]Nb-acetyl-1-methoxytryptamine 
(116a) to yield 1-methoxyindolyl-3-acetaldoxime (116, 23.7, mg, 27% yield, Pedras and 
Montaut, 2004). 
 
HPLC-DAD Method A, two peaks at tR = 14.5 and 15.4 min. 
1H NMR (500 MHz C2HCl3) δ 7.59-7.63 (m, 2H), 7.44-7.46 (m, 2H), 7.27-7.31 (m, 2H), 
7.17 (s, 1H), 7.15-7.16 (m, 2H), 6.95 (dd, J = 5.5, 5.5 Hz, 1H), 4.09 (s, 3H), 4.08 (s, 3H), 
3.85 (d, J = 5 Hz, 2H), 3.66 (d, J = 6 Hz, 2H). 
HR-EIMS m/z measured 204.0885 (204.0899 calcd for C11H12N2O2). 
EIMS m/z (relative abundance) 204 [M]+ (8), 173 (71), 160 (100), 145 (49), 129 (55), 
117 (37), 102 (33). 
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4.3.7 1-Methylindolyl-3-acetonitrile (169) 
 
N
CH3
CN
 
 
 
NaH (66.8 mg, 1.67 mmol) and ICH3 (104 µL, 1.67 mmol) were added to cooled 
solution (0 °C) of indolyl-3-acetonitrile (49, 130 mg, 0.833 mmol) in dry THF (10 mL) 
under stirring. After 105 min, the reaction mixture was diluted with ice-cold H2O (20 
mL) and was extracted with CH2Cl2 (30 mL × 3). The combined organic extract was 
dried over Na2SO4, was concentrated under reduced pressure and the residue obtained 
was subjected to FCC (CH2Cl2-hexane, 70:30, then 80:20, v/v) to yield 1-methylindolyl-
3-acetonitrile (169, 135.9 mg, 96% yield). 
 
HPLC-DAD Method A, tR = 17.7 min. 
1H NMR (500 MHz C2HCl3) δ 7.60 (d, J = 8 Hz, 1H), 7.36 (d, J = 8 Hz, 1H), 7.31 (dd, J 
= 7.5, 7.5 Hz, 1H), 7.20 (dd, J = 7.5, 7.5 Hz, 1H), 7.11 (s, 1H), 3.85 (s, 2H), 3.80 (s, 3H). 
HR-EIMS m/z measured 170.0843 (170.0844 calcd for C11H10N2). 
EIMS m/z (relative abundance) 170 [M]+ (100), 144 (60), 128 (13), 115 (12). 
4.3.8 1-Methylindolyl-3-acetaldoxime (170) 
 
N
CH3
N OH
 
 
 
A solution of DIBAH (790 µL, 1.18 mmol) in toluene was added drop wise to a 
solution of 1-methylindolyl-3-acetonitrile (169, 100 mg, 0.588 mmol) in dry toluene (6.5 
mL) cooled to -78 °C under argon atmosphere. The reaction mixture was allowed to stir 
169 
170 
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at -78 °C for 10 min, was diluted with ice-cold HCl (10 mL, 2 M) and immediately 
extracted with EtOAc (30 mL × 2). The combined organic extract was washed with H2O 
(10 mL × 2), was dried over Na2SO4 (Pedras and Okinyo 2006a), and was concentrated 
under reduced pressure to yield 1-methylindolyl-3-acetaldehyde which was used for the 
next step without purification. A solution of HONH2·HCl (104.3 mg, 1.50 mmol) and 
CH3COONa (123.1 mg, 1.50 mmol) in H2O (1 mL) was added to a cooled solution (0 
°C) of indolyl-3-acetaldehyde in EtOH (8.5 mL) under stirring. The reaction mixture 
was treated as reported above for indolyl-3-acetaldoxime (112). Separation by FCC 
(CH2Cl2-CH3OH, 98:2, v/v) yielded 1-methylindolyl-3-acetaldoxime (170, 73.3 mg, 
66% yield). 
 
HPLC-DAD Method A, two peaks at tR = 12 and 11.3 min. 
1H NMR (500 MHz C2H3CN) δ 8.84 (s, OH), 7.56 (d, J = 8 Hz, 1H), 7.37 (d, J = 8 Hz, 
1H), 7.22 (dd, J = 7.5, 7.5 Hz, 1H), 7.09 (dd, J = 7.5, 7.5 Hz, 1H), 7.06 (s, 1H), 6.84 (dd, 
J = 5.5, 5.5 Hz, 1H), 3.77 (d, J = 7.5 Hz, 2H), 3.76 (s, 3H). 
HR-EIMS m/z measured 188.0955 (188.0950 calcd for C11H12N2O). 
EIMS m/z (relative abundance) 188 [M]+ (56), 171 (22), 144 (100), 131 (14). 
4.3.9 34S-Hexamethyldisilathiane (171a) and hexamethyldisilathiane 
(171) 
 
(CH3)3SiSSi(CH3)3(CH3)3Si34SSi(CH3)3
 
 
 
Hexamethyldisilathiane (171) was synthesized in 69% yield (based on S) by a 
modification of reported procedure (So and Boudjouk, 1989; 1992). The optimized 
synthetic conditions were employed in preparation of 34S-hexamethyldisilathiane (171a). 
Finely cut pieces of Na (270.5 mg, 11.8 mmol) were added to a dry two-necked 50 mL 
round-bottomed flask charged with sulfur-34 (200 mg, 5.88 mmol) and naphthalene 
(70.9 mg, 0.553 mmol) in dry THF (6 mL). The reaction mixture was sonicated for about 
2 h during which sodium and sulfur dissolves. The color of the reaction mixture changes 
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from yellow to orange to brown to light yellow to green to light green. The reaction 
mixture was then refluxed for 2 h, was cooled in ice-bath followed by drop wise addition 
of chlorotrimethylsilane (2.2 mL, 17.64 mmol) and the reaction mixture turns purple. 
The reaction mixture was stirred in ice-bath for further 10 min, then at r.t. for 3 h. A 
short-path distillation apparatus was used to distil off THF and excess 
chlorotrimethylsilane at atmospheric pressure. 34S-Hexamethyldisilathiane (171a) was 
then distilled off under vacuum (b.p. 68-71 ºC at 510 torr) and was obtained as a 
colorless vile smelling liquid in 60% yield based on 34S (633.5 mg). The 34S-
hexamethyldisilathiane was analyzed by GC and GC-MS-EI. 
 
GC tR = 5.15 min. 
GC-MS-EI m/z (relative abundance) 180 [M]+ (50), 165 (100). 
4.3.10 [4',5',6',7'-2H4]Indolyl-3-[34S]acetothiohydroxamic acid 
(174a) 
 
N
H
NHOH
34S
2H
2H
2H
2H
 
 
 
Freshly distilled POCl3 (260 µL, 2.84 mmol) was added drop wise to a solution of 
[4,5,6,7-2H4]indole (105a, 313 mg, 2.58 mmol) in DMF (2 mL) and the reaction mixture 
was stirred at r.t. After 50 min, a solution of aqueous NH3 (10 mL, 28%) was added and 
the reaction mixture was extracted with EtOAc (60 mL × 3), the combined organic 
extract was washed with ice-cold H2O (30 mL × 2), was dried over Na2SO4 and was 
concentrated under reduced pressure to yield [4,5,6,7-2H4]indole-3-carboxaldehyde 
(106a, 332.9 mg, 87%, Pedras et al., 1998). NH4OAc (96.4 mg, 1.25 mmol) was added 
to a suspension of [4,5,6,7-2H4]indole-3-carboxaldehyde (332.9 mg, 2.23 mmol) in 
CH3NO2 (966 µL, 17.84 mmol). The resulting mixture was refluxed at 128 - 130 °C for 
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2 h (Canoira et al., 1989). The reaction mixture was then diluted with H2O (20 mL), was 
extracted with CH2Cl2 (35 mL × 3), and the combined organic extract was washed with 
H2O (40 mL), then brine (40 mL), was dried over Na2SO4 and was concentrated under 
reduced pressure to yield [4',5',6',7'-2H4]3-(2-nitrovinyl)indole (172a) in 99% (422 mg). 
To a mixture of [4',5',6',7'-2H4]3-(2-nitrovinyl)indole (422 mg, 2.20 mmol) and silica gel 
(4.40 g) in isopropanol (6.4 mL) and CHCl3 (35 mL) NaBH4 (341 mg, 92 mmol) was 
added in portions of ca 85 mg over 15 min (Sinhababu and Borchardt, 1983). The 
reaction mixture was stirred for further 60 min, during which the intense yellow color of 
the reaction mixture disappeared. The excess NaBH4 was then destroyed with 2 M HCl, 
the reaction mixture was filtered off and the silica gel was rinsed with CH2Cl2 (20 mL × 
3). The combined organic extract was washed with H2O (40 mL), was dried over 
Na2SO4 and was concentrated under reduced pressure. The reaction mixture was 
subjected to FCC (CH2Cl2) to yield [4',5',6',7'-2H4]3-(2-nitroethyl)indole (173a, 178 mg, 
42%) as a brown solid. KH (331 mg, 2.47 mmol) in a dry 50 mL round-bottomed flask 
was rinsed with n-hexanes under atmosphere of argon to give a white powder. The flask 
was kept in ice-bath and a solution of [4',5',6',7'-2H4]3-(2-nitroethyl)indole (60 mg, 0.309 
mmol) in dry THF (4 mL) was added drop wise. After stirring for 30 min with cooling in 
ice-bath, the reaction mixture was allowed to warm up to r.t. and stirred for an additional 
60 min. The reaction flask was wrapped with aluminum foil and 34S-
hexamethyldisilathiane (171a, 310 µL, 1.43 mmol) was added drop wise (Hwu and 
Tsay, 1990). After 60 min, the reaction mixture was cooled in an ice-bath, was diluted 
with ice-cold H2O (5 mL), was neutralized with 5% H2SO4 (2 mL), was extracted with 
CH2Cl2 (30 mL × 2), the combined organic extract was dried over Na2SO4, and the 
solvent was removed under reduced pressure. The residue was subjected to FCC 
(CH2Cl2-EtOAc, 100:0, then 60:40, v/v) to yield [4',5',6',7'-2H4]indolyl-3-
[34S]acetothiohydroxamic acid (174a, 49.8 mg, 76% yield) as brownish crystals (Pedras 
and Okinyo, 2008). 
 
HPLC-HRMS-ESI Method A, tR = 13.1 min. 
1H NMR (500 MHz C2HCl3) δ 8.26 (br s, 1H), 7.20 (s, 1H), 4.27 (s, 2H). 
HPLC-HRMS-ESI m/z measured 213.0797 (213.0795 calcd for C10H72H4N2O34S). 
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HPLC-MS-ESI m/z (relative abundance) 213 [M + H]+ (100), 195 (15), 180 (13), 134 
(18). 
FTIR νmax (KBr)/cm-1; 3410, 3307, 3056, 2904, 1552, 1455, 1419, 1353, 1339, 1227, 
1131, 1062, 971, 744. 
4.3.11 [4',5',6',7'-2H4]Indolyl-3-acetothiohydroxamic acid (174b) 
 
N
H
NHOH
S
2H
2H
2H
2H
 
 
 
KH (331 mg, 2.47 mmol) in a dry 50 mL round-bottomed flask was rinsed with n-
hexanes under an atmosphere of argon to give a white powder. The reaction flask was 
kept in an ice-bath and a solution of [4',5',6',7'-2H4]3-(2-nitroethyl)indole (60 mg, 0.309 
mmol) in dry THF (4 mL) was added drop wise. After stirring for 30 min with cooling in 
an ice-bath, the reaction mixture was allowed to warm up to r.t. and stirred for an 
additional 60 min. The reaction flask was wrapped with aluminum foil and 
hexamethyldisilathiane (171, 258 µL, 1.24 mmol) was added drop wise (Hwu and Tsay, 
1990). The reaction mixture was then treated as reported above for [4',5',6',7'-
2H4]indolyl-3-[34S]acetothiohydroxamic acid (174a) to yield [4',5',6',7'-2H4]indolyl-3-
acetothiohydroxamic acid (174b, 50.5 mg, 78% yield) as brownish crystals (Pedras and 
Okinyo, 2008). 
 
HPLC-HRMS-ESI Method A, tR = 13.1 min. 
1H NMR (500 MHz C2HCl3) δ 8.26 (br s, 1H), 7.20 (s, 1H), 4.26 (s, 2H). 
HPLC-HRMS-ESI m/z measured 211.0830 (211.0837 calcd for C10H72H4N2OS). 
HPLC-MS-ESI m/z (relative abundance) 211 [M + H]+ (100), 193 (16), 178 (14), 134 
(17). 
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4.3.12 Indolyl-3-acetothiohydroxamic acid (174) 
 
N
H
NHOH
S
 
 
 
NH4OAc (148.8 mg, 1.93 mmol) was added to a suspension of indolyl-3-
carboxaldehyde (106, 500 mg, 3.44 mmol) in CH3NO2 (1.5 mL, 27.5 mmol). The 
resulting mixture was refluxed at 128 - 130 °C for 2 h. The reaction mixture was then 
diluted with H2O (40 mL), was extracted with CH2Cl2 (60 mL × 3), and the combined 
organic extract was washed with H2O (60 mL), then brine (60 mL), was dried over 
Na2SO4 and was concentration under reduced pressure to yield 3-(2'-nitrovinyl)indole 
(172, 642 mg, 98%) (Canoira et al., 1989). To a mixture of 3-(2'-nitrovinyl)indole (400 
mg, 2.13 mmol) and silica gel (4.26 g) in isopropanol (6.3 mL) and CHCl3 (34 mL) 
NaBH4 (330 mg, 8.73 mmol) was added in portions of ca 83 mg over 15 min (Sinhababu 
and Borchardt, 1983). The reaction mixture was then treated as reported above for 
[4',5',6',7'-2H4]-3-(2-nitrovinyl)indole (172a) to yield 3-(2'-nitroethyl)indole (173, 204.7 
mg, 51%) as a brown solid. KH (338 mg, 2.53 mmol) was rinsed with n-hexanes under 
atmosphere of argon to give a white powder. The reaction flask was kept in an ice-bath 
and a solution of 3-(2'-nitroethyl)indole (60 mg, 0.316 mmol) in dry THF (4 mL) was 
added drop wise. After stirring for 30 min with cooling in an ice-bath, the reaction 
mixture was allowed to warm up to r.t. and stirred for an additional 60 min. The reaction 
flask was wrapped with aluminum foil and hexamethyldisilathiane (171, 306 µL, 1.48 
mmol) was added drop wise (Hwu and Tsay, 1990). The reaction mixture was then 
treated as reported above for [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a) to yield indolyl-3-acetothiohydroxamic acid (174, 48.1 mg, 74% yield) (Pedras 
and Okinyo, 2008). 
 
HPLC-HRMS-ESI Method A, tR = 13.1 min. 
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1H NMR (500 MHz C2HCl3) δ 8.26 (br s, 1H), 7.54 (d, J = 8 Hz, 1H), 7.44 (d, J = 8 Hz, 
1H), 7.28 (dd, J = 7.5, 7.5 Hz, 1H), 7.17-7.24 (m, 2H), 4.26 (s, 2H). 
13C NMR (125.8 MHz C2HCl3) δ 189.0, 136.7, 126.9, 124.5, 123.5, 121.0, 119.0, 111.9, 
107.2, 36.9. 
HPLC-HRMS-ESI m/z measured 207.0579 (207.0586 calcd for C10H11N2OS). 
HPLC-MS-ESI m/z (relative abundance) 207 [M + H]+ (100), 189 (22), 174 (39), 130 
(35). 
4.3.13 1-Methylindolyl-3-acetothiohyrodroxamic acid (178) 
 
N
CH3
NHOH
S
 
 
 
NaH (110 mg, 2.76 mmol) and ICH3 (172 µL, 2.76 mmol) were added to a cooled 
solution (0 °C) of indole-3-carboxaldehyde (106, 200 mg, 1.38 mmol) in dry THF (20 
mL) with stirring under argon atmosphere. After 45 min of stirring at 0 °C, the reaction 
mixture was poured into ice-cold H2O (40 mL), was extracted with EtOAc (60 mL × 3), 
the combined organic extract was washed with brine, was dried over Na2SO4, and was 
concentrated under reduced pressure. The crude mixture was subjected to FCC (CH2Cl2-
CH3OH, 100:0-98:2, v/v) to yield 1-methylindole-3-carboxaldehyde (175, 215 mg, 
98%). NH4OAc (54.4 mg, 0.706 mmol) was added to a suspension of 1-methylindole-3-
carboxaldehyde (200 mg, 1.26 mmol) in CH3NO2 (547 µL, 10.1 mmol) and the resulting 
mixture was refluxed at 128 - 130 °C for 2 h (Canoira et al., 1989). The reaction mixture 
was then diluted with H2O (20 mL), was extracted with Cl2Cl2 (30 mL × 3), and the 
combined organic extract was washed with H2O (20 mL), then brine (20 mL), was dried 
over Na2SO4 and was concentrated under reduced pressure to yield 1-methyl-3-(2'-
nitrovinyl)indole (176, 249 mg, 98%,). To a mixture of 1-methyl-3-(2’-nitrovinyl)indole 
(249 mg, 1.23 mmol) and silica gel (2.46 g) in isopropanol (3.7 mL) and CHCl3 (20 mL), 
NaBH4 (191 mg, 54 mmol) was added in portions of ca 48 mg over 15 min (Sinhababu 
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and Borchardt, 1983). The reaction mixture was then treated as reported above for 
[4',5',6',7'-2H4]-3-(2-nitrovinyl)indole (172a). Separation of the crude mixture by FCC 
(CH2Cl2-hexane, 80:20, v/v) yielded 1-methyl-3-(2'-nitroethyl)indole (177, 158.1 mg, 
63%). KH (262 mg, 1.96 mmol) was rinsed with n-hexanes under an atmosphere of 
argon to give a white powder. The reaction flask was kept in an ice-bath and a solution 
of 1-methyl-3-(2'-nitroethyl)indole, (100 mg, 0.490 mmol) in dry THF (5.5 mL) was 
added drop wise. After stirring for 30 min with cooling in an ice-bath, the reaction 
mixture was allowed to warm up to r.t. and stirred for an additional 60 min. The reaction 
flask was wrapped with aluminum foil and hexamethyldisilathiane (207 µL, 0.980 
mmol) was added drop wise (Hwu and Tsay, 1990). The reaction mixture was then 
treated as reported above for [4',5',6',7'-2H4]indolyl-3-[34S]acetothiohydroxamic acid 
(174a). The resulting crude mixture was separated by FCC (CH2Cl2-EtOAc, 100:0, then 
80:20, v/v) to yield 1-methylindolyl-3-acetothiohydroxamic acid (178, 71.8 mg, 67% 
yield) as brownish oil which solidified on cooling to 5 °C. 
 
HPLC-HRMS-ESI Method A, tR = 17.2 min. 
1H NMR (500 MHz C2HCl3) δ 7.53 (d, J = 8 Hz, 1H), 7.42 (d, J = 8 Hz, 1H), 7.30 (dd, J 
= 7.5, 7.5 Hz, 1H), 7.18-7.25 (m, 2H), 4.25 (s, 2H), 3.82 (s, 3H). 
HPLC-HRMS-ESI m/z measured 221.0830 (221.0837 calcd for C11H13N2OS). 
HPLC-MS-ESI m/z (relative abundance) 221 [M + H]+ (92), 203 (7), 189 (11), 165 (7), 
144 (100). 
4.3.14 1-(tert-Butoxycarbonyl)indol-3-ylmethylisothiocyanate 
(180) 
 
N
NCS
O OH3C
H3C CH3
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A solution of Boc2O (364.5 mg, 1.67 mmol) in THF (2 mL) was added to a stirred 
solution of indole-3-carboxaldehyde (106, 200 mg, 1.38 mmol) in THF (6 mL). The 
reaction mixture was cooled to 5 °C and DMAP was added. After 20 min, the reaction 
mixture was concentrated under reduced pressure and the resulting residue was subjected 
to FCC (hexane-EtOAc, 60:40, v/v) to yield 1-(tert-butoxycarbonyl)indole-3-
carboxaldehyde (345.8 mg, quant.). A solution of HONH2·HCl (133 mg, 1.92 mmol) and 
Na2CO3 (93.6 mg, 0.883) in H2O (360 µL) was added to a stirred solution of 1-(tert-
butoxycarbonyl)indole-3-carboxaldehyde (300 mg, 1.22 mmol) in EtOH (2.3 mL). The 
resulting mixture was heated for 5 min at 50 °C. the reaction mixture was then 
concentrated under reduced pressure and the residue was taken in H2O (6 mL), and was 
extracted with Et2O (10 mL × 3). The combined organic extract was dried over Na2SO4 
and was concentrated under reduced pressure to yield crude 1-(tert-
butoxycarbonyl)indolyl-3-carboxaldehyde oxime (330 mg, quant.) which was used 
without purification. A solution of 1-(tert-butoxycarbonyl)indolyl-3-carboxaldehyde 
oxime (120 mg, 0.462 mmol) in CH3OH (4.6 mL) was added to a solution of 
NiCl2·6H2O (109.8 mg, 0.462) in CH3OH (7 mL). NaBH4 (112.7 mg, 2.98 mmol) was 
added in one portion and the reaction mixture was stirred for 5 min. The black 
precipitate that formed was filtered off and the filtrate was concentrated to about a third 
of the original volume. The remaining mixture was poured into H2O (23 mL) containing 
aqueous NH3 (700 µL, 28%), and was extracted with EtOAc (15 mL × 3). The combined 
organic extract was dried over Na2SO4 and was concentrated to yield 1-(tert-
butoxycarbonyl)indol-3-ylmethanamine (179, 106.5 mg, 94%) which was used for the 
next step without purification. A solution of 1-(tert-butoxycarbonyl)indolyl-3-
methanamine (106.5 mg, 0.433 mmol) in CH2Cl2 (1.4 mL) was added drop wise (ca 6 
min) to a vigorously stirred mixture of Cl2CS (33 µL, 0.43 mmol) and CaCO3 (55.6 mg, 
0.550 mmol) in CH2Cl2/H2O (1.4/2.8 mL). After 5 min, the two layers were separated 
and the aqueous solution was extracted with CH2Cl2 (10 mL × 3). The combined organic 
extract was filtered over charcoal, the solvent was removed under reduced pressure and 
the residue was subjected to FCC (benzene) to yield 1-(tert-butoxycarbonyl)indolyl-3-
methyl isothiocyanate (180, 74 mg, 56% yield, Kutschy et al., 1997; 1998). 
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HPLC-DAD Method A, tR = 37.6 min. 
1H NMR (500 MHz C2HCl3) δ 8.18 (d, J = 6.5 Hz, 1H), 7.65 (s, 1H), 7.59 (d, J = 8 Hz, 
1H), 7.40 (dd, J = 7.5, 7.5 Hz, 1H), 7.33 (dd, J = 7.5, 7.5 Hz, 1H), 4.83 (s, 2H), 1.71 (s, 
9H). 
HR-EIMS m/z measured 288.0937 (288.0933 calcd for C15H16N2O2S). 
EIMS m/z (relative abundance) 288 [M]+ (10), 232 (22), 205 (9), 174 (21), 130 (64), 57 
(100). 
4.3.15 1-Acetylindol-3-ylmethylisothiocyanate (183) 
 
N
NCS
O
 
 
 
Pyridine (4 mL) was added to a stirred suspension of indole-3-carboxaldehyde 
(106, 200 mg, 1.38 mmol) in Ac2O (4 mL). After 90 min, the reaction mixture was 
diluted with toluene and concentrated to yield 1-acetylindole-3-carboxaldehyde (253 mg, 
98%) which was used in the next step without purification. A solution of HONH2·HCl 
(74.4 mg, 17 mmol) and CH3COONa (87.8 mg, 17 mmol) in H2O (2.5 mL) was added to 
a solution of 1-acetylindole-3-carboxaldehyde (200 mg, 17 mmol) in EtOH (17 mL), the 
resulting mixture was heated for 10 min (47 - 50 °C) with stirring. The reaction mixture 
was concentrated under reduced pressure, the residue was taken in H2O (10 mL), was 
extracted with Et2O (30 mL × 3), the combined organic extract was dried over Na2SO4, 
and was concentrated to yield 1-acetylindole-3-carboxaldehyde oxime (182.1 mg, 84%). 
A solution of NiCl2·H2O (141 mg, 0.594 mmol) in CH3OH (6 mL) was added to a 
solution of 1-acetylindole-3-carboxaldehyde oxime (120 mg, 0.594 mmol) in CH3OH (9 
mL). The reaction mixture was cooled to 0 °C and NaBH4 (144.1 mg, 6.45 mmol) was 
added in one portion (Kutschy et al., 1997; 1998). After stirring for 10 min, the black 
precipitate that formed was filtered off and the filtrate was concentrated to about a third 
of the original volume. The remaining mixture was poured into H2O (20 mL) containing 
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aqueous NH3 (1 mL, 28%), and was extracted with EtOAc (30 mL × 2). The combined 
organic extract was dried over Na2SO4, was concentrated, and the crude mixture was 
subjected to FCC (CH2Cl2-CH3OH-NH4OH 28%, 92:8:1, v/v) to yield 1-acetylindol-3-
ylmethanamine (182, 78 mg). A solution of 182 in CH2Cl2 (1.5 mL) was added drop 
wise (ca 8 min) to a vigorously stirred mixture of Cl2CS (31 µL, 0.41 mmol) and CaCO3 
(53 mg, 0.52 mmol) in CH2Cl2-H2O (1.5:3 mL, Kutschy et al., 1997; 1998). After being 
stirred for 5 min the two layers were separated and the aqueous solution was extracted 
with CH2Cl2 (10 mL × 3). The combined organic extract was filtered over charcoal, the 
solvent was removed under reduced pressure and the residue was purified by FCC 
(CH2Cl2) to yield 1-acetylindolyl-3-methyl isothiocyanate (183, 42 mg, 31% yield from 
1-acetylindole-3-carboxaldehyde oxime). 
 
HPLC-DAD Method A, tR = 24.9 min. 
1H NMR (500 MHz C2HCl3) δ 8.46 (d, J = 8 Hz, 1H), 7.55 (s, 1H), 7.56 (d, J = 8 Hz, 
1H), 7.47 (dd, J = 8, 8 Hz, 1H), 7.36 (dd, J = 7.5, 7.5 Hz, 1H), 4.85 (s, 2H), 2.66 (s, 3H). 
13C NMR (125.8 MHz C2HCl3): δ 168.6, 136.4, 134.7, 128.5, 126.4, 124.4, 123.6, 118.9, 
117.2, 116.6, 41.1, 24.2. 
HR-EIMS m/z measured 230.0520 (230.0514 calcd for C12H10N2OS). 
EIMS m/z (relative abundance) 230 [M]+ (18), 172 (32), 130 (100), 102 (7). 
4.3.16 [4',5',6',7'-2H4]Brassinin (16a) 
 
N
H
2H
2H
2H
2H
NH
SCH3
S
 
 
 
A solution of HONH2·HCl (102.6 mg, 1.48 mmol) and Na2CO3 (78.2 mg, 0.738 
mmol) in H2O (1.5 mL) was added to a solution of [4,5,6,7-2H4]indole-3-carboxaldehyde 
(110 mg, 0.738 mmol) in EtOH (3 mL). The resulting mixture was refluxed (68 - 70 ºC) 
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for 45 min. EtOH was evaporated and the residue was washed with ice-cold H2O (3 mL) 
to yield [4',5',6',7'-2H4]indolyl-3-carboxaldehyde oxime (185a, 105.5 mg, 87%). A 
solution of NaOH (24 mL, 1 M) was added to a solution of [4',5',6',7'-2H4]indolyl-3-
carboxaldehyde oxime (95 mg, 0.638) in CH3OH (4.7 mL) and the resulting solution 
was cooled in an ice-bath. Devarda’s alloy (3 g) was added to the cooled mixture with 
stirring at r.t. After 50 min the reaction mixture was diluted with H2O (20 mL), and was 
filtered under vacuum. The reaction mixture was concentrated under reduced pressure, 
and the remaining mixture was extracted with Et2O (60 mL × 3). The combined organic 
extract was dried over Na2SO4 and was concentrated under reduced pressure to yield 
[4',5',6',7'-2H4]indolyl-3-methanamine (117a, 61.3 mg, 71%) which was used in the next 
step without purification. Et3N (57 µL, 0.41 mmol) and CS2 (24 µL, 0.42 mmol) were 
added to a cooled solution (0 ºC) of [4',5',6',7'-2H4]indolyl-3-methylamine (61.3 mg, 0.41 
mmol) in pyridine (580 µL). After stirring for 60 min at 0 ºC, ICH3 (26 µL, 0.41 mmol) 
was added and the reaction mixture was kept at 5 ºC for 90 min. The reaction mixture 
was then diluted with H2O (4 mL), was extracted with Et2O (15 mL × 3), the combined 
organic extract was dried over Na2SO4 and concentrated under reduced pressure. The 
crude product was separated by FCC (hexane-CH2Cl2, 60:40 to 80:20, v/v) to yield 
[4',5',6',7'-2H4]brassinin (16a, 69.6 mg, 50% yield from 185a, Pedras et al., 1998). 
 
HPLC-DAD Method A, tR = 20.1 min. 
1H NMR (500 MHz C2H3CN) δ 9.25 (br s, 1H), 8.25 (br s, 1H), 7.31 (s, 1H), 5.04 (d, J = 
5 Hz, 2H), 2.55 (s, 3H). 
HR-EIMS m/z measured 240.0694 (240.0693 calcd for C11H82H4N2S2); EIMS m/z 
(relative abundance) 240 [M]+ (36), 166 (12), 134 (100), 106 (13). 
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4.3.17 Brassinin (16) 
 
N
H
NH
SCH3
S
 
 
 
A solution of HONH2·HCl (190 mg, 2.74 mmol) and Na2CO3 (161 mg, 1.52 mmol) 
in H2O (2.7 mL) was added to a solution of indole-3-carboxaldehyde (106, 200 mg, 1.38 
mmol) in EtOH (6 mL). The resulting mixture was refluxed (68 - 70 ºC) for 45 min. 
EtOH was evaporated and the residue was filtered off and washed with ice-cold H2O (10 
mL) to yield indole-3-carboxaldehyde oxime (185, 213 mg, 96%). A solution of NaOH 
(10 mL, 1 M) was added to a solution of indole-3-carboxaldehyde oxime (40 mg, 0.25 
mmol) in CH3OH (2 mL) and the resulting solution was cooled in an ice-bath. Devarda’s 
alloy (1.2 g) was added to the cooled mixture with stirring at r.t. After 50 min the 
reaction mixture was diluted with H2O (10 mL), and was filtered under vacuum. The 
reaction mixture was then concentrated under reduced pressure, the remaining aqueous 
mixture was extracted with Et2O (30 mL × 3). The combined organic extract was dried 
over Na2SO4 and was concentrated under reduced pressure to yield indolyl-3-
methanamine (117, 31 mg, 85%) which was treated as reported above for [4',5',6',7'-
2H4]brassinin (16a) to yield brassinin (16, 31.1 mg, 53% yield from 117, Pedras et al., 
1998). 
 
HPLC-DAD Method A, tR = 20.1 min. 
1H NMR (500 MHz C2H3CN) δ 9.26 (br s, 1H), 8.25 (br s, 1H), 7.63 (d, J = 8 Hz, 1H), 
7.42 (d, J = 8 Hz, 1H), 7.30 (s, 1H), 7.16 (dd, J = 8, 8 Hz, 1H), 7.08 (dd, J = 8, 8 Hz, 
1H), 5.03 (d, J = 5 Hz, 2H), 2.55 (s, 3H). 
HR-EIMS m/z measured 236.0438 (236.0442 calcd for C11H12N2S2). 
EIMS m/z (relative abundance) 236 [M]+ (27), 162 (8), 130 (100), 102 (11). 
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4.3.18 [3,3,3-2H3]1-Methoxybrassinin (18a) 
 
N
OCH3
NH
SC2H3
S
 
 
 
A solution of Na2WO4·2H2O (98.3 mg, 0.298 mmol) in H2O (600 µL) was added to 
a stirred solution of indoline (186, 199 mg, 1.70 mmol) in CH3OH (5 mL) and the 
suspension was then cooled to -20 °C. A solution of H2O2 (1.4 mL, 15 mmol) in CH3OH 
(1.7 mL) was added drop wise to the cooled suspension over 10 min, the reaction 
mixture was stirred at r.t. for 10 min, after which solid K2CO3 (1.88 g, 13.6 mmol) and 
(CH3O)2SO2 (245 µL, 2.72 mmol) were added under vigorous stirring (Somei and 
Kawasaki, 1989). After being stirred for 10 min, the reaction mixture was diluted with 
H2O (20 mL), was extracted with Et2O (30 mL × 3), the combined organic extract was 
dried over Na2SO4 and was concentrated under reduced pressure. The crude material was 
separated by FCC (hexane-CH2Cl2, 70:30, v/v) to yield 1-methoxyindole (187, 112 mg, 
45%). Freshly distilled POCl3 (69 µL, 0.75 mmol) was added to a solution of 1-
methoxyindole (100 mg, 0.68 mmol) in DMF (600 µL) and the reaction mixture was 
stirred at r.t. After 40 min, a solution of aqueous NH3 (4 mL, 28 %) was added to the 
reaction mixture followed by extraction with Et2O (10 mL × 3). The combined organic 
extract was dried over Na2SO4 and was concentrated under reduced pressure to yield 1-
methoxyindole-3-carboxaldehyde (113 mg, 96 %). A solution of HONH2·HCl (91 mg, 
1.2 mmol) and Na2CO3 (61.5 mg, 0.580 mmol) in H2O (870 µL) was added to a solution 
of 1-methoxyindole-3-carboxaldehyde (114.7 mg, 0.655 mmol) in EtOH (3 mL). The 
resulting reaction mixture was refluxed (83 - 85 ºC) for 60 min, was diluted with H2O (3 
mL) and was extracted with Et2O (20 mL × 3). The combined organic extract was 
washed with brine (10 mL × 2), was dried over Na2SO4 and was concentrated under 
reduced pressure to yield 1-methoxyindole-3-carboxaldehyde oxime (188, 131.4 mg, 99 
%). NaBH3CN (182 mg, 2.88 mmol) and NH4OAc (245.5 mg, 3.18 mmol) were added 
to a solution of 1-methoxyindole-3-carboxaldehyde oxime (55 mg, 0.29 mmol) in 
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CH3OH (695 µL) cooled to 0 ºC and the resulting mixture was treated with TiCl3 in 2 M 
HCl (892 µL, 2.04 mmol) neutralized with NaOH (Pedras and Zaharia, 2000). After 
being stirred for 15 min at 0 ºC the reaction mixture was diluted with H2O (2.4 mL), was 
basified with 5 M NaOH (mL) and was extracted with CH2Cl2 (15 mL × 3). The 
combined organic extract was dried over Na2SO4 and was concentrated under reduced 
pressure to yield crude 1-methoxyindolyl-3-methanamine (189, 43 mg) which was used 
in the next step without purification (Pedras and Zaharia, 2000). Et3N (38 µL, 0.27 
mmol) and CS2 (15 µL, 0.25 mmol) were added to a solution of the amine 189 (43 mg, 
0.24 mmol) in pyridine (115 µL) cooled to 0 ºC. After being stirred for 60 min at 0 ºC, 
IC2H3 (15 µL, 0.24 mmol) was added and the reaction mixture was kept at 5 ºC for 90 
min. The reaction mixture was diluted with H2O (2 mL), was extracted with Et2O (10 
mL × 2), the combined organic extract was dried over Na2SO4 and was concentrated 
under reduced pressure. The reaction mixture was separated by FCC (hexane-CH2Cl2, 
60:40 to 50:50, v/v) to yield [3,3,3-2H3]1-methoxybrassinin (18a, 41 mg, 53% yield from 
oxime 188, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 25.3 min. 
1H NMR (500 MHz C2HCl3) δ 7.62 (d, J = 8 Hz, 1H), 7.47 (d, J = 8 Hz, 1H), 7.35 (s, 
1H), 7.32 (dd, J = 7, 7 Hz, 1H), 7.18 (dd, J = 7.5, 7.5 Hz, 1H), 7.02 (br s, 1H), 5.04 (d, J 
= 4 Hz, 2H), 4.12 (s, 3H). 
HR-EIMS m/z measured 269.0732 (269.0736 calcd for C12H112H3N2OS2). 
EIMS m/z (relative abundance) 269 [M]+ (7), 238 (100), 187 (14), 160 (81), 145 (19), 
129 (37). 
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4.3.19 [4',5',6',7'-2H4]1-Methoxybrassinin (18b) 
 
N
OCH3
2H
2H
2H
2H
NH
SCH3
S
 
 
 
NaBH3CN (195 mg, 1.68 mmol) was added to a stirred solution of [4,5,6,7-
2H4]indole (105a, 135 mg, 1.12 mmol) in glacial acetic acid (2 mL) under an argon 
atmosphere. The reaction mixture was stirred at r.t. for 60 min, was diluted with H2O (4 
mL), was basified with NaOH (mL), was extracted with Et2O (30 mL × 3), the combined 
organic extract was dried over Na2SO4 and was concentrated under reduced pressure. 
The crude material was separated by FCC (CH2Cl2) to yield [4,5,6,7-2H4]indoline (186a, 
113.2 mg, 82%). A solution of Na2WO4·2H2O (53 mg, 0.16 mmol) in H2O (0.35 mL) 
was added to the stirred solution of [4,5,6,7-2H4]indoline (113.2 mg, 0.920 mmol) in 
CH3OH (3 mL) and the suspension was cooled to -20 °C. A solution of H2O2 (766 µL, 
7.96 mmol) in CH3OH (1 mL) was added drop wise to the cooled suspension. The 
reaction mixture was stirred at r.t. for 10 min, after which solid K2CO3 (12 g, 7.36 
mmol) and (CH3O)2SO2 (133 µL, 1.47 mmol) were added under vigorous stirring (Somei 
and Kawasaki, 1989). After being stirred for 10 min, the reaction mixture was diluted 
with H2O (20 mL), was extracted with Et2O (30 mL × 3), the combined organic extract 
was dried over Na2SO4 and was concentrated under reduced pressure. The crude material 
was separated by FCC (hexane-CH2Cl2, 70:30, v/v) to yield [4,5,6,7-2H4]1-
methoxyindole (187a, 73 mg, 52%). Freshly distilled POCl3 (69 µL, 0.75 mmol) was 
added to a solution of [4,5,6,7-2H4]1-methoxyindole (102 mg, 0.68 mmol) in DMF (600 
µL) and the reaction mixture was stirred at r.t. After 40 min, a solution of aqueous NH3 
(4 mL, 28%) was added to the reaction mixture, the reaction mixture was extracted with 
Et2O (10 mL × 3), the combined organic extract was dried over Na2SO4 and was 
concentrated under reduced pressure to yield [4,5,6,7-2H4]1-methoxyindole-3-
carboxaldehyde (113 mg, 93%). A solution of HONH2·HCl (80.6 mg, 1.16 mmol) and 
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Na2CO3 (61.5 mg, 0.580 mmol) in H2O (810 µL) was added to a solution of [4,5,6,7-
2H4]1-methoxyindole-3-carboxaldehyde (103 mg, 0.580 mmol) in EtOH (2.7 mL). The 
resulting mixture was refluxed (85 ºC) for 60 min, was diluted with H2O (3 mL) and was 
extracted with Et2O (20 mL × 3). The combined organic extract was washed with brine 
(10 mL × 2), was dried over Na2SO4 and was concentrated under reduced pressure to 
yield [4',5',6',7'-2H4]1-methoxyindolyl-3-carboxaldehyde oxime (188a, 122.1 mg, 99 %). 
NaBH3CN (163 mg, 2.58 mmol) and NH4OAc (219 mg, 2.84 mmol) were added to a 
solution of 188a (50 mg, 0.26 mmol) in CH3OH (640 µL) cooled to 0 ºC and the 
resulting mixture was treated with TiCl3 in 2 M HCl (795 µL, 24 mmol) neutralized with 
NaOH (Pedras and Zaharia, 2000). After being stirred for 15 min at 0 ºC, the reaction 
mixture was diluted with H2O (2.2 mL), was basified with NaOH (5 M) and was 
extracted with CH2Cl2 (15 mL × 3). The combined organic extract was dried over 
Na2SO4 and was concentrated under reduced pressure to yield crude [4',5',6',7'-2H4]1-
methoxyindolyl-3-methanamine (189a, 40.33 mg) which was used in the next step 
without purification. Et3N (34 µL, 0.25 mmol) and CS2 (13 µL, 0.22 mmol) were added 
to a cooled solution (0 ºC) of [4',5',6',7'-2H4]1-methoxyindolyl-3-methanamine (40.3 mg, 
0.224 mmol) in pyridine (105 µL). After being stirred for 60 min at 0 ºC, ICH3 (14 µL, 
0.22 mmol) was added to the reaction mixture which was kept at 5 ºC for 90 min. The 
reaction mixture was diluted with H2O (2 mL), was extracted with Et2O (10 mL × 2), the 
combined organic extract was dried over Na2SO4 and was concentrated under reduced 
pressure. The resulting crude reaction mixture was separated by FCC (hexane-CH2Cl2, 
60:40 to 50:50, v/v) to yield [4',5',6',7'-2H3]1-methoxybrassinin (18b, 46.5 mg, 67% 
yield from 188a, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 25.3 min. 
1H NMR (500 MHz C2HCl3) δ 7.35 (s, 1H), 7.04 (br s, NH), 5.04 (d, J = 4.5 Hz, 2H), 
4.12 (s, 3H), 2.67 (s, 3H). 
HR-EIMS m/z measured 270.0794 (270.0795 calcd for C12H102H4N2OS2). 
EIMS m/z (relative abundance) 270 [M]+ (6), 239 (64), 222 (15), 191 (8), 164 (100), 149 
(15), 133 (43). 
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4.3.20 [3,3,3,4',5',6',7'-2H7]1-Methoxybrassinin (18c) 
 
N
OCH3
2H
2H
2H
2H
NH
SC2H3
S
 
 
 
Et3N (37 µL, 0.27 mmol) and CS2 (15 µL, 0.24 mmol) were added to a cooled 
solution (0 ºC) of freshly prepared amine 189a (44 mg, 0.24 mmol) in pyridine (118 µL). 
After being stirred for 60 min at 0 ºC, IC2H3 (16 µL, 0.24 mmol) was added and the 
reaction mixture was treated as reported above for [4',5',6',7'-2H3]1-methoxybrassinin 
(18b) to yield [3,3,3,4',5',6',7'-2H7]1-methoxybrassinin (18c, 52.7 mg, 68% yield from 
oxime 188a, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 25.3 min. 
1H NMR (500 MHz C2HCl3) δ 7.32 (br s, 1H), 7.04 (br s, NH), 5.02 (br s, 2H), 4.11 (s, 
3H). 
HR-EIMS m/z measured 273.0984 (273.0987 calcd for C12H72H7N2OS2). 
EIMS m/z (relative abundance) 273 [M]+ (7), 242 (100), 191 (12), 164 (85), 149 (19), 
133 (40).
 
4.3.21 1-Methoxybrassinin (18) 
 
N
OCH3
NH
SCH3
S
 
 
 
Et3N (37 µL, 0.27 mmol) and CS2 (14 µL, 0.24 mmol) were added to a solution of 
freshly prepared amine 189 (42.1 mg, 0.238 mmol) in pyridine (112 µL) cooled to 0 ºC. 
18c 
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After being stirred for 60 min at 0 ºC, ICH3 (15 µL, 0.238 mmol) was added and the 
reaction mixture was treated as reported above for [4',5',6',7'-2H3]1-methoxybrassinin 
(18b) to yield 1-methoxybrassinin (18, 44.6 mg, 57% yield from oxime 188, Pedras and 
Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 25.3 min. 
1H NMR (500 MHz C2HCl3) δ 7.62 (d, J = 8 Hz, 1H), 7.47 (d, J = 8 Hz, 1H), 7.35 (s, 
1H), 7.32 (dd, J = 8, 8 Hz, 1H), 7.19 (dd, J = 8, 8 Hz, 1H), 7.03 (br s, 1H), 5.04 (d, J = 4 
Hz, 2H), 4.12 (s, 3H), 2.67 (s, 3H). 
HR-EIMS m/z measured 266.0556 (266.0548 calcd for C12H14N2OS2). 
EIMS m/z (relative abundance) 266 [M]+ (5), 235 (89), 187 (14), 160 (100), 145 (29), 
129 (61).
 
4.3.22 1-Methylbrassinin (192) 
 
N
CH3
NH
SCH3
S
 
 
A solution of HONH2·HCl (87.6 mg, 1.26 mmol) and Na2CO3 (66.7 mg, 0.629) in 
H2O (826 µL) was added to a stirred solution of 1-methylindole-3-carboxaldehyde (175, 
100 mg, 0.629 mmol) in EtOH (3 mL). The resulting mixture was refluxed (80 – 83 °C) 
for 30 min. The solvent was evaporated and the residue was taken in H2O (20 mL), and 
was extracted with Et2O (20 mL × 3). The combined organic extract was dried over 
Na2SO4 and the reaction mixture was concentrated under reduces pressure to yield crude 
1-methylindole-3-carboxaldehyde oxime (190, 101.9 mg, 93 %). A solution of NaOH 
(18 mL, 1 M) was added to a solution of 190 (80 mg, 0.46 mmol) in CH3OH (4 mL) and 
the resulting mixture was cooled in an ice-bath. Devarda’s alloy (2.13 g) was added to 
the cooled mixture with stirring at r.t. After 90 min the reaction mixture was diluted with 
H2O (20 mL), and was filtered under vacuum. The reaction mixture was concentrated 
under reduced pressure, and the remaining aqueous mixture was extracted with Et2O 
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(120 mL × 3). The combined organic extract was dried over Na2SO4 and was 
concentrated under reduced pressure to yield crude 1-methylindolyl-3-methanamine 
(191, 64 mg, 90 %) which was used in the next step without purification. Et3N (61 µL, 
0.44 mmol) and CS2 (24 µL, 0.40 mmol) were added to a cooled solution (0 ºC) of the 
amine 191 (64 mg, 0.40 mmol) in pyridine (190 µL). After being stirred for 60 min at 0 
ºC, ICH3 (25 µL, 0.40 mmol) was added and the reaction mixture was treated as reported 
above for [4',5',6',7'-2H3]1-methoxybrassinin (18b) to yield 1-methylbrassinin (192, 60.2 
mg, 52% yield from oxime 190). 
 
HPLC-DAD Method A, tR = 24.4 min. 
1H NMR (500 MHz C2HCl3) δ 7.63 (d, J = 8 Hz, 1H), 7.36 (d, J = 8 Hz, 1H), 7.30 (dd, J 
= 8, 8 Hz, 1H), 7.18 (dd, J = 8, 8 Hz, 1H), 7.10 (s, 1H), 5.05 (d, J = 3.5 Hz, 2H), 3.80 (s, 
3H), 2.66 (s, 3H). 
HR-EIMS m/z measured 250.0603 (250.0598 calcd for C12H14N2S2). 
EIMS m/z (relative abundance) 250 [M]+ (25), 144 (100), 176 (11). 
4.3.23 1-(tert-Butoxycarbonyl)brassinin (181) 
 
N
NH
SCH3
S
O OH3C
H3C CH3
 
 
 
Et3N (62 µL, 0.45 mmol) and CS2 (24 µL, 0.41 mmol) were added to a cooled 
solution of freshly prepared amine 179 (100 mg, 0.407 mmol) in pyridine (600 µL) at 0 
ºC. After stirring for 60 min at 0 ºC, ICH3 (26 µL, 0.41 mmol) was added and the 
reaction mixture was kept at 5 ºC. After 90 min the reaction mixture was diluted with 
H2O (5 mL), was extracted with Et2O (20 mL × 3), the combined organic extract was 
dried over Na2SO4 and was concentrated. The crude product was purified by FCC 
181 
 175 
(hexane-EtOAc, 70:30, v/v) to yield 1-(tert-butoxycarbonyl)brassinin (181, 112 mg, 
72% yield from 1-(tert-butoxycarbonyl)indolyl-3-carboxaldehyde oxime, Kutschy et al., 
1997; 1998). 
 
HPLC-DAD Method A, tR = 34.1 min. 
1H NMR (500 MHz C2HCl3) δ 7.68 (d, J = 8 Hz, 1H), 7.56 (d, J = 8 Hz, 1H), 7.31 (dd, J 
= 8, 8 Hz, 1H), 7.25 (dd, J = 8, 8 Hz, 1H), 6.90 (s, 1H), 5.06 (d, J = 3.5 Hz, 2H), 2.66 (s, 
3H), 1.74 (s, 9H). 
HR-EIMS m/z measured 336.0967 (336.0966 calcd for C16H20N2O2S2). 
EIMS m/z (relative abundance) 336 [M]+ (5), 288 (10), 232 (22), 174 (22), 130 (64), 57 
(100). 
4.3.24 1-Acetylbrassinin (184) 
 
N
NH
SCH3
S
O
 
 
 
Et3N (49 µL, 0.35 mmol) and CS2 (21 µL, 0.35 mmol) were added to a solution of 
freshly prepared amine 182 (33 mg, 0.18 mmol) in CH2Cl2 (2 mL) at r.t. After stirring 
for 90 min, ICH3 (13 µL, 0.21 mmol) was added with stirring for further 20 min. The 
reaction mixture was concentrated, and the crude product was subjected to FCC 
(CH2Cl2) to yield 1-acetylbrassinin (184, 28.4 mg, 41% yield from 1-acetylindole-3-
carboxaldehyde oxime). 
 
HPLC-DAD Method A, tR = 22.2 min. 
1H NMR (500 MHz C2HCl3) δ 7.65 (d, J = 8 Hz, 1H), 7.53 (d, J = 8 Hz, 1H), 7.28 (dd, J 
= 8, 8 Hz, 1H), 7.22 (dd, J = 8, 8 Hz, 1H), 7.01 (s, 1H), 5.07 (d, J = 3.5 Hz, 2H), 2.66 (s, 
3H), 2.64 (s, 3H). 
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HR-EIMS m/z measured 278.0550 (278.0548 calcd for C13H14N2OS2). 
EIMS m/z (relative abundance) 278 [M]+ (9), 230 (16), 172 (29), 130 (100), 102 (7). 
4.3.25 [4',5',6',7'-2H4]Indolyl-3-acetonitrile (49a) 
 
N
H
2H
2H
2H
2H
CN
 
 
ICH3 (400 µL, 2.80 mmol) was added to Mg (turnings, 80 mg, 3.3 mmol) in dry 
Et2O (5 mL) with stirring under argon atmosphere. After the Mg was consumed, excess 
ICH3 was distilled off and fresh dry Et2O (4 mL) was added. A solution of [4,5,6,7-
2H4]indole (105a, 100 mg, 0.830 mmol) in dry Et2O (700 µL) was added drop wise and 
the mixture was allowed to stir for 15 min at r.t., followed by drop wise addition of 
bromoacetonitrile (160 µL, 2.70 mmol, Pedras et al., 2003a). After being stirred for 20 
min, the reaction mixture was concentrated under reduced pressure and the residue was 
taken in H2O (40 mL). The resulting mixture was neutralized with HCl (2 mL, 1 M) and 
was extracted with CH2Cl2 (30 mL × 3). The combined organic extract was dried over 
Na2SO4 and was concentrated to dryness under reduced pressure. Separation by FCC 
(hexane-CH2Cl2, 50:50 to 20:80) yielded [4',5',6',7'-2H4]indolyl-3-acetonitrile (49a, 75.7 
mg, 57% yield, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 12.9 min. 
1H NMR (500 MHz C2HCl3) δ 8.23 (br s, NH), 7.24 (s, 1H), 3.86 (s, 2H). 
HR-EIMS m/z measured 160.0940 (160.0939 calcd for C10H42H4N2). 
EIMS m/z (relative abundance) 160 [M]+ (62), 159 (100), 134 (32). 
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4.3.26 [4,5,6,7-2H4]Indole (105a) 
 
N
H
2H
2H
2H
2H
 
 
 
A solution of [2,3,4,5,6,-2H5]nitrobenzene (168a, 4.2 mL, 39 mmol) and 
chloroacetonitrile (250 µL, 3.94 mmol) in DMSO (3.9 mL) was added drop wise over 30 
min to a thoroughly stirred suspension of NaOH (1.60 g, 39.4 mmol) in DMSO (3.9 mL) 
at 20 ºC (Makosza and Winiarski, 1984). After 60 min, the reaction mixture was poured 
into ice-cold HCl (25 mL, 1 M), was diluted with H2O (10 mL), and was extracted with 
CHCl3 (50 mL × 3). The combined organic extract was washed with H2O (70 mL), was 
dried over Na2SO4 and was concentrated under reduced pressure. Separation by FCC 
(hexane-CH2Cl2, 100:0 to 25:75) yielded a mixture of [3,4,5,6,-2H4]2-
nitrophenylacetonitrile and [2,3,5,6,-2H4]4-nitrophenylacetonitrile (in a 10:1 ratio, 40% 
yield). Next, 10% Pd/C (220 mg) was added to the solution of [3,4,5,6,-2H4]2- and 
[2,3,5,6,-2H4]4-nitrophenylacetonitrile (200 mg) in freshly distilled EtOAc (20 mL) and 
the resulting reaction mixture was stirred under H2 atmosphere (balloon pressure) at r.t. 
After 40 h, the catalyst was filtered off, and the filtrate was concentrated under reduced 
pressure. The residue was taken in CH2Cl2 (15 mL), was washed with HCl (10 mL × 2, 1 
M), was dried over Na2SO4 and was concentrated under reduced pressure to yield 
[3,4,5,6,-2H4]indole (105a, 97.7 mg, 61% yield, Pedras and Okinyo, 2006a). 
 
HPLC-DAD Method A, tR = 15.1 min. 
1H NMR (500 MHz C2HCl3) δ 8.12 (br s, NH), 7.23 (br s, 1H), 6.61 (br s, 1H). 
HR-EIMS m/z measured 121.0827 (121.0830 calcd for C8H32H4N). 
EIMS m/z (relative abundance) 121 [M]+ (100), 94 (22), 71 (11), 69 (12), 57 (17). 
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4.3.27 [4',5',6',7'-2H4]Cyclobrassinin (28a) 
 
N
H
2H
2H
2H
2H
S
N
SCH3
 
 
 
Pyridinium bromide perbromide (41 mg, 0.13 mmol) was added to a stirred 
solution of [4',5',6',7'-2H4]brassinin (16a, 30 mg, 0.13 mmol) in dry THF (4 mL). After 
40 min, DBU (59 µL, 0.40 mmol) was added and reaction mixture was stirred for further 
60 min. The reaction mixture was concentrated under reduced pressure and was 
subjected to FCC (CH2Cl2-hexane, 80:20 to 100:0, v/v) to yield [4',5',6',7'-
2H4]cyclobrassinin (28a, 17.4 mg, 58% yield, Pedras et al., 1998). 
 
HPLC-DAD Method A, tR = 25.7 min. 
1H NMR (500 MHz C2HCl3) δ 7.92 (br s, 1H), 5.10 (s, 2H), 2.57 (s, 3H). 
HR-EIMS m/z measured 238.0537 (238.0536 calcd for C11H62H4N2S2). 
EIMS m/z (relative abundance) 238 [M]+ (11), 165 (100), 121 (60). 
4.3.28 Cyclobrassinin (28) 
 
N
H
S
N
SCH3
 
 
 
Pyridinium bromide perbromide (27.8 mg, 0.087 mmol) was added to a stirred 
solution of brassinin (16, 20 mg, 0.085 mmol) in dry THF (2.5 mL). After stirring for 40 
min, DBU (40 µL, 0.27 mmol) was added and the reaction mixture was treated as 
28a 
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reported above for [4',5',6',7'-2H4]cyclobrassinin (28a) to yield cyclobrassinin (28, 8.7 
mg, 44%, yield, Pedras et al., 1998). 
 
HPLC-DAD Method A, tR = 25.7 min. 
1H NMR (500 MHz C2HCl3) δ 7.92 (br s, 1H), 7.49 (d, J = 7.5 Hz, 1H), 7.33 (d, J = 8 
Hz, 1H), 7.14-7.20 (m, 2H), 5.10 (s, 2H), 2.57 (s, 3H). 
HR-EIMS m/z measured 234.0274 (234.0285 calcd for C11H10N2S2). 
EIMS m/z (relative abundance) 234 [M]+ (13), 161 (100), 117 (43). 
4.3.29 1-Methylcyclobrassinin (193) 
 
N
CH3
S
N
SCH3
 
 
 
NaH (5.1 mg, 0.13 mmol) and ICH3 (8 µL, 0.13 mmol) were added to a stirred 
solution of cyclobrassinin (28, 15 mg, 064 mmol) in dry THF (2 mL) at 0 ºC. After being 
stirred for 1 h at 0 ºC, the reaction mixture was treated with ice-cold H2O (10 mL), was 
extracted with CH2Cl2 (15 mL × 3), the combined organic extract was dried over Na2SO4 
and was concentrated. The residue obtained was subjected to FCC (CH2Cl2-hexane, 
60:40 and 100:0, v/v) to yield 1-methylcyclobrassinin (193, 13 mg, 82% yield, Kutschy 
et al., 1998). 
 
HPLC-DAD Method A, tR = 32.5 min. 
1H NMR (500 MHz C2HCl3) δ 7.50 (d, J = 8 Hz, 1H), 7.31 (d, J = 8 Hz, 1H), 7.21 (dd, J 
= 8 Hz, 1H), 7.14 (dd, J = 7.5, 7.5 Hz, 1H), 5.10 (s, 2H), 3.66 (s, 3H), 2.59 (s, 3H). 
HR-EIMS m/z measured 248.0440 (248.0442 calcd for C12H12N2S2). 
EIMS m/z (relative abundance) 248 [M]+ (14), 175 (100), 130 (15). 
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4.3.30 [4',5',6',7'-2H4]Sinalbin B (31a) 
 
N
OCH3
2H
2H
2H
2H
S
N
SCH3
 
 
 
N-Bromosuccinimide (13.2 mg, 0.074 mmol) was added to a solution of [4',5',6',7'-
2H4]1-methoxybrassinin (18b, 20 mg, 0.074 mmol) in dry CH2Cl2 (1 mL). After being 
stirred for 10 min at r.t., Et3N (21 µL, 0.15 mmol) was added and the reaction mixture 
was stirred for further 5 min (Pedras and Zaharia, 2000). Silica gel was immediately 
added to the reaction mixture which was concentrated to dryness at r.t. and was 
subjected to FCC (hexane-EtO2, 90:10, v/v) to yield [4',5',6',7'-2H4]sinalbin B (31a, 9.3 
mg, 47% yield). 
 
HPLC-DAD Method A, tR = 33.9 min. 
1H NMR (500 MHz C2H3CN) δ 5.10 (s, 2H), 4.02 (s, 3H), 2.61 (s, 3H). 
HR-EIMS m/z measured 268.0648 (268.0642 calcd for C12H82H4N2OS2). 
EIMS m/z (relative abundance) 268 [M]+ (19), 236 (46), 195 (68), 165 (100), 121 (58). 
4.3.31 [3,3,3-2H3]Sinalbin B (31b) 
 
N
OCH3
S
N
SC2H3
 
 
 
N-Bromosuccinimide (13.2 mg, 0.074 mmol) was added to a solution of [3,3,3-
2H3]1-methoxybrassinin (18a, 20 mg, 0.074 mmol) in dry CH2Cl2 (1 mL). After being 
stirred for 10 min at r.t., Et3N (21 µL, 0.15 mmol) was added and the reaction mixture 
31a 
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was stirred for further 5 min (Pedras and Zaharia, 2000). The reaction mixture was then 
treated as described above for [4',5',6',7'-2H4]sinalbin B (31a) to yield [3,3,3-2H3]sinalbin 
B (31b, 10 mg, 51 % yield). 
 
HPLC-DAD Method A, tR = 33.9 min. 
1H NMR (500 MHz C2H3CN) δ 7.53 (d, J = 8 Hz, 1H), 7.49 (d, J = 8 Hz, 1H), 7.27 (dd, 
J = 8, 8 Hz, 1H), 7.18 (dd, J = 8, 8 Hz, 1H), 5.11 (s, 2H), 4.03 (s, 3H). 
HR-EIMS m/z measured 267.0578 (267.0579 calcd for C12H92H3N2OS2). 
EIMS m/z (relative abundance) 267 [M]+ (21), 235 (33), 191 (69), 161 (100), 117 (54). 
4.3.32 Sinalbin B (31) 
 
N
OCH3
S
N
SCH3
 
 
 
N-Bromosuccinimide (13.3 mg, 075 mmol) was added to a solution of 1-
methoxybrassinin (18, 20 mg, 075 mmol) in dry CH2Cl2 (1 mL). After 10 min of stirring 
at r.t., Et3N (21 µL, 0.15 mmol) was added and the reaction mixture was stirred for 
further 5 min (Pedras and Zaharia, 2000), and was treated as reported above for 
[4',5',6',7'-2H4]sinalbin B (31a) to yield sinalbin B (31, 8.3 mg, 42% yield). 
 
HPLC-DAD Method A, tR = 33.9 min. 
1H NMR (500 MHz C2H3CN) δ 7.52 (d, J = 8 Hz, 1H), 7.48 (d, J = 8 Hz, 1H), 7.26 (dd, 
J = 8, 8 Hz, 1H), 7.18 (dd, J = 7.5, 7.5 Hz, 1H), 5.10 (s, 2H), 4.06 (s, 3H), 2.60 (s, 3H). 
HR-EIMS m/z measured 264.0387 (264.0391 calcd for C12H12N2OS2). 
EIMS m/z (relative abundance) 264 [M]+ (22), 232 (100), 191 (69), 161 (90), 117 (71). 
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4.3.33 [4',5',6',7'-2H4]1-Methoxyspirobrassinin (35a) 
 
N
OCH3
2H
2H
2H
2H
O
S
N SCH3
 
 
 
PCC (111.7 mg, 0.518 mmol) was added in one portion to a stirred solution of 
[4',5',6',7'-2H4]1-methoxybrassinin (18b, 20 mg, 0.074 mmol) in CH2Cl2 (1 mL). After 
being stirred for 60 min at r.t. (Pedras et al., 2006a), the reaction mixture was diluted 
with CH2Cl2, silica gel was added and the mixture was concentration to dryness, and was 
subjected to FCC (hexane-EtOAc, 80:20, v/v) to yield [4',5',6',7'-2H4]1-
methoxyspirobrassinin (35a, 8.6 mg, 41% yield). 
 
HPLC-DAD Method A, tR = 18.2 min. 
1H NMR (500 MHz C2H3CN) δ 4.60 (d, J = 15.5 Hz, 1H), 4.46 (d, J = 15.5 Hz, 1H), 
3.99 (s, 3H), 2.62 (s, 3H). 
HR-EIMS m/z measured 284.0588 (284.0591 calcd for C12H82H4N2O2S2). 
EIMS m/z (relative abundance) 284 [M]+ (78), 253 (11), 225 (28), 180 (46), 152 (100), 
120 (17). 
4.3.34 1-Methoxyspirobrassinin (35) 
 
N
OCH3
O
S
N SCH3
 
 
 
35a 
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PCC (113.2 mg, 0.525 mmol) was added in one portion to a stirred solution of 1-
methoxybrassinin (18, 20 mg, 0.075 mmol) in CH2Cl2 (1 mL). After being stirred for 60 
min at r.t., the reaction mixture was treated as reported above for [4',5',6',7'-2H4]1-
methoxyspirobrassinin (35a) to yield 1-methoxyspirobrassinin (35, 8.7 mg, 41% yield, 
Pedras et al., 2006a). 
 
HPLC-DAD Method A, tR = 18.2 min. 
1H NMR (500 MHz C2H3CN) δ 7.39-7.43 (m, 2H), 7.17 (d, J = 7.5 Hz, 1H), 7.06 (d, J = 
7.5 Hz, 1H), 4.60 (d, J = 15.5 Hz, 1H), 4.46 (d, J = 15.5 Hz, 1H), 3.99 (s, 3H), 2.62 (s, 
3H). 
HR-EIMS m/z measured 280.0343 (280.0340 calcd for C12H12N2O2S2). 
EIMS m/z (relative abundance) 280 [M]+ (73), 249 (11), 221 (28), 176 (45), 148 (100), 
116 (16). 
4.3.35 1-Methylspirobrassinin (194) 
 
N
CH3
S
N SCH3
O
 
 
 
NaH (4.8 mg, 0.12 mmol) and ICH3 (7.5 µL, 0.12 mmol) were added to a cooled 
solution (0 ºC) of spirobrassinin (34, 15 mg, 0.06 mmol) in dry THF (2 mL) under 
stirring. After stirring for 60 min at 0 ºC, ice-cold H2O (10 mL) was added. The resulting 
mixture was extracted with EtOAc (15 mL × 3), the combined organic extract was dried 
over Na2SO4 and was concentrated under reduced pressure. The crude extract was 
subjected to FCC (CH2Cl2-CH3OH, 99:1 and 98:2, v/v) to yield 1-methylspirobrassinin 
(194, 14.4 mg, 91% yield, Pedras and Hossain, 2006). 
 
HPLC-DAD Method A, tR = 16.9 min. 
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1H NMR (500 MHz C2HCl3) δ 7.38 (d, J = 7.5 Hz, 1H), 7.34 (dd, J = 8, 8 Hz, 1H), 7.12 
(dd, J = 7.5, 7.5 Hz, 1H), 6.85 (d, J = 8 Hz, 1H), 4.63 (d, J = 15 Hz, 1H), 4.53 (d, J = 15 
Hz, 1H), 3.25 (s, 3H), 2.67 (s, 3H). 
HR-EIMS m/z measured 264.0397 (264.0391 calcd for C12H12N2OS2). 
EIMS m/z (relative abundance) 264 [M]+ (71), 217 (67), 191 (100), 159 (35), 130 (38). 
4.3.36 1-Acetylspirobrassinin (195) 
 
N
O
S
N SCH3
O
 
 
 
Pyridine (500 µL) was added to a stirred solution of spirobrassinin (34, 5 mg) in 
Ac2O (500 µL). After being stirred for 60 min, the reaction mixture was diluted with 
toluene and was concentrated under reduced pressure to yield 1-acetylspirobrassinin 
(195, 4.8 mg, 80% yield). 
 
HPLC-DAD Method A, tR = 16.9 min. 
1H NMR (500 MHz C2HCl3) δ 7.39 (d, J = 7.5 Hz, 1H), 7.36 (dd, J = 8, 8 Hz, 1H), 7.14 
(dd, J = 7.5, 7.5 Hz, 1H), 6.88 (d, J = 8 Hz, 1H), 4.62 (d, J = 15 Hz, 1H), 4.48 (d, J = 15 
Hz, 1H), 2.66 (s, 3H), 2.64 (s, 3H). 
HR-EIMS m/z measured 292.0339 (292.0340 calcd for C13H12N2O2S2). 
EIMS m/z (relative abundance) 292 [M]+ (100), 250 (70), 203 (26), 177 (100), 145 (38), 
117 (34). 
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4.3.37 1-(tert-Butoxycarbonyl)spirobrassinin (196) 
 
N
O OH3C
H3C CH3
S
N SCH3
O
 
 
 
A solution of Boc2O (21 mg, 0.096 mmol) in THF (200 µL) was added to a stirred 
solution of spirobrassinin (DO-075, 20 mg, 0.08 mmol) in THF (600 µL). The reaction 
mixture was cooled to 5 ºC and DMAP (0.21 mg, 0.0017 mmol) was added. After being 
stirred for 40 min, the reaction mixture was concentrated under reduced pressure and 
was subjected to FCC (hexane-EtOAc, 50:50, v/v) to yield 1-(tert-
butoxycarbonyl)spirobrassinin (196, 31.4 mg, quant.). 
 
HPLC-DAD Method A, tR = 30.1 min. 
1H NMR (500 MHz C2HCl3) δ 7.40 (d, J = 7.5 Hz, 1H), 7.37 (dd, J = 8, 8 Hz, 1H), 7.16 
(dd, J = 7.5, 7.5 Hz, 1H), 6.80 (d, J = 8 Hz, 1H), 4.64 (d, J = 15 Hz, 1H), 4.55 (d, J = 15 
Hz, 1H), 2.65 (s, 3H), 1.75 (s, 9H). 
HR-EIMS m/z measured 350.0767 (350.0759 calcd for C16H18N2O3S2). 
EIMS m/z (relative abundance) 350 [M]+ (7), 250 (61), 203 (15), 177 (31), 149 (19), 116 
(11), 57 (100). 
4.3.38 [SC2H3]Brassicanal A (39b) 
 
N
H
CHO
SC2H3
 
 
 
196 
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NaHCO3 (504 mg, 6 mmol) and P4S10 (800 mg, 1.80 mmol) were added to a 
solution of oxindole (197, 400 mg, 3 mmol) in dry THF (8 mL). The reaction mixture 
was stirred at r.t. for 2.5 h and then filtered, the filtrate was concentrated to remove THF. 
Ice-cold H2O was added to the residue and the flask kept in an ice-bath. The precipitate 
that formed was filtered off to yield indoline-2-thione (198, 322.4 mg, 72%). NaH (373 
mg, 15.8 mmol) was added to a stirred solution of indoline-2-thione (200 mg, 1.34 
mmol) in HCOOEt (3.8 mL, 47.4 mmol). After 5 min, the reaction mixture was diluted 
with H2O (10 mL), was acidified with HCl (2.5 M), and the precipitate that formed was 
filtered off to yield 2-mercaptoindole-3-carboxaldehyde (113 mg). The remaining 
aqueous solution was extracted with EtOAc (100 mL × 3), the combined organic extract 
was dried over Na2SO4 and was concentrated to yield 2-mercaptoindole-3-
carboxaldehyde (135, 100 mg). The total yield of 2-mercaptoindole-3-carboxaldehyde 
obtained was 213 mg (90%, Pedras and Okanga, 1999). Et3N (35 µL, 0.25 mmol) and 
IC2H3 (32 µL, 0.51) were added to a solution of 2-mercaptoindole-3-carboxaldehyde (30 
mg, 0.17 mmol) in dry Et2O (2 mL). The reaction mixture was allowed to stir for 20 min 
and the precipitate that formed was filtered off and rinsed with Et2O (5 mL × 3). The 
filtrate was washed with H2O (10 mL), was dried over Na2SO4 and was concentrated. 
The crude reaction mixture was subjected to FCC (CH2Cl2-CH3OH, 98:2, v/v) to yield 
[SC2H3]brassicanal A (39b, 18.3 mg, 56% yield). 
 
HPLC-DAD Method A, = 11.3 min. 
1H NMR (500 MHz C2H3CN) δ 10.14 (s, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.45 (d, J = 8.5 
Hz, 1H), 7.22-7.24 (m, 2H). 
HR-EIMS m/z measured 194.0591 (194.0593 calcd for C10H62H3NOS). 
EIMS m/z (relative abundance) 194 [M]+ (100), 176 (25), 160 (63), 148 (22), 121 (11). 
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4.3.39 Brassicanal A (39) 
 
N
H
CHO
SCH3
 
 
 
Et3N (47 µL, 0.34 mmol) and ICH3 (42 µL, 0.68) were added to a solution of 2-
mercaptoindole-3-carboxaldehyde (40 mg, 0.27 mmol) in dry Et2O (2 mL). The reaction 
mixture was allowed to stir for 20 min and was treated as described above for 
[SC2H3]brassicanal A (39b) to yield brassicanal A (39, 24 mg, 56% yield, Pedras and 
Okanga, 1999). 
 
HPLC-DAD Method A, = 11.3 min. 
1H NMR (500 MHz C2H3CN) δ 10.14 (s, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.45 (d, J = 8.5 
Hz, 1H), 7.22-7.24 (m, 2H), 2.64 (s, 3H). 
HR-EIMS m/z measured 191.0409 (191.0405 calcd for C10H9NOS). 
EIMS m/z (relative abundance) 191 [M]+ (100), 176 (27), 158 (89), 148 (26), 130 (15). 
4.4 Administration of precursors to rutabaga and 
turnip 
4.4.1 Extraction of phytoalexins 
Rutabaga (B. napus L. ssp. rapifera) and turnip (B. rapa) roots tubers were cut 
horizontally in 10-15 mm thick discs and cylindrical holes (16 mm in diameter) were 
made on one surface of the discs with a cork-borer (Pedras et al., 2004). The discs were 
kept in tightly sealed plastic boxes and incubated at 20 °C in darkness. After 24 h, the 
discs were UV-irradiated on the surface with holes for 20 min, and were incubated for 
further 24 h. Precursors (5 × 10-4 M) dissolved in H2O-CH3OH-Tween 80 (95/5/0.05 
v/v) or H2O- CH3OH-Tween 80-DMSO (95/5/0.05/0.1 v/v for cyclobrassinin, 28) were 
39 
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pipetted into each hole (500 µL per hole) and the discs were further incubated at 20 °C 
in darkness. Following adsorption of precursor solution, the holes were filled with water. 
The aqueous solution in the holes was withdrawn with a pipette after appropriate 
incubation period (24, 48, 72 or 96 h) and was extracted with EtOAc (30 mL × 2). The 
combined organic extract was dried over Na2SO4 and solvent was removed under 
reduced pressure. The residue obtained was dissolved in CH3CN (400 µL) and was 
analyzed by HPLC-DAD. The residue was then subjected to preliminary clean up by 
micro-FCC in a Pasteur pipette column packed with silica gel to 35 mm, eluting with 20 
mL of CH2Cl2 and then 20 mL of CH2Cl2-EtOAc (40:60, v/v) to yield two fractions. The 
phytoalexin containing fractions obtained were analyzed by HPLC-DAD, HPLC-MS-
ESI, and HPLC-HRMS-ESI. Control experiments were similarly prepared by incubating 
rutabaga and turnip root tubers with non-labeled precursors or with carrier solution only. 
4.4.2 Extraction of glucosinolates 
Tissue around the holes was cut, was soaked in CH3OH, was ground (pestle and 
mortar) and was extracted with an aqueous CH3OH solution. Extraction was carried out 
overnight on a shaker at 170 rpm, after which the tissue was filtered off and the filtrate 
was concentrated under reduced pressure. The residue obtained was subjected to RP-
FCC (H2O-CH3CN, 100:0; 90:10, 80:20, v/v) to yield 3 fractions containing a mixture of 
indole glucosinolates. The fractions were dissolved in H2O-CH3OH (50:50) and were 
analyzed by HPLC-DAD, HPLC-MS-ESI, and HRMS-ESI. 
4.5 Administration of precursors to E. gallicum (dog 
mustard) 
4.5.1 Time course experiments 
In order to carry out feeding experiments with dog mustard, the maximum 
production period of erucalexin (38) and 1-methoxyspirobrassinin (35) was determined 
using detached leaves. Dog mustard plants were grown in growth chambers with a 16-h 
photoperiod (22ºC/18ºC) at ambient humidity. The 28-day old plants were sprayed with 
CuCl2 (2 × 10-3 M) solution in the growth chambers. After 24-h incubation, the leaves 
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were excised at the base of petiole and immediately immersed into distilled H2O (1 mL) 
in a vial. The petiolated leaves were sprayed with CuCl2 (2 × 10-3 M) solution followed 
by incubation at r.t. under continuous light. After 24-h incubation, leaves were frozen in 
liquid nitrogen, ground with a glass rod and were extracted in EtOAc (30 mL) overnight. 
The extract was filtered and was concentrated under reduced pressure. The residue 
obtained was subjected to preliminary clean up through a micro-FCC column employing 
a Pasteur pipette column packed with silica gel to 35 mm and eluting with 20 mL of 
CH2Cl2 and then 20 mL of CH2Cl2-EtOAc (25:75, v/v). The leaves were similarly 
extracted after 48-, 72-, 96- and 120-h incubation periods, each experiment was 
performed in duplicate. The fractions obtained were analyzed by HPLC-DAD and the 
amounts of erucalexin and 1-methoxyspirobrassinin present was determined from 
calibration curves prepared from pure erucalexin and 1-methoxyspirobrassinin. From 
these experiments, the maximum production of erucalexin was detected after 48-h 
incubation and this incubation period was adapted for feeding experiments. To prove 
that the observed metabolites were phytoalexins, similar experiments were carried out 
with leaves sprayed with water. HPLC-DAD analysis did not indicate the presence of 
erucalexin, 1-methoxyspirobrassinin or any elicited metabolites in these extracts. 
4.5.2 Administration of precursors 
Plants were grown and elicited as discussed for the time course analyses. The 
petiolated leaves from elicited 28-day-old plants were placed in vials containing 1 mL of 
precursor (5 × 10-4 M) dissolved in H2O-CH3OH-Tween 80 (95/5/0.05 v/v). Following 
uptake of precursor solution, the vials were filled with H2O and were incubated for 48 h 
under continuous light. The leaves were extracted as described for time course analyses, 
and the phytoalexin containing fractions were analyzed by HPLC-DAD, HPLC-MS-ESI 
and HPLC-HRMS-ESI. 
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Appendix 
A.1 Quantification of [4',5',6',7'-2H4]1-methoxyspiro-
bassinin (35a) using LC-MS-ESI and LC-HRMS-ESI 
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Figure A.1 1-Methoxyspirobrassinin (35) and [4',5',6',7'-2H4]1-methoxy-
spirobrassinin (35a). 
 
In this work, incorporation of isotopically (2H, 34S) labeled precursors into 
secondary metabolites (phytoalexins and indolyl glucosinolates) were established by LC-
MS-ESI [Ion Trap (IT)], LC-HRMS-ESI [quadrupole-time of flight (Q-ToF)], and 
HRMS-EI [double focusing magnetic sector (DFMS)] analyses. The reproducibility and 
accuracy of the LC-MS-ESI (IT) and LC-HRMS-ESI (Q-ToF) methods of anlyses were 
compared using standard mixtures (Tables A.1 and A.2) of 1-methoxyspirobrassinin 
(35) and [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a). The standard mixtures were 
prepared to allow comparison of incorporation levels between 1 and 50%. Additional 
analytical methods, 1H-NMR and HRMS-EI (DFMS), were used to analyze the standard 
mixtures and the results obtained were compared with those of LC-MS-ESI (IT) and LC-
HRMS-ESI (Q-ToF) analyses (Tables A.1 and A.2). 
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The percentage amounts of [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a) present 
in the mixtures (Tables A.1 and A.2) were determined by the methods: 
 
1) LC-MS-ESI, LC-HRMS-ESI, and HRMS-EI analyses 
 
(Eq.1) % of 35a = {[M + n]+/−/([M]+/− + [M + n]+/−)} × 100 (n = 4) 
n is the number of deuterium atoms, and M is the peak area or relative 
intensity of the molecular ion peak in the mixtures containing 35 and 35a. 
 
2) 1H NMR analyses 
 
(Eq.2) % of 35a = {([H-4a/b] – [H-7'])/[H-4a/b]} × 100 
[H-7'] is the integration of proton peak due to H-7', and [H-4] is the 
integration of the proton peak due to 2H-4a/b (δH 4.60 or 4.46) in the 
mixtures containing 35 and 35a. 
 
The proton peak due to H-7' (δH 7.06) is well separated and simple, this peak was 
integrated and calibtrated as 1, and was used as a standard to intergrate the peaks due to 
2H-4a/b (δH 4.60 and 4.46) (Figures A.1 and A.2). The integration values of proton 
peaks due to H-4a (δH 4.60) and H-4b (4.46) (Figure A.2) were therefore used to 
calculate the percentage amounts of [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a) in the 
mixtures according to equation Eq.2 and are summarized in Table A.1. 
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Figure A.2 1H NMR spectra of 1-methoxyspirobrassinin (35) and [4',5',6',7'-2H4]1-
methoxyspirobrassinin (35a). Spectrum 1 = 1-methoxyspirobrassinin; Spectrum 2 = 
mixture of 1-methoxyspirobrassinin (35) and [4',5',6',7'-2H4]1-methoxyspirobrassinin 
(35a). 
 
A.1.1  Deuterated component is 10 - 50% of the mixture 
(Standard mixtures A) 
Stock solutions of 1-methoxyspirobrassinin (35) and [4',5',6',7'-2H4]1-
methoxyspirobrassinin (35a) were prepared at concentrations of 1.76 × 10-3 M. From 
each stock solution of 35 and 35a, 500.0 µL were withdrawn, combined, and were 
evaporated to dryness. The resulting mixture (A-1) was taken in C2H3CN (500.0 µL) and 
was analyzed by 1H-NMR. From mixture A-1, 100.0 µL were withdrawn and analyzed 
by HPLC-MS-ESI (IT), HPLC-HRMS-ESI (Q-ToF), and HRMS-EI (DFMS) (Table 
H-4b 
1 
2 
H-7' 
 
H-4a 
 
H-4a 
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H-7' 
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A.1). To the remaining mixture A-1 was added 500.0 µL from stock solution of 1-
methoxyspirobrassinin (35). The resulting mixture, A-2, was evaporated to dryness and 
similarly analyzed as A-1 above. Following 1H-NMR analysis, 100.0 µL of A-2 were 
withdrawn and the remaining portion was treated as A-1 above to prepare mixtures A-3 
and A-4 respectively (Table A.1). Stock solutions of 1-methoxyspirobrassinin (35) and 
[4',5',6',7'-2H4]1-methoxyspirobrassinin (35a) were similarly analyzed by 1H-NMR, 
HPLC-MS-ESI, HPLC-HRMS-ESI, and HRMS-EI. 
 
Table A.1 Quantification of the amounts of [4',5',6',7'-2H4]1-methoxyspirobrassinin 
(35a) present in a mixture with 1-methoxyspirobrassinin (35) using LC-MS-ESI. 
LC-MS-ESIa,c,e 
(IT) 
Mixture 
Av (%) STD 
LC-HRMS-ESIa,d,e 
(Q-ToF) 
HRMS-EIa,d 
(DFMS) 
1H-NMRb,d 
A-1 50.0 0.57 50.0 50.0 50.0 
A-2 34.0 1.07 33.0 36.0 37.0 
A-3 18.0 0.84 17.0 21.0 25.0 
A-4 12.0 0.45 10.0 16.0 20.0 
aThe percentage amounts of [2H4]1-methoxyspirobrassinin (35a) in the mixtures A-1 to 
A-4 calculated according to equation Eq.1. 
bThe percentages amounts of [2H4]1-methoxyspirobrassinin (35a) in the mixtures A-1 to 
A-4 calculated according to equation Eq.2. 
c% of 35a calculated from average of three independent determinations ± standard 
deviation (STD). 
d% of 35a calculated from one determination. 
ePositive ion mode. 
 
As shown in Table A.1, LC-MS-ESI (IT) analyses were conducted in triplicate 
measurements. There were no significant differences in the percentage amounts 
calculated for LC-MS-ESI (IT) and LC-HRMS-ESI (Q-ToF) analyses (Table A.1). The 
percentages obtained from HRMS-EI (DFMS) analyses were slightly higher than those 
obtained from LC-MS-ESI and LC-HRMS-ESI, but showed similar trend (Table A.1). 
Although percentages from 1H-NMR analyses were slightly higher than those obtained 
by LC-MS-ESI, LC-HRMS-ESI, and HRMS-EI, these analyses have shown that either 
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or both LC-MS-ESI (IT) and LC-HRMS-ESI (Q-ToF) can be used to determine levels of 
incorporation in the study of biosynthetic pathway(s) of crucifer phytoalexins. 
A.1.2  Deuterated component is less than 10% of the mixture 
(Standard mixtures B) 
The accuracy of the of LC-MS-ESI (IT) method in the determination of secondary 
metabolites incorporating less than 10% of the precursor was established with standard 
mixtures of [4',5',6',7'-2H4]1-methoxyspirobrassinin (35a) and 1-methoxyspirobrassinin 
(35). Thus, stock solutions of 35a and 35 were prepared at concentrations of 2.85 × 10-4 
M. Stock solution of 1-methoxyspirobrassinin (90.0 µL) was added to that of [4',5',6',7'-
2H4]1-methoxyspirobrassinin (10.0 µL), followed by addition of CH3CN (400.0 µL) to 
the resulting solution to give mixture B-1. The prepared mixture B-1 was analyzed by 
LC-MS-ESI (IT) and HRMS-EI (DFMS) in triplicate measurements (Table A.2). The 
remaining mixtures, B-2 to B-5 were similarly prepared by mixing stock solutions of 1-
methoxyspirobrassinin (92.0, 94.0, 96.0 and 98.0 µL) with that of [4',5',6',7'-2H4]1-
methoxyspirobrassinin (8.0, 6.0, 4.0, and 2.0 µL), respectively, that were treated as B-1 
above, followed by LC-MS-ESI and HRMS-EI analyses. The percentage amounts of 
[4',5',6',7'-2H4]1-methoxyspirobrassinin in the mixtures were calculated (similar to 
standard mixtures A) and are summarized in Table A.2. 
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Table A.2 Quantification of the amounts of [4',5',6',7'-2H4]1-methoxyspirobrassinin 
(35a) present in a mixture with 1-methoxyspirobrassinin (35). 
LC-MS-ESIa,b,c (IT) HRMS-EIa,b (DFMS) Mixture 
Av. (%) STD Av. (%) STD 
B-1 8.0 0.4 11.0 0.1 
B-2 6.0 0.3 9.0 0.2 
B-3 5.0 0.3 7.0 0.0 
B-4 3.0 0.2 5.0 0.2 
B-5 2.0 0.1 2.0 0.1 
aThe percentage amounts of [2H4]1-methoxyspirobrassinin (35a) in the mixtures B-1 to 
B-5 calculated according to equation Eq.1. 
b% of 35a calculated from average of three independent determinations ± standard 
deviation (STD). 
cPositive ion mode. 
 
As shown in Table A.2, the percentage amounts of [4',5',6',7'-2H4]1-
methoxyspirobrassinin (35a) in the mixtures from LC-MS-ESI (IT) analyses were 
slightly lower than those obtained from HRMS-EI (DFMS) analyses. The percentage 
amounts of up to 2% of [4',5',6',7'-2H4]1-methoxyspirobrassinin in the mixtures were 
detected with good reproducibility. 
A.1.3  Conclusion 
These analyses (Tables A.1 and A.2) show that both LC-MS-ESI (IT) and LC-
HRMS-ESI (Q-ToF) methods can be used to accurately establish the incorporation of 
various precursors into different secondary metabolites even at low incorporations. The 
data obtained from these quantification studies suggest that the two methods, LC-MS-
ESI (IT) and LC-HRMS-ESI (Q-ToF), provide sufficient information for accurate 
determination of levels of incorporation. 
The HRMS-EI (DFMS) analysis is also accurate and reproducible (Tables A.2). 
Howeve, unlike LC-MS-ESI (IT) and LC-HRMS-ESI (Q-ToF) that analyzes mixtures of 
secondary metabolites, HRMS-EI requires sample separation. Secondary metabolites are 
normarly obtained in very small quantities, thus limiting the applicability of HRMS-EI 
in their analysis. 
